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The structural relationship of cholesterol and bile acids
was established on a chemical basis as early as the beginning
of the 20th Century by Windaus. (For a review see "Steroids"
by Fieser and Fieser.) but the first direct evidence that
cholesterol was a biological precursor of bile acids was
reported in 1943 (Bloch et.al J.Biol.Cliem. 149, 511). Since
then, many studies on the degradation of cholesterol to bile
acids have been made. These studies require postulated
synthesized intermediates for biological testing, therefore
the chemical synthesis of hypothetical intermediates is
important. The main pathway for the biogenesis of cholic acid
possibly involves initial hydroxylation of cholesterol at the
7o(-position, followed by oxidation of the 3/3-hydroxyl group
to give cholest-4-en-3-one-7<*-ol. The 12<*-hydroxyl group is
probably then inserted and the molecule then reduced to the
5/5-cholestan-3«<,7<>c,12cc-triol. This is followed by co-oxidation
of the side chain and then ^-oxidation and cleavage to cholic
acid. The subject has been reviewed in this work.
The aim of the present work was to produce a series of
cholesterol derivatives which may be intermediates in cholesterol
metabolism in living cells. In certain cases newer methods
for the synthesis of known sterols were evolved. Methods for
the improved separation of certain sterols had also to be
worked out, and modern methods for criteria of purity were
examined.
The 7<*-hydroxy derivatives of cholesterol, 12<*-, 24, 25 and
II
<J6-bydroxycholesterols - the triols, were prepared through
the respective 7«-hydroperoxides by means of photosensitized
14
oxygenations. Studies with the cholesterol-4-C revealed
that with either very dilute solutions or concentrated
solutions, the attack of molecular oxygen was not as highly
specific as often stated. The stereospecificity of the mode
of attack of molecular oxygen has been reviewed. The isolation
of cholest-4-en-3/J,6/5-diol in photosensitized oxygenation of
cholesterol is reported and its mode of formation discussed.
It is known that the l&x-hydroxylation reaction does not
occur after either the i!6-hydroxylation has been effected or
the side chain oxidised to a C^-acid. Certain novel
compounds such as cholest-5-en-3/3»7oc,24£-triol and cholest-5-
en-3/3,7oC,*!5-triol, are in the course of tritiation and the
in vitro studies will be of interest to ascertain whether they
are converted into cholic acid.
The substance 7^-hydroxycholesterol was prepared by the
NaBH^ reduction of 7-ketocholesterol. Separation of the 7oc-
and 7/3-epimers was achieved by chromatography of the diacetate
as well as the free diols on neutral alumina. For successful
separation of the free diols the amount of water in the alumina
was critical. No separation was possible when no water was
used, while the best separation was obtained with 1% water in
the support.
The sterol, 12«C-hydrocholesterol was prepared by a modified
method of Danielsson (196£k b)# - , e.:i . . ydl '
Ill
Deoxycholic acid was coupled with isovaleric acid, and
5/3-cholestan-3°(,12°(-diol thus obtained was oxidised to the
3-oxo compound by an Oppenauer method. The 4,5—double bond
was introduced using SeO^ in ethanol and cholest-4—en—3—one-
liio(.-ol obtained in good yields. The reported method of
Danielsson involved a 3-stage synthesis for the introduction
of a 4,5-double bond, and the yields were low. The reduction
of the enol-acetate of the oc,/3-unsaturated ketone with NaBH.
gave the desired product. The working up procedure was also
modified, and a new compound cholest-3,5-diene-12o<—ol was
isolated and identified as a side product.
Another new compound i.e. 5/$-cholestan-3<*,12<*—diol—24—one
was prepared by utilizing the known reaction of an acid
chloride and di-isopropyl-cadmium. This compound could be
used to prepare cholest-5-en-3/3,12°(,24£.*-triol using the
sequence of reaction described previously. Another interesting
biological compound, cholest-5-en-3/3,7oC,l2ix,24&-tetrol, can be
obtained from this triol on photo-oxygenation and reduction as
described in this work.
The 4/3, 22^, 24, 25, 26—hydroxycholesterols were prepared
by modifications of the reported methods and 26-hydrocholesterol
was prepared by two different routes. An impurity separated
from 25-keto-nor-cholesterol acetate was identified as
3/J-acetoxy-20-hydroxy-5—cholenic acid lactone.
Cholestun-3/3,5<X,6/3-triol, cholestan-3/3,5c(-diol-6-one,
5o£,6°(—epoxycholesterol, cholest-6-en-3/3,5oC-diol and cholestan-
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3/$,5oC-diol were prepared essentially by known methods*
Cholest-4-en-3-one-7oC-ol was prepared by a known sequence
but modification was made in the preparation of cholest—4,6-
diene-3-one by the use of chloranil in the dehydrogenation of
cholest-4-en-3-one.
A number of intermediates involved in the inversion of
the configuration at C_ and the saturation of the double bond
o
were synthesized* The starting materials for these compounds
were saturated coprostanes, which were prepared by
electrolytic coupling of the respective bile acids and
isovaleric acid.
however, there are still gaps in our knowledge of
complete sequence of the degradation of cholesterol to the
bile acids. A comprehensive understanding of the subject
will only be possible when all the relevent hypothetical
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The steroids form a group of structurally related
colourless, crystalline compounds which are widely distributed
in animals and plants. They all possess a phenanthrene ring
> system with an additional five membered ring attacned to the
1, a position, giving rise to a cyclopentanophenanthrene skeleton.
The unsaponiliable fraction of oils and fats contain
among other chemical compounds a class of crystalline
substances called sterols, which are C^ — C^ secondary
alcohols possessing the characteristic perhydro-1,2-cyclo-
pentanophenanthrene ring system. Cholesterol is the predominant
mammalian sterol. The present day formulation of its structure
is based on the classical researches of *ieland, windaus, Diels,
Rosenheim and king (review by Fieser and Fieser 1959). The
stereochwmiStry and nomenclature of steroids are reviewed by
klyne (1957) and .Shoppee (1964). ( iee figs. 1, and 2. )
Cholesterol has been found in all tissues and is the
principal constituent of gall stones deposited from bile.
The 3)$-hydroxyl group in cholesterol is alcoholic in nature
and in all tissues except adult nervous tissues it is
sometimes esterified with a variety of fatty acids. For
example, in liver, cholesterol is esterified with poly¬
unsaturated fatty acids such as linoieic, oleic, and to a
lesser degree with saturated acids like palmitic acid. The
esters of short chain fatty acids do not occur in any
d.
significant amounts.
The adrenal cortex, ovary and testis of most vertebrates
are rich in cholesterol esters, liver, kidney and lungs are
intermediate whereas bone, muscular tissue and cartilage are
low in sterol esters. In adult nervous tissue there is a
large amount of sterol, but it exists in the non esterified
oi* "free" form, except in the developing brain where
cholesterol is present in the esterified form. Chole berol
accounts for approximately 10/^ of the dry weight of brain in
contrast to less than 1$ found in most other organs (Davison
1965). Cholesterol is present in all parts of cells, bound
to lipo—protein in the form of a complex, which appears to be
an integral part Of cell membrane.
iiile Acids
llile acids are hydroxy derivatives of cholanic acid with
a cis-A/B ring junction. I'hey possess a carboxyl group
attached to C^ and the number and position of the hydroxy
groups vary in different bile acids. In general all the
natural bile acids possess one hydroxyl group at the Op¬
position. Other positions where hydroxyl groups may occur
are carbon atoms 6,7,Id and d3.
Modern vertebrates which are more advanced than amphibians
have C ,^-bile acids. These bile acids are produced in the
liver mainly by degradation of cholesterol and occur in bile
as water soluble sodium salts of peptide conjugates with glycine
or tuurine. These conjugates or bile salts promote the
3.
a-b sorption of futs and water insoluble substances in the
intestinal tract by acting us emulsifying agents and by
facilitation of certain enzymic hydrolyses and re-
esterifications.
Cholic acid (3°f,7<*,ld«<-trihydroxycholanic acid) and
chenodeoxycholic acid (3*, 7<<-dihydroxycholanic acid) are
regarded as 'primary' bile acids in mammals. Deoxycholic
acid (3«,ld°C—dihydroxycholanic acid) and lithocholic acid
(3<-hydroxycholanic acid) have been shown to be formed from
cholic acid and chenodeoxycholic acid respectively by the
action of the intestinal bacteria. These bile acids return
to the liver during the entero-hepatic circulation, where
further 7<-hydroxylation occurs in some species (Norman and
Sjoval 1958) or 16«-hydroxylation as in Boidae (Haslewood
1967) may occur in the case of deoxycholic acid. In the
case of 11 thocholic acid such hydroxylations may take place
at positions 6 or 7 or both giving rise to hyocholic acids
or<x und)^ uuricholic acids. Evidence for a pathway suggesting
the formation of iithocholic acid as a primary bile acid has
been recently advanced by Aiitropoulos and Myant (1967).
Although most of the bile acids present in the gut are
reabsorbed into the blood and transported to the liver during
the entero-hepatic circulation a small quantity is excreted
in the faeces with the result that new bile acids are
constantly being synthesised to compensate for daily losses.
Pathways of biologicul degradation of cholesterol leading
Fig. 3.
Pathways representing the known biological degradation of
eholesterol to different bile acids.
A» Cholesterol; £» Cholest-5-en-3/3.7<jt-diol; £, Cholest-4-en-3-one
-7«-ol; 4# Cholest-4-en-5-one-7^tl2«--diol; £, 5/3-cholestan-3-
ono-7^112oc~diol; 6» 5/3-choleatan-3°(,7*tl2«--triol; £, 5/^-
chole3tan~3<x,7<*»12<*» 26-tetrol; 3<*»7<*» 12<x-trihydroxy-5/5-
cholestanoio acid; Cholio acid; 10, 5A-cbolestan~3°cf7^-diol
11. Cholest-5-en-3/^»7oC»12c<f-triol; 12» Cholest-5~en-3/3»26--diols
13» Cholest-5-en-3/3»7<*.»26-triol; 1^. Chenodeoxycholic acid;
15. oc-muricholic acid; 16, /3-muricholio acid) 1J» 3/3-bydroxy
cholest-5-enoic acid) 18, 3/S-hydroxychol-5-enoic acid)
19. Lithocholic acid; 20, 3**6/3-dihydroxy-5/3~cholanoic acid.
4.
to the formation of bile acids and steroid hormones have been
suggested. The catabolism of cholesterol to these compounds
is physiologically important. The intermediates involved in
the stepwise degradation of cholesterol have not been fully
elucidated, but they seem to involve certain stages in which
there is the interaction of molecular oxygen with cholesterol
forming various hydroxylated and oxygenated derivatives.
UEGBADATION TO BILL ACIDS.
Bloch, Berg and iiittenberg (1943) and then Fukushima and
Gallagher (195B) demonstrated that cholesterol is the precursor
of bile acids when they administered by intravenous infusion
deutero—cholesterol to a dog whose bile duct was connected to
the kidney and obtained labelled cholic acid from the urine.
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Similar experiments using cholesterol-4-C on rabbits
(hkdahl and Sjovall 1955) and rats (Bergstrom and Norman
1953) demonstrated the conversion of cholesterol to
physiological bile acids.
Theoretically, therefore, four structural changes in
the cholesterol molecule must take place in order that
cholesterol is converted to bile acids. These changes can
be summarised as under:
(a) Epimerisation of 3/3-hydroxy group to 3°c-hydroxy group.
(b) Saturation of the 5,6 double bond to give rise to 5fi
or cis-series (coprostane type) of compounds.
(c) Hydroxylation at 7<* or 12°c positions or both.
(d) Oxidation of the side chain to give a terminal C
carboxylic acid.
5.
.Since the exact sequence of changes in structure leading
to the biosynthesis of bile acids from cholesterol are not
known, therefore by permutation and combination the number
of possible intermediates is very great. One of the recent
experimental approaches involved in solving the mechanism of
degradation of cholesterol to bile acids, is to study the
metabolism of different hypothetical intermediates both
in vivo and in vitro.
I. CAIAUULISM 01' CliULLSTLUOL TO blLL ACIDS.
A. NUCLLAU CHANGES
According to the recent view as to how cholesterol is
/the
degraded to cholic acid in vivo, saturation of/5,6-double
/the
bond, epimerization of/3p-hydroxyl group and hydroxylation
at positions 7<* and 12 take place before oxidation and
cleavage of the side chain occurs. i'he main evidence for
this concept is based on the fact that experiments with
labelled cholest-5-en-3J3,7«c-diol (Uergstrom and Lindstedt 1956)
and labelled 5/V-cholestan-3rf,7<<,12oC-triol (hergstrom, faabo
and Humpf 1954) using the bile-fistula technique resulted in
the conversion of these compounds to cholic acid, whereas
cholest -5-en-3^,26-diol (iianielsson 1961) or 3^-hydroxychol-5
-enoic acid (fiergstrom 1955) were not converted to cholic acid.
3p-Hydroxy-chol-5-enic acid was however found to be
hydroxylated at position 7 (Usui and Yamasaki I960) but the
configuration of the newly introduced group was not
ascertained. Later on it was found that both 7oC and 7/S-hydro-
6.
xylases, of 3jJ-hydroxychol-5-enic acid (Yamasaki et.al.1906)
are present in liver microsomes. Therefore it is reasonable
to assume that whereas in the formation of cheuodeoxycholic
acid, 7of—hydroxyiation could be effected, 1 d°c-hydroxylation
f01/biosynthesis of cholic acid does not proceed after
modification of the side chain (Danielsson 1963; Mitropolous
and hyant 1967).
(i) BVIUi^Ch FPU 7pC.-HYDH0£YLATI0N.
In order to ascertain whether epimerisation of the
3^-hydroxyl group and saturation of 5,6—double bond precede
the introduction of^^fe-hydroxy or 12°C-hydroxy or both in the
steroid nucleus, the following hypothetical intermediates in
the degradation of cholesterol to bile acids were tried in
bile-fistula rats by llarold, Jayko and Chaikoff (1955);
Harold, Chapman and Chaikoff (1957) and Bergstrom (1955).
(a) Cholest-5—en-3-one, (b) Cholest—5—en-3otol, (c) Cholest-4
-en-3-one, (d) 5yi-cholestune—3/5-ol, (e) S/i-cholestane-S^-ol.
Of these mono-oxygenated C^-steroida none but
cholesterol gave rise to cholic acid, indicating that
epimerisation and saturation of the double bond must occur
after "^-hydroxylation at C^ or C^ or both. This conclusion
obtained support from the later investigations of Bergstrom
and Lindstedt (1956) and then Lindstedt (1957) who studied the
labelled products excreted in the bile of cannulated rats,
after administration of isotopically labelled cholest-5-en-3/3,
7<<-diol and 5^-cholestan-3cf, 7<<-diol. Both these sterols were
a/y\*cL cJx^oCuc. auc^cL
converted to chenodeoxycholic ucid^ cholest-5-en-3p, 7/X"-diol
being a better intermediate in the formation of cholic acid.
On the basis of these experiments dergstrom and nindstedt
concluded that the introduction of an o( —hydroxyi group at
position 7 is an early step in the formation of both cholic
acid and chenodeoxycholic acid, and cholest-5-en-3/5,7<<-diol
probably being an early intermediate (also Mendelsohn and
Staple 1963).
This suggestion seems to be in accordance with the
chemical aspect because the 7 position is very active due
to the double bond at the 5—6 (allylic) position as shown
by the ease of oxidation at that position.
The stereo-cheinical mode of 7°C-hydroxylution was
investigated by bergstrom, Lindstedt, Sumuelson, Corey and
Gregoriou (1958). These workers studied the conversion of
cholesterol stereospecifically labelled with tritium in thfe 7<<
and 7[S positions, and found that the 7-hydroxyl group
specifically replaced the 7<<-hydrogen with essentially
complete retention of configuration leaving the 7|3-hydrogen
intuct. Thus the possibility of hydroxylation -position
by hydration of an olefinic intermediate or a 7—keto
intermediate is completely eliminated.
The actual identification of 7<*-hyuroxychole3terol as a
biological intermediate was shown in 1964 when banielsson and
Einarsson isolated enzymically formed labelled 7ac—hydroxyclioles
erol from labelled cholesterol in their studies on rat liver
8.
homogenates. They also reported that the 7<<-hydroxylase was
microsomal. Mendelsohn, Mendelsohn and Staple (1965) also
confirmed the enzymic formation of both 7<- and 7yi-hydroxy-
cholesterols in their in vitro experiments.
Hat liver is capable of 7H-hydroxylation of taurodeoxy-
cholic acid, but this enzyme is different from the other
7ot-hydroxylase which requires cholesterol as substrate.
OsruA 'ryvasru
heoxycholic acid in this animal as well as in the rabbit/is
known to be formed from cholic acid by the action of intestinal
bacteria and enters the liver via the entero-hepatic
circulation. Therefore such formation of cholic acid from
deoxycholic acid cannot be regarded on the line of formation
of primary bile acids in the rat.
11 • MVIhlM.Ch FPU lHoc-HYDHOXYLATION.
The order in which hydroxyiations at 7 and 12 positions
take place during the formation of cholic acid appears to be
established by the fact that cholest-5-en—3^,7<<-diol is
converted in good yield to cholic acid in the bile fistula
rat, cholest—5-en—3^t12<*—diol on the contrary is converted
less efficiently to cholic acid in the bile fistula raouit
b
(Danielsson 1962; see also Danielsson 1961^).
Also in their in vitro studies of conversion of
cholesterol to 5/3-cholegtan-3rf, 7H-diol and 5/$-cholestan-3«<,
a,
12<—diol, Mendelsohn, Mendelsohn and .Staple (1965^) detected
no significant activity in 5^-cholestan-3«*,l2«<-diol used as
a trapping agent after the incubation was performed. Such
9.
treatment of the incubation mixture with 5JV-cholestan-3<<,7<*-diol
affords a distinctly active preparation. This suggests that
7c<-hydroxylation of the steroid nucleus is a prerequisite for
124—hydroxylase activity. Further cholest—5-en-3/*,25-diol
(Frederickson and Ono 1956) cholest-5-en—3 ,26-diol
c
(Danielsson 1962) cholest-5-en-3/3,7°c,26-triol (Danielsson 1961/)
5/3-cholestan-3<<, 7^,26-triol, (herseus and Danielsson 1963)
5/3-cholestan-34,7<x-diol-26-oic acid (Bridgewater and Lindstedt
1963) 3<*,7<<-dihydroxycholanic acid (Lindstedt and Sjovall 1957)
in all of these compounds where the side chain is modified,
they have been reported to give rise to mainly chenodeoxycholic
acid, and the formation of cholic acid is very insignificant.
On the other hand 3«,7<<,12°(-trihydroxycoprostanic acid is
converted very efficiently to cholic acid both in the bile
fistula rat and in liver homogenalea (hergstrom, Bridgewater
and Oioor 1957). These observations clearly demonstrate
that in the formation of cholic acid the introduction of the
12<-hydroxy group uoes not take place after any change which
entails modification of" elimination of the terminal isopropyl
group in the side chain; however 6f$ hydroxylation may take
place instead. ( See figure 3 also. )
LVIDLNCh FOB INVARSIOft OF CONFIGURATION AT 3 and 5 POSITIONS.
Yomasaki, koda, and Shimizu (1959) incubated cholest-5-en
-3/3,74-diol with a cell-free preparation from rat liver and on
the basis of an increase in optical density at 240 proposed
that cholest-5-en-3/l,7«C-diol was oxidised to cholest-4-en-3-one-
7«c-ol, as an intermediate during conversion of 7*-hydroxy-
10.
choleaterol to 5p-cholestan-3<*., 7<*-diol. This suggestion
implies the epimerisation of the 3£-hydroxy to 3<<-hydroxy
through the intermediate formation of a ketone*
Indeed when liosenfeld and llellman 11961) administered
34—tritio-cholesterol to a patient with a bile fistula no
radioactivity was found in the chenodeoxycholic acid and
cholic acid obtained from the bile* Similar experiments
by Samuelsson (1963) led him to believe that inversion of the
3^-hydroxy proceeds via a 3-ketone as tritium in the 3<*-positi
of cholesterol was lost during formation of cholic acid in
rat liver* The same author in 1959 demonstrated that the
saturation of/o^S double bond tukes place after its
isomerization to/^B-position in a stereospecific manner by
cis- addition from the fi-side of the molecule as in the
metabolism of certain steroid hormones. Green and
Jamuelsson (1964) on the conversion of 3°c- H—cholesterol and
3
4/i- ii—cholesterol to bile acids in bile fistula rat also
indicated that the transformation of the 5-ene—3yS-ol
configuration into 5/i-3*-ol involved a 3—keto steroid with
the 5,6 double bond isomerised to the allylic 4,5 position
before reduction. A similar mechanism for the epimerisation
of carditonic steroids at position 3 in rat liver has been
proposed by Hapke and 3amuelsson (1964). Very recently it
has been shown that the biogenis of 54-bile alcohols may also
involve the formation of an oc unsaturated ketone for example
the formation of 5<*—Cyprinol (hoshita 1967).
11.
c
iJunielsson ^1961^) studied the metabolism of cholest-
5-en-3jJ, 7«c-diol in mouse liver homogenates and identified
cholest-4-en-3—one-7°c-ol as one of the two main metabolites,
the other one being assigned the structure of choiest—4—en-3-
one-7«,db-uioi on the basis of its mobility on thin layer
chromatographic plates, the characteristic absorption of
<<,JS-unsaturated ketone, and also that it was converted to
chenodeoxycholic acid when injected into a bile fistula rat.
Cholest—5—en—3|3,7°c,h6—triol was also identified as a minor
metabolite.
ilutton and hoyd (19bu) in their in vitro experiments
also obtained similar results. They found that the liver
microsomal fraction was four times as efficient as the
mitochondrial fraction in converting 7°f-hydroxy cholesterol
to cholest-4-en—3-one—7«t—ol. They also suggested that
eholest-4—en-3-one-7cC,^b-diol must have been formed from
cholest—b-en-3/i, 7°c,2b—triol in mitochondria.
tvhen tritium labelled cholest-4—en-3-one-7°t-r-ol was
4-
injected into a dile fistula rat, hanielsson (19t>lj) found
that the radioactivity was excreted in bile as bile acids
and was distributed mainly in chenodeoxycholic acid and
cholic acid. Several unidentified acids were also formed.
co the
button and hoyd (19tib^) studieu^metaboiism of cholest-4-en
-3-one-7<<-ol with different cell fractions of liver and found
that in mitochondria this compound was converted to
choiest—4—en-3—one—7°c-ab-diol and in microsomes alone it
remained unchanged. They also reported that with the cell
supernatant fraction choiest-4—en-3-one—7°c-ol was reduced
to cholest—4-en-3oc, 7<*-diol and 5/3-cholestan-3°c, 7<*-diol •
Similarly 5/t-cholestan-3-one-7<*-ol was converted readily to
5p- cholestan-3oc, 7oC-diol whereas cholest-4-en-3°<, 7<=c-diol was
not readily converted to 5/t-eholestan-3°t, 7o^-diol. Thus they
proposed two possible routes for the formation of 5^-oholestan
-3<£, 7<<-dioi from cholest-4-en-3—one-7oC-ol depending upon
whether the 4,5 double bond or the 3 ketone is reduced first.
There seem to be two schools of thought regarding the
order in which 3-ketone and 4,5 double bond is reduced so
that finally a 5[S-3<<-ol grouping is obtained. Danielsson
e
(1961^) reported the conversion of 5^-cholestan-3-one—7o(—ol
to cholic and chenodeoxycholic acids, when administered
intraperitoneally to a bile fistula rat and he favoured first
reduction of the double bond leaving the 3—keto intact.
ct
button and doyd. ^196^) studied the comparative ease of
reduction of 5/S-cholestan—3—one—7«c-ol and cholest-4—en-3°£,7<=c
-diol and found that in vitro the former was readily and
completely converted to 5|3—cholestan-S1*, 7oC—diol whereas the
latter compound was only partially reduced to 5/3-cholestan—3°c,
7<<—diol. because ofi—cliolestan—3—one—7°c-ol was converted
very readily to 5^-cholestunt-3°c,7o<-uiol (dihydroxycoprostane)
it did not accumulate and therefore could not be detected.
They favoured both routes in which case 5^-cholestan-3-one~7oC-ol
qs well as cliolest-4-eii-3oc,7<<-uiol would be intermediates.
13.
Mendelsohn Mendelsohn and Staple (i960) on the basis of
in vitro experiments where they detected virtually no radio¬
activity in the area of coprostan-3-one-7oC-ol in their assay
on thin layer chromatography, maintained that in such
experiments coprostan-3-one-7«c-ol was not an ii. temediate.
They also claimed that the 3—keto group would not reduce to
the corresponding alcohol in the saturated keto steroid,
and further proposed that reduction of the 3-keto group
could take place just prior to or simultaneously with the
reduction of the 4,5 double bond. In the first case
cholest—4-en—3*,7<C-diol would be an intermediate*
PUhTiLtmt nVIJJhNCh FPU ldcC-llYIhlOXyLAII; : .
.Theoretically there can be several possibilities of
ld"<-hydroxylation. hither it can take place just after
7«-hydroxylation i.e. formation of 7°C-hydroxycholesterol in
which case cholest-5-en-3p,7«, 12oC-iriol will be an intermediate,
(iierseus, banielsson, hinarsson (1967) or after the oxidation
of the 3^-hydroxyl group to a ketone with simultaneous
allylic shift of the double bond to the 4,5 position when
cholest—4—en-3—one—7°t,ld«c-diol would be an intermediate
Cbanielsson and hinarsson 1966), and cholest—4—en-3-one-7«C-ol
would be the substrate for the 12°t—hydroxylase. If
12«c-hydroxylation takes place after complete reduction of the
4eue-3one grouping to the 3<<-ol—5^ grouping, in that case
5^-cholestun—3<<, 7<*, ldo(-triol can be an intermediate and the
substrate for 12«t-hydroxyla3e would be 5/1-cuoles tan-3°<, 7°c-diol
14.
(Lendelsohn, Mendelsohn and Jtaple 1966). Should
ldoc-hyaroxylation take place after partial reduction of the
°c,fl unsaturated ketone the substrate for ldec-hydroxylase
would be cholest—1—en—3<*, 7<=c—diol, choiest—i—en—3^, 7oc-diol
or 5J3-choiestan-3—one-7<x-ol, depending whether the 3-ketone
is reduced while the 4,5 double bond was intact or vice versa
and ,-ence cholest-4-en-3<*, 7<>c, ld°c-triol, cholest—4-en-3^, 7<=c,
ljeC—trio! and 5|5-cholestan—3—one—7°c,12oc-diol would probably
be intermediates in the formation of cholic acid. In
in vivo experiments choiest-4-en-3/i,7oC,ld°c-triol and
cholest—4-en-3°c, 7<<,Ida-—triol have been converted to cholic
acid (lijorkhein and Danielsson 1965).
Both/ife-hydroxylase and t^e enzyme systems for
dehydro^enation and isomerization of the 5-ene,3|3-ol grouping
to the corresponding oc,^-unsaturated ketone are located in
the endoplasmic reticulum of liver cells, while the reducing
enzymes are present in the cytoplasm or cell sap. It would
seem more logical to assume that a molecule such as
cholest-4-en-3-one—7<-ol would be ld°c~hydroxylated while in
the endoplasmic reticulum before moving to the cell sap to be
reduced to 5^-cholestan-3oC,7<*,ld<*-triol rather than shuttling
between events in the endoplasmic reticulum and events in the
cell sap.
Cholest-5—en-3/i, 7°(—diol, cholest—4-en-3-one-7«:—ol,
cholest—1—en-3°c,7°c—diol and 5/S—cholestan-3—one-7<*—ol are all
reported to be converted into cnolic acid and chenodeoxycholic
15.
ucid in good yield therefore in vivo experiments on bile
fistula animals do not provide sufficient information as
to the identity of the physiological substrate for the
1 ^-hydroxylase system. This lack of selectivity by the
1^-hydroxylase may be attributed to the abnormal nature
of such animals whose entero-hepatic circulation has been
broken by bile duct cannulation, which causes enhanced liver
hydroxylase activity when compared with the intact (normal)
animals.
whether lh<£—hydroxylati on occurs immediately after the
formation of 7cc-hydroxycholesterol or after the initiation
of the set of reactions involved in the formation of
cholest—4—en-3-one—7°<-ol nevertheless cholest-4-en-3-one—7°c,12°c
-diol would be an intermediate in the formation of cholic acid.
In fact choIest-4-en-3—one-7°c,ld«c-diol has been identified as
one of tne major metabolites formed from cholesterol,
cholest-5—en-3/l-7«<-diol and cholest—4-en-3-one—7<-ol
(ilanielsson and hinarsson 1966).
Hum * i-|.
16.
B^EVIUENCh FOR THE STEPS IK SIDE-CHAIN OXIDATION.
Metabolic degradation of the side chain may occur
either (a) by direct cleavage of carbon-carbon bond between
Ca4 and of the sterol molecule giving a and a Cg unit
or (b) by gradual oxidation of the three terminal carbon
atoms or (c) byo*-oxidation followed by /J-oxidation*
The sequence of events in side chain cleavage is still
open to speculations and the literature on this,points to
at least three possible pathways. However, all the evidence
points to the involvement of tetrols or pentols or both in
the formation of cholic acid (Danielsson 1963). It is
difficult to assess which of the three mechanisms in the
main pathway for formation of the C^-bile acids, but the
recent studies favours-oxidation followed by ^-oxidation.
If in the biogenesis of bile acids from cholesterol
the side chain is cleaved between bond, 3 hypothetical
schemes (fig. 4.) can be drawn, and 24 or 25-hydroxyj 24,25-
dihydroxy; 24-dehydro and 25-hydroxy-24—keto-derivatives
could be possible intermediates. The cleavage of the last
9" I?
type i.e. substances with a -C-C— grouping is a reaction
well established in steroid biochemistry as examplified by
the degradation of C^ to steroid hormones.
In the formation of 24,25 dihydroxy derivative it is
probable that 25-hydroxylation could be the primary step
followed by 24-hydroxylation since tertiary carbon atoms
are known to be more reactive than secondary or primary
Hx/H
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carbon atoms towards oxidation. Also by analogy with the
mechanism of cleavage of the cholesterol side chain in
adrenal mitochondria yielding pregnenolone, where
20%-hydroxycholesterol and 20«,22(-dihyuroxycholesterol are
regarded as possible intermediates. The reported formation
of acetone by the cleavage of the bond suggests that
there may be more than one pathway (Whitehouse et.al I960
and 1961). In the oxidation of the side chain the initial
hydroxylation could occur at or C^ followed by further
oxidation to a carbonyl derivative. Either this compound
would decarboxylate giving rise to a C^-steroid and this
could ultimately provide the desired C ,^-bile acid.
Alternatively byld-oxidation of the side chain which involves
26 or 27-hydroxylation as an intermediate step the molecule
may undergo jV-oxidation to a C^-bile acid as represented
in fig.5 . This mechanism appears to be established by
the work of Danielsson (i960); Suld et.al (1962); Aiasui
et.al (1966); Okuda and Hanielsson (1965); and Mitropoulos
and Myant (1956).
As early as 1953 Anfiasen and Horning described a
mitochondrial system capable of oxidizing labelled cholesterol
to CO cicaon* aiicffjno (1956) using the same
A
mitochondrial system identified 25-hydroxy and 26-hydroxy-
cholesterol in the non-volatile products in addition to
acidic products of unknown nature.
There is now evidence that the first step in the
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degradation of the side chain is the hydroxylation at
position 26. Various 26-hydroxylated steroids have been
isolated in in vivo and in vitro stuaies the most important
being 26—hydroxycholesterol (Danielsson 1961a..; see also
Von Lier and Smith 1967) 5Jl-cholestan-3«,7oc,12oc,26-tetrol
(Danielsson I960) cholest—5-en-3/S,7«<—26-triol (Danielsson
<X, C. JoC-
196]^) and cholest-4-en-3-one-^26-diol (Danielsson 1961c >
OL
button and Doyd 1966^). It looks as if in higher vertebrates
the 26-hydroxylation is stereospecific for example in the
mouse (Derseus 1965) alligator and human where the 25<<-isomer
of 3«C|7of,12«c-trihydroxy-5j5-cholestanoic acid is found (Carey
and Haslewood 1963). On the other hand both 25<* and 25/3
isomers of 3ec,7«c, 12<*-trihydroxy-5j3-cholestanoic acid have
been isolated from frog bile (Kurauti and Kazuno 1939;
Mabuti 1941).
iiie further metabolism of 26-hydroxy derivative entails
oxidation to/o^-cholestanoic acid derivative thus effecting
completion of the a-oxidation. The substance 3<*, 7oc, 12oc-
trihydroxy—5j3-cholestanoic acid has been isolated from mouse
and rat liver homogenates, (Derseus, Danielsson and Kaiiner
1965) and from other vertebrates including human (Staple and
liabinowitz 1962). This C ,^-acid has been reported to be
converted to cholic acid both in vivo and in vitro (briggs,
fthitehouse and Staple 1961).
After completion of the ^-oxidation, there occurs
p> -oxidation and cholic and propionic acids are formed (Suld,
19'
Staple and Gurin 1962).
The contention that the side chain hydroxylations
resulting in the formation of tetrols or pentols in the
biogenesis of C^-bile acids especially cholic acid is
supported by the work of Japanese workers on the less
evolved vertebrates where the ultimate change from cholesterol
is to C^7-bile alcohols. These bile alcohols have essentially
the same nuclear part as found in cholic acid, but differ in
retaining an intact side chain. The formation of bile
alcohols may represent an "older type" of cholesterol
metabolism which lacked certain more complicated or evolved
enzymes as are present in higher vertebrates capable of
utilizing these intermediate (bile alcohols) for further
degradation to C^-bile acids. The importance of these
bile alcohols in the evolutionary tree, such as chimaeral
(3°<,7oc,12oc,24$,20—pentahydroxycoprostane) ; 3°c,7°c, 12oC,26-
c
te trahydroxycopros tane, 3°c, 7<*, 12°c, 25,26—pentahydroxyi^Dprostane
(Enomoto 1962) and 5^-ranol (Betsuki 1966) and their acid
derivatives such as 3°t,ToCjiaaf-trihydroxycoprostanic acid,
and 3<*,7°c,12oC,24$-tetrahydroxycoprostanic acid (Betsuki 1966)
are important in this concept of the degradation of cholesterol
to bile acids. In some animals secreting C^-bile alcohols
or C^-bile acids a trace of cholic acid has also been
detected. This may be regarded as the start of the enzyme
systems present in higher animals where C -bile acids are
the principal product of cholesterol metabolism. Some of
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these C^-bile alcohols and C^-bile acids have been shown
to be intermediates in bile acid biosynthesis in rats for
example. 5/3-ranol has been reported to be converted
efficiently to cholic acid in bile fistula rats (Danielsson
and Kazuno 1064).
Although 26-hydroxylation is a mitochondrial event,
cytoplasmic enzymes are also required for the degradation
of the side chain so that C ..-bile acids are produced
b
(Danielsson 1960$.,Mendelsohn, Mendelsohn and Staple 1965^).
Since transformations in the side chain take place after
events in the nuclear part of the molecule have taken place
in the endoplasmic-reticulum, therefore the substrate for
26-hydroxylation could either be 5/}-cholestan-3oC,7<*,12eC-triol
7«c,
or cholest-4-en-3-one-j^.2oC~diol for the formation of cholic
acid and 5/)-choles tan—3°c, 7oC, lS^-triol has long been regarded
as an intermediate for 26-hydroxylation. In order that
cholest-4-en-3-one—7oC,12°<-diol could be the substrate it would be
necessary for the mitochondria to lie in a favourable
juxtaposed position with the endoplasmic reticulum so that
the molecule in question does not come in contact with the
reductases present in the cytoplasmic part of the cell while
moving from the endoplasmic reticulum to the mitochondria,
fijorkhem and Danielsson (1965) studied the metabolism of
cholest-4—en-3°c,7<<,12«(—triol and cholest—4—en—3^,7oC,12«<-triol
and found that both were transformed efficiently into cholic
acid ir/Wile fistula rat, and that the formation of cholic
I
acid occurred mainly through a 3-keto-steroid. Their
results also indicate that cholest-4~en-3«-|7"t>12oc-triol
might be transformed into cholic acid to some extent through
a pathway involving direct saturation of the 4,0 double bond*
In the light of experimental evidence obtained so far
by various workers the sequence in the breakdown of
cholesterol to C^-bile acids the following steps seem to
occur in order:
(l) The nucleus of cholesterol is hydrogenated and
extra <<-hydroxyl groups at position 7 or 13 (or
both)are inserted*
(d) The end of the side chain is oxidised to give
alcohols (Cgj) and then acids (C,^).
(3) The side chain is shortened so that a C^-bile
acid is produced.
In some cases part of step (3) may occur before step (l).
There is suggestive evidence that during embryonic
development every higher animal traces back its ancestry.
The morphological recapitulation in this connection is highly
fascinating. If during the differentiation of foetal or
embryonic liver the enzymological developments also follow
the evolutionary conception, then the catabolisa of
cholesterol with respect to bile acid formation at different
stages may offer valuable information, especially in so far
as the intermediates in the side chain degradation of cholesterol
are concerned. In other words it is just possible that at
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a certain stuge of development the degradation of cholesterol
may not reach the ultimate formation of C^-bile acids, but
possibly stop short at on early stage.
II CATABOLISM OF CHOLLSThitOL TO STUlOIn iiUdiiONES.
Of great physiological importance is the catabolism of
cholesterol to the steroid hormones, which takes place in
the eiidocrine tissues. The 20°C-hydroxylation is regarded
as the initial step in the cleavage of the side chain of
cholesterol to give pregnenolone, and isocaproic aldehyde
is also formed (Constantopolous and Tchen 1961). When
labelled cholesterol was incubated with adrenal homogenates
Solomon et.al (1956) were able to isolate labelled
20«—hydroxycholesterol, and no radioactivity was found in
•or ao«<-
22<-hydroxy, 22/}—hydroxy,/22—keto-jfhydroxy-choiesterols.
Since aOot-hydroxycholesterol was more efficiently converted
to pregnenolone than cholesterol (Shimizu, Hayano, Gut and
Borfman 1961) by adrenul homogenates, this suggested that
the dOcC-hydroxylating system was required for pregnenolone
formation. The further transformation of 20°c-hydroxy-
cholesterol may be through a labile 20<<-22$-dihydroxycholesterol,
Later these workers were able to identify 20«,22^—dihydroxychol-
esterol as an intermediate. Although the isomeric
22—hydroxycholesterols (Chaudhuri, iiaruda, Shimizu, Gut and
Dorfman 1962) as well as cholest-5-en-3/£,20ocy-diol—22one
(Constantopoulos, Carpenter, Satohand Tchen 1966) have also been
reported to be converted to pregnenolone in good yields this
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does not eliminate the possibility of 2l)ac,22^-dihydroxy-
cliolesterol formation. Formation of cholest~5,20(22)-diene,
3p>-ol can also be envisaged in the former case. Simpson and
Boyd (1967) could not detect the formation of 20«:,222;-
dihydroxycholesterol or 20<x-hydroxycholesterol in adrenal
mitochondrial preparations. However they isolated an
intermediate, having the mobility between cholesterol and
20<x-hydroxycholesterol. On reduction with LiAlH^ this
compound was reduced to a more polar product having the same
mobility on TLC as 22t-hjdroxycholesterol. The possibility
that this compound could be a hydroperoxide was also
eliminated, as it was not reduced to a diol with acidified
KI solution in alcohol, and hence it might be
20,22-epoxycholesterol.
d4.
In the foregoing account it was pointed, out that in the
degradation of cholesterol to bile acids in the liver
7°c-hydroxylation of cholesterol is an early event. There is
a possibility that this hydroxylation is accomplished by an
intermediate formation of a hydroperoxide, which could then be
cleaved reductiveiy in the presence of an electron donor to
furnish the hydroxylated derivative. Although the formation
of a 7<£-hydroperoxy derivative has not been demonstrated in
biological hydroxylation reactions nevertheless the hypothesis
remains attractive in view of the fact that there seems to be
a marked similarity between the mechanism of photochemical
oxidation and biological hyuroxylations. Further, almost all
of the 'non-enzymic' products encountered in the biochemical
in vitro work, namely cholest-5—en—3/5-ol-7—one , cholest-5—en—
3p,7/i-diol, cholest—5—en-3p>, 7<<-diol and cholestun-3p,5«,6p—triol
are also either uirectly formed in the photo-oxygenation reaction
mixture or can be predicted to be formed from the break-down
products of the primary hydroperoxides. For example cholest—
5—en-3p—ol—7<*—hydroperoxide is known to decompose to cholest—
5-en—3 -ol-7-one. experimental evidence suggests that such
a hydroperoxide can epoxidize cholest-o-en—3/S-ol to give 5,6
epoxy-choiesterol while the hydroperoxide is reduced to
cholest-5-en-3p,7<x-diol analogous to the epoxidation reactions
of olefins by peracids. hence cholest-5-en-3^5,7<<-uiol may
arise directly and not through the reduction of cholest—5—en—
3/5—ol-7-one, which would give mainly cholest-5—en-3^, 7/3-diol.
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The 5,6 epoxy-cholesteroi on hydrolytic cleavage, analogous
to refluxing in aqueous acetone in the presence of periodic
acid (us a catalyst; would give a trunsdiuxial cholestan-3/S,
5ec,G^-triol which is another non-enzymic product of biological
in vitro reactions. These autoxidation products were
synthesized and purified for reference purposes.
Once an oc-hydroxy group is inserted at the 7<*—position
then oxiuation of the 3p-hyuroxyi group seems to be the next
step. From chemical consiuerations the specific oxidation of
an equatorial less hinaered hydroxyl can be achieved in
preference to a more activated hydroxyl group at the 7«=C-
position through an Oppenauer oxidation. In practice this
reaction suffers from the ready dehydration of the 7<<-hydroxy
group to yiela cholest—4,6—diene-3-one. Since the action of
the 5—ene-3-keto isomerase during isomerization of the
5—ene-3-keto steroids to corresponding 4—ene—3-ketone can be
compared with the acid- or base-catalysed reactions, the above-
mentioned dehydration of the K—hydroxyl group would be
expected to occur biologically unless the 7cc-hydroxy group
was protected. Chemically a tewporury protection of the
7<-hydroxyl group as an ether is indicated (dreenhagh et.al
1953). henzoylation and esterification do not protect the
7of-hydroxyi group from dehydrogenation under acid or alkaline
couditions.
After the formation of choiest-4—en-3-one—7<*-ol probably
the next step is the l2<*-hydroxyiation. Discussing the
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autoxiuution reactions of paru.ffi.nic hydrocarbons Waters (1964)
and Hawkins (1961) have mentioned that substances containing
tertiury C-H are more easily oxidized to form hydroperoxides
whilst methyl groups are more resistant. The methylene group
in a straight chain saturated hydrocarbon or in cyclic
hydrocarbon can be autoxidized similarly by molecular oxygen.
High temperature and certain metals promote such reactions.
It is therefore quite probable that hydroxylation at saturated
centres like C-ll,12,22,24 and 26 could proceed through
intermediary hydroperoxide formation catalysed by enzymes,
thereby avoiding the free radical type mechanism proposed for
autoxidation, and perhaps reducing the energy requirements for
the reaction.
The 7«-hydroxylations in this work were achieved through
7cC-hydroperoxides of cholest—5—en—3fi, 26-diol, cholest—5-en—3p>t
25-uiol, eholest—5—en-3p—ol-24—one and cholest—5—en—3jif 12<<—diol,
and the four corresponding triols were prepared.
Cholest-5—en-3[i, 7<<,24^-triol, cholest-o—en—3[i, 7eC, 25—triol
and cholest—3—en—3flf 7«<,26—triol can be randomly tritiated and
injected into a bile fistula rat in order to confirm the notion
that after any modification of the side chain 12<<—hydroxylation
cannot take place. Also their rate of conversion to cheno-
deoxycholic acid (3«,7«c-dihyd.roxy-5p-cholanoic acid) can also
be studied in fortified mitochondrial preparations with a view
to studying which one of these triols may be the principal
intermediate.
It is generally believed that the conversion of the
sterol 5oC-si>ries to the 5/5-series or vice versa is possible
by conversion to a 4,5 double bond or 5,6 double bond and
hydroaenation. The catalytic hydrozonation of sterols with
5,6 double bonds gives almost exclusively the 5<<-series if the
molecule is devoid of a 3=(-hydroxyl or other substituents.
In the latter case solely compounds of the 5/1-series are
obtained. These results can be interpreted on the principle
of steric hindrance during the catalytic hydrogenation, and
arguments have been advanced that the 3<*-substituents possess
axial conformation in such compounds and because of their
bulkier nature are able to compel preferential adsorption of
the p -side rather than the normally more accessible "t-side of
the steroid molecule.
Conclusive evidence has been obtained that epimerization
of the 3/S-hydroxyl takes place through the 3-ketone formation
and that the 5,6 double bond migrates to a position of
conjugation with the carbonyi group before being reduced enzymi
ally. Therefore, although chemically the reduction of the
5,6 double bond with a 3°C-hydroxyl group in a sterol molecule
affords exclusively the 5/3-series, the same analogy cannot be
drawn with the biological conversion of the 3/S-hydroxyl group
to the 3<X-hydroxyl group in which case the 3-ketone formed
would be reduced to give a 5-ene—3°c-ol grouping followed by
reduction of the 5,6 double bond to the 5/3-series. Similarly
on the basis of chemical evidence it is difficult to predict
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that in a biological system the ketone will be reduced in
preference to the 4,5 double bond to give a 3°<—hydroxyl group.
if such an enzymic reaction is compared with the rnetul hydride
/an
reduction of/<*, p-unsaturuted ketone then the 3/J-hydroxyl group
(equatorial) rould be expected to be formed becuuse the
3—ketone is unhindered (barton 1953). Catalytic reduction of
3-ketones in an acid medium is known to give axial hydroxyl
groups (3<*) but in the presence of a 4,5 double bond the
saturation of the olefinic bond would take place first.
Although chemical evidence also points that the catalytic
reduction of cholest-4-en-3°c-ol affords a mixture of/bk- and
5p-series both in neutral and acid environments the presence
of a 7"C-hyaroxy group (axial) or a 12°t-hydroxyl (axial) or
both in such a molecule would be expected to increase the
hindrance for the catalyst to approach from the °c-side of the
molecule, with the result that preferential /i-attack would be
uireoteu and consequently reduction to the 5/i-series would be
achieved. however, no chemical analogy can be drawn in which
case 3—ketones would give rise to 3°c—hydroxyl groups in the
presence of a 4,5 uouble bond. On the other hand if these
enzymic reactions are compared with catalytic hydrogenations
one would expect to reduce the 4,5 double bond first possibly
exclusively to the 5p-series compounds, when cc-hydroxyl groups
at 7 and 12 are present, and the reaction would be favoured in an
acid medium. The 3—ketone of the 5/3-series would then give a
3°c-bydroxyl (equatorial) in a neutral medium on catalytic
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reduction. The same end can also be achieved by tetul
hydride reduction. hence the action of the oji-reductases
can be compared with catalytic hydrogenation in acidic medium
and the 3 -ketosteroid:^acceptor) oxidoreductase with that
of the catalytic reduction in neutral solvents or metal
hydride reduction.
In order to confirm the hindrance effect caused by the
the
oC-hyuroxyl groups ut^7 and 12 positions, cholest-4-en-3-one,
cholest-4-en-3-one-7°C-ol and cholest-4-en-3-oiie-7<*,l2<*-diol
can be partially reduced cutalytically under identical
conditions and the ratio of the 5<x-to 5|)-compounds established.
These compounds together with the 5^-cholestan-3-one-7<*-ol and
5^>-cholestan-3—one-7<*,l2«—diol have been synthesized for
reference purpose.
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OBJECT OF Tliii. EHESENT STUDY.
This work was undertaken in order to synthesise chemical
models of possible biological oxidation products of
cholesterol. Various hydroxylated und oxygenated derivatives
of cholesterol were synthesised, which could be used as
reference compounds in the identification of intermediates
encountered in in vivo studies of bile acid biosynthesis.
With the methods available for random isotopic labelling of
cold compounds these chemical models can also be used in
biological studies both in in vivo and in vitro
to test whether or not these labelled compounds were converted
to the expected biological products, so that a conclusion
could be drawn about the possibility of their being obligatory
intermediates in the sequence of cholesterol catabolism to
bile acids. Since sterols are notable for their ability to
form molecular compounds and mixed crystals, this property
often rendered purification by fractional crystallization
almost impracticable or impossible. The application of
modern methods of analysis revealed that in certain instances
a compound synthesised by a published route gave physical
and chemical characteristics comparable to those reported.
Nevertheless by newer methods tlxe material was shown to be
heterogeneous. In all preparations chromatography was
invariably used for the purpose of separation and the compound
was regarded as pure when it gave only a single spot on TLC
using several suitable solvent systems in which impurities if
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any vera detected. Optical rotations, ultra-violet and
infra-red spectrascopy were employed as tools in determining




1. Melting points were determined on a Kofler micro-stage
(microscope KCU) apparatus.
2. Optical rotations vere measured on iiilger polarimeter
M 412 in chloroform. Hhere the compound was not sufficiently
solttble» minimum amounts of ethanol were employed.
3. Infrared spectra (lit) were recorded on an 'Infracord'
spectrophotometer (Perkin-hlmer) using potassium bromide
disc procedure. The Ift figures numbers refer to the
Infrared spectra given in the Appendix.II.
4. Ultraviolet absorption measurements were performed in an
'Optica' CF4DH double beam recording spectrophotometer and
'Unicam' 3.P.500 spectrophotometer. The compound was read in
an ethanol solution. For fluorescent thin layer chromatography
an ultraviolet mercury lamp (Maximum emission 254 mjx ) was used.
5. Hadioactive measurements were performed in a Packard Tricarb
scintillation system 314EX. The scintillation liquid consisted
of 2)5-diphenyloxasole (PPO) 5 g. and l>4-bis-2-(4 inethyl-5-
phenyloxazoyl) -benzene (POPUP)) 0.03 g in toluenei 1L ).
Hadioactive measurements were also performed on thin layer




PliO TU -OX YG-hN AT ION
When molecular oxygen attacks a molecule such as
cholesterol various hydroperoxy products are possible (fig. 6.).
Under conditions that favour a free radical mechanism the
attack of oxygen on allylic radicals can lead to bothoC- and
/3-hydroperoxidea in almost e^ual proportions with rearranged
and unarranged double bonds, because of the planar nature of
the postulated free radicals. For example if the oxygen
molecule is introduced at the 5—position cholest-G—en-3/J-ol
5-aC and 5|3-hydroperoxides can result. If the attack is at
the 6-position, both cholest-4-en-3|3-ol, 6/S-hydroperoxide and
cholest—l-en-3^ol-6oc-hydroperoxide can be expected. A
pseudo—aliylic attack at the 4-position similarly may result
in cholest-5-en-3^-ol-4|5-hydroperoxide and cholest-5-en-3/J-ol—
4d.-hydroperoxide. An allylic attack at the 7-position can
form both cholest-5-en-3/3-ol-7cC-hydroperoxide and cholest-5-en-
3^5-oi -7^-hydroperoxide.
From these initial products other secondary compounds
can be hypothesized. For example cholest-C-en-3£-cl-5°(-
hydroperoxide can isomerize to yield cholest-5-en-3/S-ol-7°C-
hydroperoxide. It can react with one molecule of cholesterol
to form eholest-6-en-3/i, 5o<-dioi and cholestan-3^-ol-5,6-epoxide,
or it can be reduced to cholest-P-en-3/ir5<<-diol or cholestan—3ft,
5<<-diol. Similarly cholest-5-en-3jB-ol-7oC-hydroperoxide can
form cholest-5—en-3p, 7oC-aiol and cholestan-3y?-ol-5,^epoxide
following its reaction with another cholesterol molecule.
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It can also yield cholest-5-en-3/$-ol-7-one on removal of a
molecule of water, and it can also decompose to give
cholest-5-en-3/*,7ec-diol and a ketone* On reduction
cholest-5-en-3/s-ol-7<<-hydroperoxide can give cholest-5-en-3/3,
7<*-diol or 5°<-cholestan-3p,7<<-diol.
A corresponding series of compounds would be expected to
be formed from eholest-4-en-3^-ol-6°c-hydroperoxide, cholest-
4-en-3/3-ol-6/3-hydroperoxide, cho 1 est-5-en-3p-o1-Aji-hydro-
peroxide and cholest-5-en-3/3-ol-4<<-hydroperoxide, but these
compounds are not expected to undergo allylic rearrangement
like the tertiary hydroperoxides to secondary hydroperoxides*
Further cholestan—3/3-ol—5,6—epoxide can produce
cholestan-3/3,5<*,6/3-triol on hydrolytic cleavage of the oxide
ring or it can rearrange to give cholestan—3/5—ol-6—one.
Reduction of cholestan-3/S-ol-5°<,6«-epoxide will afford mainly
cholestan-3/3,5°(-diol, whereas cholestan-3/3-ol-5/3,6/S-epoxide
will give a mixture of cholestan-3/3,5/3-diol and cholestan-3/3,
6/3—diol •
Since this work was concerned with photo-sensitized
oxygenations in dilute solutions (0.00R5M) a different
pathway seemed to have predominated in which hydroperoxidation
was followed by an allylic shift of the double bond* Although
this type of reaction predominated over the free radical
pathway, nevertheless, the latter cannot be completely
suppressed and therefore such products which are formed by
the removal hydrogen may derive their origin from
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the radical chain process particularly when°C, and /3-epimers
at a certain position are formed*
MECHANISM:
The combination of molecular oxygen with olefins is well
known and°C-methylenic groups are potentially reactive centres,
where the oxidation appears to be initiated by the removal of
a hydrogen atom*
Under the influence of molecular oxygen, a labile methylene
group can form a free radical to which oxygen forms a peroxyl
radical* This molecule subsequently abstracts a hydrogen
from a nearby labile site of another unsaturated molecule to
form another free radical and thus propagates the chain
reaction* Where several such methylene groups are present
the most likely point of attack may be expected to be that
one in which the tendency to dissociation of hydrogen will be
most facilitated by normal electronic polarisation. This is
roughly the mechanism advanced for the auto—oxidation of
unsaturated fatty acids (Bolland and Koch 1945).
The lack of satisfactory source of energy required for the
rupture of an oc-methylenic carbon-hydrogen bond (80kcal/mole)
led various workers to suggest an attack at the double bond as
the initial reaction. This type of additive attack by oxygen
need occur only to a minor degree at the double bond of a few
molecules and then later continues as a substitutive attack at
the allylic position during the predominating reaction. This




















is formed with subsequent rearrangement and further reaction
giving riae to aaturated hydroperoxides aa well* (fig.7.)
In contrast when oxygenation of sterols having the
5-ene-3/J-ol grouping with or without one hydroxyl group
elsewhere (12, 24, 25, 28 positions) in the molecule was
conducted photochemically in dilute solutions in pyridine in
presence of a small amount of sensitizing agent (haemato-
porphyrin) chain reactions of free radical type did not appear
to be involved in any detectable extent and the mode of attack
of oxygen was more stereospecific and markedly subject to
steric hindrance*
The peroxides formed largely survived further breakdown*
The initial and predominant mode of oxygen attack seemed to
be at the C_ of the 5-6 double bond from the rear of the sterol
o
molecule giving rise to a biradical, which stabilized to an
allylic hydroperoxide by allylic shift of the double bond,
accompanied by hydrogen abstraction. The carbon-hydrogen bond
cleaved and the carbon hydrogen bond laid down therefore
required a cis relation, and the whole mechanism may or may not
be concerted.
2
Studies with the H-lubelled cholesterol established that
the oC-hydrogen at C-7 is selectively abstracted and the result
led to a postulation of a cyclic mechanism for the sensitized
pathway (Kickon and bagli 1959; 1961). Further work with
other steroid olefins such as cholest-3-ene (Nickon et. al 1965)
and cholest—4-ene showed that such attacks by a suitably
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activated oxygen molecule on one of the termini of the double
bond are on the ~n~ electrons from a direction perpendicular to
the plane of the double bond. Such sensitizer mediated photo-
oxygenations can be substantially blocked vhen the incipient
C-0 bond is in 1,3-diaxial relationship to an alkyl group or
when the allylic hydrogen is rigidly equatorial or quasi-
cc
equatorial (Nickon and Mendelson 196oj),
The stereospecific behaviour of the 5-ene-steroids with
regard to the mode of oxygen attack at the 5«-position can
therefore be interpreted on the basis of a cis- mechanism
proposed by Nickon and co-workers.
The attack at C-5 from the <*-side of the sterol molecule by
oxygen is greatly favoured because it meets no steric
hinderance and the quasi-axial <*-hydrogen at C-7 is available
for the cis addition for production of a 5<*-hydroperoxide.
In contrast the approach of oxygen molecule from the /3-side will
encounter an almost eclipsed 1,2-interaction at C-5 from the C-10
methyl group. Further the allylic /3-hydrogen at C-7 is quasi-
equatorial, which is an unfavourable conformation for a cis—
mechanism. These factors will therefore seriously discourage
any frontal attack by molecular oxygen. Indeed no 7/2-hydroxy
isomer was found in the photo-oxygenatioa reaction mixture
after isomerization in chloroform, reduction with LiAlH^ and
chromatography of the acetylated product on neutral,
deactivated alumina. The absence of a 7/?-hydroxy isomer
explains three things. First there was no detectable amount
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of 6-ene-5/3-hydroperoxy derivative formed) since such a
tertiary hydroperoxide would be expected to isomer!ze to a
secondary 5-ene-7/3-hydroperoxide derivative and thus would
give a 7/3—hydroxy derivative on reduotion* This would be
like cholest-6-enr-5<<-hydroperoxide isomerizing to cholest-5-
en—7<<—hydroperoxide, and the cholest-3-en-5°C-hydroperoxids
and cholest-3-en-5/^-hydroperoxide isomerizing to cholest-4-en-
3«:-hydroperoxide and cholest-4-en-3^-hydroperoxide respectively*
Secondly it explains that no decomposition to a 7-keto
derivative occurs under our experimental conditions* Thirdly,
it also explains that no 7-hydroperoxy derivative was formed
through the free radical mechanism which would be expected to
realize both << and fi isomers*
The possibility of oxygen attack at the other termini
of the 5,6 double bond i.e* C-6 is considered now* The
oC-attack of the oxygen molecule at C-6 meets no serious
steric hinderance, but the 4<*-hydrogen is equatorial, which
is therefore unfavourably disposed for a cis mechanism.
However, the ring A is free to assume different shapes
ranging from/thermodynamica11y most stable chain form of the
cyclohexane ring to the less stable boat form* Therefore
it is reasonable to assume that the 4°c-hydrogen probably
assumes an axial conformation as a result of ring A distortion,
thus facilitating 6<c-hydroperoxide formation. This reaction
consequently will involve the shift of the double bond from
the endo- to the exo-position with respect to the ring B.
39.
the
Suoh a ahift of double bond may restrict this reaction but
does not seem to completely prohibit it) by analogy with the
formation of cholest-5-en—4f?>—hydroperoxide in 8,5% yield from
cholest-4-ene among other major products of photochemical
oxygenation.
The p-attack by molecular oxygen at C-6 is subject to a
1)3 interaction of the methyl group at C-10 with the
developing C-0 bond. The 4^-hydrogen (axial) although
ideally situated for a cyclic transfer also experiences a
1)3 interaction with the methyl group at C-10. Therefore
if the formation of a 6^-hydroperoxy derivative with an
allylic shift of the double bond is on the pathway of photo¬
sensitized oxygenation reactions these interactions are
insufficient to stop the reaction though they may retard it
to a considerable extent.
As far as the proportion of 6°c- and 6^-hydroperoxides
is concerned, it will depend on whether the 1,3 interactions
at C-4 and C-6 for the 6^3-hydroperoxidation are more
prohibitory than the ring A distortion for the 6<-hydroperoxi-
dation.
The possibility of allylic oxidation by a free radical
pathway cannot be completely eliminated, in photo-oxygenation
in^jfreaence of a sensitizer. therefore it is worthwhile to
discuss the possibility of oxygen attacking a 5-ene system
through a free radical mechanism.
By analogy with the behaviour of other steroids this free
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radical pathway is expected to produce a mixture of epimere
at the point of attack of oxygen in the case of allylio free
radicals, because in such a system the single p-electron
(free) delocalizes in the direotion of the adjacent 2 TT
electrons,as they are coplanar. For example a free radical
type of oxygenation of/colloidal solution of cholesterol
produces both cholest-5-en-3/3,7/3-diol and oholest-5-en-3/*,
7®c-diol (Wintersteiner and Bergstrom 19411 Bergstrom and
Wintersteiner 1941-42). Similarly photo-oxygenation of
cholest-5-en-3-one in the absence of a sensitiser follows a
free radical mechanism which produces approximately equal
amounts of cholest-4—en-3-one-6<x—hydroperoxide and cholest-
4—en—3—one-6/3-hydroperoxide (Nickon and Mendelson 1965 ox
1965). Autoxidation of steroid 3,5-diene-3-ol ethers
similarly give 6°t and 6/J-hydroxy epimers (Gardi and Lusignani
1967). Other examples are given by Shapiro, Legatt and
Oliveto (1964), for the hydroperoxldation of homo-allylic
ketones to °c,^-unsaturated ketones.
It has been found that no 5/3-hydroperoxide or 7/?>-hydro¬
peroxide were formed in the photochemical oxygenations hence
it can safely be assumed that the 5«or 7<—hydroperoxide that
were formed exclusively arose from the photo-sensitized
pathway. Since both the 6*- and the 6/3-hydroperoxides can
be formed through a photosensitized path, it is very difficult
to apply the same reasoning in order to exclude or include
the chain reaction mechanism for their formation. The auto-
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oxidative behaviour of cholesterol must be taken into account,
recently omith, Matthews, Price, Bachmann and Reynolds (1967)
have studied autoxidation products under six different
conditions* In all cases among a variety of products
the only common feature was the presence of epimeric
7-hydroxycholesterols* These results demonstrate the
outstanding reactivity of the cholesterol molecule at the
allylic 7-position, as compared to other positions*
Therefore it can be argued that since in photochemical
oxygenations in/presence of a sensitizer no detectable free
radical type of product was found at the 7-position, any
hydroperoxy product formed at C-6 could not have originated
through a free radical mechanism*
Similarly the formation of a free radical at C-4 seems
remote and under photosensitized conditions no 4<*er 4/1-
hydroperoxide arising by a free radical pathway seems possible*
EVIDENCE FOR OXYGEN ATTACK AT C-6
On catalytic reduction after isomerization of the photo-
oxygenation products of cholesterol in pyridine a minor product
cholest-4-en-3/l,6/l-diol was isolated and its identity
established by co-chromatography on TLC and mixed melting point
etc* This is therefore the first example of oxygen attack
from the fh-aide of cholesterol molecule under the adverse 1,3-
interaction of both the C-0 forming and C-H breaking bonds*
EVIDENCE FOR THE FORMATION OF 5.6-EPOXIDE
Even in the initial stages of the photo-oxygenation as
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followed by fluorescent thin layer chromatography there were
small spots with the mobilities of 5-ene-7<x.-hydroxy and
6-ene-5<*—hydroxy products without any traces of 7-keto
derivatives. This formation of hydroxy products from
corresponding hydroperoxides in the absence of a ketonic
product requires an explanation. The formation of a
7^-hydroxy product from a 7oc—hydroperoxy product in pyridine
solution is not surprising because the 6-ene-5<>(-hydroperoxide
is known to decompose to 7-keto derivative in the presence
of a sensitizer. This decomposition of a 6—ene—5«c-hydro-
peroxide is known to involve isomerisatlon to 5-ene—7*-
hydroperoxide, whioh on dehydration would give a 7—ketone.
(Schenck, Neumuller and £isfeld 1908). Therefore it is
possible that even in pyridine some of the 6-ene-5°c-hydro-
peroxide is isomer!zed to the secondary 6-ene-7*-hydroperoxide.
Indeed in the preparation of cholest-6-en-3/Sy5c(-diol through
photo-oxygenation of cholesterol in pyridine cholest-5-en-3/3,
7°c-diol was deteoted.
The absence of a ketone in the decomposition of
5-ene-7<*-hydroperoxide or 6-ene-5«c-hydroperoxide can be
explained if a direct attack on the 5,6-double bond by these
hydroperoxides to give simple 5tG-epoxides is proposed.
This reaction will be analogous to the oxidation of olefins
to epoxy-derivatives by peracids such as perbenzoic and
perphthalic acids. However these hydroperoxides are expected
to be less effective for this reaction than the peracidst
fiq. 8 A















I ^ °5X u













probably because there is no adjacent carbonyl group in these
hydroperoxides) which would remove the peroxidic proton*
The reaction might be initiated either by the polarisation
of the tt-electrons or by the loss of a peroxide proton) and
might involve a chargeless transition state as given in
fig*8A * Alternatively the transference of a proton might
occur intramolecularly under the influenoe of a hydrogen
bonding solvent (H-Y) as represented in fig.8B. Such a
reaction therefore provides a possible explanation for the
formation of 6—ene—5*—ol and 5-ene—7°c-ol derivatives in the
absence of any ketonic products in photochemical reaction
mixtures* These epoxides (5°<,6* and 5£,6/*) are known to
furnish trans-diaxial glycols on hydrolytic fission and
monohydrie alcohols on reduotive opening. If a close
analogy is drawn between photo—oxygenation and ensymic
hydroxylations then the formation of cholestan-3/2>l5'*)6/&-triol
and 5«-cholestai*-3p-ol-6—one, the non-enzymic autoxidation
products could well be explained through the formation of
such epoxides, probably by an "enzymic" hydrolytic cleavage
and isomerization respectively.
EXPERIMENTAL EVIDENCE FOR HYPOTHESISED MECHANISM
14
In a preliminary experiment cholesterol-4-C in benzene
solution was added to the solution of cholest-6-en-3£-ol-5«—
hydroperoxide in benzene and the mixture allowed to stand
for five hours* An aliquot of the mixture was spotted in
a line on the plate and then irrigated in benzene, ethyl acetate
Fig. 9
■ « , , n„ radioactivity peak designated by'A'representscholesterol»lha peak'B* occupies an area covered by the reference
compound cholest-6-en-3|5-ol-5oc-hydroperoxide, and the third peak
designated by'C• has the same mobility as the reference compound
5<*f 6«-epojtycholesterol.
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mixture (7:13). The TLC plate was cut into small sections,
and the silicic acid scraped off into the counting rials and
then radioactivity assayed in Packard Tri-carb Liquid
Scintillation Spectrometer using toluene with FPO and POPOP.
The main area of radioaotirity was distributed in the region
of choleatan-3p-ol-5*,6c(-epoxide and cholestan—3)3-ol-5/3,6^-
epoxide which do not separate from each other*
Conversion of the cholesterol-4-C** to 5,6-epoxy-
14
cholesterol-4-C was less than 2%,
The bulk of the reaction mixture was left at room
temperature for several days and then chromatographed on TLC
plate as described above* The plate was assayed for radio¬
activity using a windowless gas-flow TLC scanner* Three
peaks of radioactivity corresponding to cholesterol,
cholest-5-en-3/3-ol-7<<-hydroperoxide or cholest-6—en-3/3-ol—5°c-
hydroperoxide and 5,6-epoxycholesterol were shown, (fig.9.)
The difficulty in the Identification of such reaction
products as 5,6-epoxides, 4—ene—6—isomeric hydroperoxides
and probably the 5-ene-4—isomeric hydroperoxide (pseudo-
allylic) is due to many factors:
1) They are not completely separated on TLC from each
other or from the 0-ene-5<*-hydroperoxides - the main product
of the reaction of the 5-ene-7<-hydroperoxide.
2) Their isolation as such from the reaction mixture
by chromatography or fractional crystallization is made
difficult by their instability (except epoxides) coupled with
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minute quantities.
REDUCTION WITH LITHIUM ALUMINIUM HYDRIDE
Several methods for the reduction of a hydroperoxide to
corresponding aloohol have been reported* These include the
use of Nal, NaHSOg, SnCl^, SO^, LiAlH^, Zn—acetic acid,
H^-platinum or palladium (Davies and Feld 1966) Davies 1968).
Hydride reduction was preferred over controlled catalytic
reduction as the former reagent is considered to form complex
anions from a simple metal hydride. These anions are
nucleophilic reagents vhich normally attack polarised multiple
bonds (e.g. >C«0, >C-N, -CsN,-N«0) at the more positive atom,
but usually leave the isolated carbon-carbon multiple bond
unaffected.
SOLVENTS
In the case of sterols, photo-induced oxygenations have
been conducted in many solvents. The photo-oxygenation of
sterols having a 5-ene-3/i-ol grouping with a suitably
orientated hydrogen at the allylic carbon atom gives mainly
two initially formed of-unsaturated hydroperoxides
derivatives namely 6-ene-5<<-hydroperoxide or 5-ene-7<<—
hydroperoxide depending upon the kind of solvent used; thus
the
in chloroform or dioxane cholest-5-en-3^-ol, gave 7°c-hydro-
peroxy product, in contrast when pyridine, benzene, alcohol
or acetone was used,hydroperoxidation occurred at the
unsaturated tertiary carbon atom 5 with the subsequent shift
of the double bond to the allylic 6,7-position. On this
■w
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basis these solvents can be classified roughly as chloroform-
type or pyridine-type.
i'he suggestion that in chloroform solution, the attack
of molecular oxygen is stereospecifioally at the allylic
7°c-position (Schenck, Neumuller,& Eisfeld 1058) seems
attractive but the source of energy required for the rupture
of anoC—methylenic carbon-hydrogen bond (80 kcul/mole) would
be difficult to explain. If a free radical type of reaction
is envisaged then both and 7^-hydroperoxides will be
expected unless 7<<-hydroperoxidation takes place by some
abnormal mechanism. Further, since choiest-6-en-3p-ol-5<-
hydroperoxide is known to undergo mutarotation or allylic
rearrangement which is catalysed by light in chloroform
solution to form cholest-5-en-3p-ol-7°c-hydroperoxide (Schenck
1958a: x
et. al 1958;a hythgoe and irippet 1959; it is reasonable to
propose that the first and the main attack is at the tertiary
termi. I of the 5,6 double bond, and the 5°C-hydroperoxide
formed through cis- addition then isomerises to a 7k-hydro-
peroxide (for mechanism of isomerization see Schenck et. al 1958
and Lyth oe et. al loc.cit). The attack of oxygen at the
C-6 with subsequent shift of double bond to the pseudo-allylic
4,5-position can not be overruieu. In fact in the reduction
A
product of photo-oxygenation performed in/chloroform solution
of cholesterol a product less mobile than cholest-5-en-3^, 7<<-
diol has been detected having the same mobility as cholest—4—
en-3p,6^-diol on TLC plate, apart from two main products which
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corresponded to choiest-5—eu-3fl, 7<K—diol and cholest-b-en-3/S,
5<x-diol or cholest-5—en-3)5,7/J-diol, or a mixture of the latter
two compounds. No attempt was made for further isolation or
identification of the cholest-4-en-3/i,6/J-diol like product or
characterization of c holes t-6-en-3/5,5oC-diol or cliolest-5-en-3/5,
7/J-diol at this stage.
Irrespective of the nature of mode of attack of oxygen
for 7«C-hydroperoxidation in chloroform solution although
directly 7oC-hydroperoxides could be obtained and 011 reduction
these hydroperoxides would furnish the desired 7<*-hydroxy
derivatives. The method suffered from the drawback that the
hydroperoxy compounds formed were very labile under the
conditions of reaction and gave rise to both more mobile and
less mobile break-down products. kven though the reaction
mixture was stored at low temperatures after the removal of
-ri
the photo-catalyst the break-down products were still formed*
Further, during the reaction the break-down products were in
some cases formed fast, hence the time of photo-reaction was
limited and had to be stopped while there was substantial
amounts of starting material unreacted. The instability of
hydroperoxides could be due to the decomposition products of
chloroform itself,which is known to give rise to acidic
products like curbonyl chloride, hydrochloric acid and chlorine.
No decomposition of a 6-ene-5of-hydroperoxide was detected in
its isomerization to the more stable 5—ene-7<x-hydroperoxide
in chloroform (free from hydrogen chloride and alcohol) under
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the influence of light and absence of air even after standing
for several days at room temperature. On the other hand in
pyridine solution the 0-ene-5<*-hydroperoxy compound formed
was stable and the reaction mixture could be stored at room
temperature oversight without any decomposition. For this
reason most of the reactions were conducted in pyridine and
the photo—oxygenation continued until most of the starting
material had been reacted.
■jJENoITIAnHJ (CAXAmY j'To)
A large number of synthetic and natural dye stuffs have
been employed as photo-sensitizers in photochemical
oxygenations for example certain dyes such as eosin, rose—
bengal, or natural colouring matters like chlorophyll,
carotenoids, anthocyanidins, haematoporphyrins, protoporphyrins
etc. (Jchenck et. al 1958a; Oster et. al 1959; Livingston and
Owens 1956). The concentration of the sensitizer affects
the rate of the reaction, and the quantum yield of the
reaction decreases markedly with increasing dye concentrations
(Oster et. al 1959). Some sensitizers act within five
minutes of the light exposure while others have a lag phase
of as much as twenty minutes.
Two mechanisms have been advanced. One mechanism implies
that the sensitizer on absorption of light energy is excited
—9
to its singlet state ^short lived, 10 sec.) with subsequent
transition to a triplet state (metastable) which is a longer
lived excited state. The metastable or phosphorescent state
(j) Sens * 'Sens
(II) 'Sens ► 3Sens
(iii) 3Sens + 302 * 'Sens-O-O* (Sldduct)
(iv) »Sens-0-0* + A > A0t$ + Sens
(Hia) 3Sens + 302 ——> Sens + 'Og
(iva) 102 + A *■ A O2




interacts with triplet state oxygen molecules to form reactive
labile adducts of sensitizer and oxygen. This intermediate
then reacts with the acceptor olefin to form a peroxidic
product. In the second mechanism the reactive intermediate
is an excited singlet state of molecular oxygen (Foots and
Wexler 1964; Corey and Taylor 1964; Kearn, Hollins, Khan,
Chambers and Radlick 1967; Kearn, Hollins, Khan and Radlick
1967).
Both mechanisms can be represented as in fig.10•
In most cases pyridine was used as the solvent and
haematoporphyrin was used as the sensitizer. In the case
when chloroform was used, haematoporphyrin methyl ester was
employed for solubility considerations.
LIGHT SOURCE
Various light sources had been used by Naqvi and Boyd
(1964). Fluorescent lamps (Phillips TL AD, 16 w. 18 long),
Tungsten filament lamps (8M long), Rubidium lamp (8")> and
a HgZnCd lamp (Phillips, Holland: type 93145E) were tried and
all gave the hydroperoxide. The fluorescent lamps were
found to be the most satisfactory because with this lamp the
temperature of the reaction mixture did not rise above 80°C,
while with the other two kinds the rise in temperature was
troublesome. In general an elevated reaction temperature
produced more side products.
In all the experiments described in this work four
fluorescent lamps were used for illumination purpose. The
Figure* l l ■
Thin layer radiochromatograma of the photo-oxygenation
reaction mixture of cholesterol-4-C4 at different intervals*
shoving almost exclusive formation of a hydroperoxide*
Fig* 12..
Thin layer chromatograma showing the formation of
hydroperoxide and other pfoduots at different intervals of the
14
photo-oxygenation of 4-C-cholesterol in pyridine*
50.
reaction tube was made up of •pyrex* glass provided with an
oxygen inlet through a sintered disc at the bottom.
XlMh COVASE
Cholesterol-4—(l/*c) was diluted with 100 mg of cold
cholesterol, and was dissolved in 10 ml pyridine containing
1 mg of hueuiatoporphyrin. The solution was transferred into
the broader limb of the U-shaped photo-oxygenation tube
provided with a sintered glass at the bottom. Oxygen was
led through the thinner limb via the sintered glass and the
apparatus was illuminated by means of four fluorescent tubes
(fhillips TL AD 15 w. 18" long). Aliquots (0.1 ml) were
taken out after two hours, four hours and twelve hours, and
were chromutographed on thin layer chromatoplates. Fig. 11,
shows radio-chromatograms. After twelve hours of irradiation
cholesterol was almost quantitatively converted to a product
with the mobility of cholest-6-en-3jJ-ol-5«:-hydroperoxide.
then the concentration of cholesterol was dropped to
0.1^9 or increased to 5the reaction did not seem to progress





3JV-ucetoxy-choleat-5-en-<i4-one (a50 mg,|Rf.0.63 in
benzene:petroleum etherrether::3:3:l) was dissolved in freshly
distilled tetrahydrofuran (THF) (6ml). The solution was
carefully added to a suspension of lithium aluminium hydride
(LiAlH^) (150 mg) in THF (5 ml) and the mixture boiled under
reflux for one hour. Ethyl acetate (10 ml) was added to
decompose the excess hydridet and the whole poured into a
saturated solution of potassium sodium tartrate (Rochelle
salt). After standing for one hour the product was extracted
with ether (4 x 15 ml). The ether extract was dried over
anhydrous sodium sulphate and then evaporated to dryness in
vacuo. The residue (0.343 g) was chromatographed on
deactivated (5$) neutral alumina (10 g).
The reduction product was dissolved in benzene and passed
through the column* Elution with increasing amounts of ethyl
acetate in benzene furnished cholest-5-en~3/})34^-diol in 15$
and 30$ ethyl acetate fractions (30 ml each). These fractions
were pooled and the residue (309 mg) was crystallized from
ethyl acetate to give white needles (167 mg; Kf.0.53 in
benzene:ethyl acetate:acetone::1Q:5:3).
Reported
m.p, m 169.5-173.5 isomer I • 176^ isomer II 183°
C*)j;6- -39 (C,0.8) -48 -36.8
IR (V) - Fig. 3.
Ck>_H,o0o requires C - 80.5$, H - 11.4$; found C=80.69, H=11.64.«s7 4o A
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The low rotation of isomeric choleat-5-en-3/3-r24°(-diol and
choleat-5-en-3p,24p-diol mixture (for physical characteristic
of these two isomers see Ercoli and De Huggieri 1953) suggests




35-hydroxycholesterol was prepared by the reaction of
3p-acetoxy--cholest-5-en-35-one (35 keto—nor—choleaterylacetate)
with methyl magnesium iodide (liyer, Gebert and Uurrill 1950;
Dauben and Bradlow 1950)*
35-keto-nor-cholesteryl acetate was a gift from
'Organon', Newhouae, Lanarkshire. It showed several
impurities on TLC and was purified by chromatography on
deactivated (10^) neutral alumina.
Impure 35-keto-nor-acetate (5.9 g) was dissolved in the
minimum volume of benzene and adsorbed on deactivated alumina
(0g). The benzene was evaporated under vacuo and the sterol
plus alumina poured on to a column of alumina (I30g) made in
petroleum ether. Llution with 107' benzene in petroleum ether
(350 ml) removed the more mobile impurity which was identified
as cholesterol acetate. Subsequently 30,30,40 and 50#
benzene in petroleum ether (350 ml) gave pure 35-keto-nor-
cholesterol acetate (4.6g m.p. 140-141.5 analytical sample
Ik=Figure 3.
crystallized from ethyl acetate, m.p. 143—144;^ Kf. 0.46
benzene:petroleum ether :etlier: :3:3:l) .
Further elution with 75# benzene followed by pure
benzene gave a more polar product 'x' (150 mg m.p. 316-318.5°;
Hf, 0.3) which will be described elsewhere.
A tiriguard reagent was prepared from methyl iodide and
magnesium in dry ether. Lther-washed and dried magnesium
(0.96g; 40.0 m. moles) was dissolved in freshly distilled
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methyl iodide (2*48 ml or 5.68 g; 40 m.mole) in anhydrous
ether (50 ml), A solution of 25-keto-nor-cholesterol
acetate (4 g; 9*8 m.mole) in dry benzene (25 ml) was added
to the Orignard solution and the mixture refluxed for
4 hours and then left at room temperature for 12 hours.
The produot was decomposed with water (100 ml) followed by
50$ acetic acid and finally steam distilled. The reaction
mixture was extracted with ether) washed with water and dried
over anhydrous sodium sulphate. The ether extract was
0
evaporated and the residue dried at 80 C in a drying-pistol
yielding 3.75 g of 25-hydroxycholesterol.
The analytical sample was prepared by chromatography of
the foregoing material on deactivated (3$) neutral alumina
(17 g). A suspension of 0.33 g in benzene (25 ml) was
chromatographed. The material was applied to the column in
5$ ethyl acetate in benzene (25 ml) and elution was achieved
by 10$, 15$, 20$ and 35$ ethyl acetate in benzene. The
40-00$ fractions were pooled and on evaporation gave 309 mg
pure 25-hydroxycholesterol. Crystallization from methanol
with small amounts of ether afforded 280 mg of white needles.
Methanol alone furnished a white amorphous powder,
m.p. 182.5 Reported m.p. 182
- -40 (C,0.5, d-0.10) -39
IR (D) - Fig. 4.
C27H46°2 re9uire* C - 80.5$, H - 11.4$} found













• 9 1— ORIGIN
Fig. 15.
The alphabets A - C represent the following compounds.
Solvent system «» benzene t petroleum ether t ether at 2 a 2 a 1.
(A) Cholest-5~®»~5^-,acetato.
(B) 25-keto-nor-cholesterol.
(0) 3/3-acetoxy-20<x-hydroxy-5-cholenic acid lactone.
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Compound 'x':
lie a idue 216-218*5 from pooled fractions (see prerious
section) was dissolved in 40^ benzene in petroleum ether
and rechromatographed on deactivated (10$) neutral alumina
(IS g).
Elution was accomplished with increasing amounts of
benzene followed by pure benzene and then 2$ and 5$ ethyl
acetate in benzene. This gave 110 mg of a pure compound*
In spite of chromatography the residue was slightly yellow,
and was decolourised by treatment with activated charcoal
in ethyl acetate solution* Crystallization of the residue
from ethyl acetate - ether mixture afforded 90 mg of white
needles, highly soluble in benzene and sparingly soluble in
ethanol* The compound was more mobile than cholesterol on
TLC (lif* 0*75, benzenexethyl acetate:acetone: :10:5:3) .
,the
Infrared spectrum revealed/absence of hydroxyl peaks and
«• : • —I —1
presence of two ketonic peaks at 1738 cm and 1763 cm ,
the former oan be ascribed to the carbonyl stretching of
3/)-acetate, while the latter is typical of a V-lactone
(ftyer and Gebert 1952) carbonyl stretching vibrations*
From these considerations and also that 25-keto-nor-cholesterol
acetate was prepared by the chromic aeid oxidation of
cholesterol acetate dibromide, this compound 'x* vas




■ •p. - <£<22-223.6 Reported 218-219
C*)*6 - -26.0 (c,0.406|d,0.06)
ia (V) . Fig. 5.












Thin layor ohromatogram 3howing relative mobilities of
the purified compounds in the solvent system* benzene s ethyle acetate













purified by crystallization from ethyl acetate:heOH, and
26-hydroxycholesterol was prepared according to the method
of Scheer, Thompson, and Mossetig (1956).
l) Clemensen Reduction of Kryptogenin
Kryptogenin (5 g) was dissolved in ethanol (350 ml) and
the solution was added to freshly prepared zinc-amalgam from
105 g zinc powder, 130 ml water, 10 g mercuric chloride and
6 ml conc.hydrochloric acid in an r.b. flask fitted with a
condenser and a dropping funnel. The mixture was heated to
reflux temperature and 84 ml of hydrochloric acid was added
over 3 hours. Kefluxing was continued for another 30 minutes.
The reaction was followed on TLC (benzene:ethyl acetate:
acetone::10:5:3). Kryptogenin was totally converted to
more mobile products (3 spots) during/first twenty minutes,
the most mobile being an unknown product, the least mobile
was identified as cholest-5-en-3J3,26-diol-16-one, and the
middle spot being 26-hydroxy-choleaterol, whioh increased
during the course of reaction, and the least mobile product
decreased subsequently. At the end of three and a half
hours there were three products more mobile than 26-hydroxy-
cholesterol and two products less mobile than the 16-keto-diol•
The mixture was cooled, decanted off from zinc amalgam
which was washed twice with 30 ml ethanol. Water was added
to the ethanolic solution and extracted with ether. The
58.
ether extraat was worked up in the usual way. The residue
was cryatullized from hot benzene and the crystals were
free from the more mobile impurities. Repeated
crystallization of the needles obtained from benzene did
not remore the traces of the keto—diol from 26-hydroxy-
cholesterol. This keto-diol impurity could not be removed
eren after repeated treatment with Girard reagent T or P.
In this way only a partial ketonic fraction was removed.
Column chromatography on active (type '0* Peter Spence) as
well as neutral alumina or silicic acid could not achieve
their separation.
Finally the mixture of keto-diol and 26-hydroxycholesterol
in methanol was reduced with an aqueous solution of sodium
boro-hydride (NaBH^) (l g in 4 ml water) and worked/alt usual.
The reduction product was then chromatographed on deactivated
(5$) neutral alumina.
The reduction product (3.0 g) wua suspended in benzene
and chromatographed on alumina (120 g)• The column was
eluted with benzene (250 ml), 0.3% MeOH in benzene, followed
by 0.75$ methanol in benzene (1100 ml). The last fraction
gave pure 26-hydroxycholesterol which after crystallization
from methanol gave 1.8 g of white needles,
m.p. - 177-178° Reported 177-178°
(?<)jj7 - -31.9 -30
IR (V) - Fig. 7.
C27H46°2 re<luires C " 80.59, H » n«44j found C - 80.61,H«11.28
59.
d) by iluan^-Alinlon reduction
Kryptogenin (10 g) was reduced first with Clemmensen's
method for two hours and forty-five minutes. The reaction
mixture was worked up as before (total recovery 91$).
The recovered mixture (9.1 g) was heated with freshly
distilled triethylene glycol (175 ml) and hydrazine hydrate
(99-100$, 15 ml) on a heating mantle, in a r.b. flask fitted
with an air condenser. After refluxing for half an hour,
potassium hydroxide (17 g) was added carefully over a period
of 20 minutes. Addition of potassium hydroxide depressed
the boiling point of the mixture to 145°C. The air
condenser was removed and the solvent was allowed to
evaporate until the temperature reached 160°C, when the
condenser was replaced and more hydrazine (5 ml) was added.
The mixture was allowed to boil at 155-156° for half an hour.
Finally the air condenser was removed and the temperature
allowed to rise to 187°, and the mixture refluxed for two
hours. The reaction mixture was allowed to cool and then
poured into 0.5 N HC1 (1000 ml) and left at 3°C for eighteen
hours. White needles were collected on a sintered-glass




IK (V) = Fig. 7.




Mother liquors from the Clemmensen reduction and
Huang-Minion reaction were pooled (residue about 4 g) and
acetylated at room temperature in pyridine and acetic
anhydride. The acetylated product was poured on to
crushed ice and extracted with ether, washed, dried and
evaporated. The residue was chromatographed on silicic
acid.
A solution of 20$ benzene in petroleum ether was
passed through the column, and elution was effected with
increasing amounts of benzene followed by ether in benzene.
In the 70$, 80$ benzene in petroleum ether and 4$ ether in
benzene fractions about 0.7 g of pure diacetate was obtained
which on crystallization from methanol afforded white needles
(0.5 g} itf.0.6 benzene:petroleum etliersethyl acetate::
40:20:5).
m.p. 128° reported 129°
figure, 16.
61.
Cho 1 e s t—5—en—3p>« 25-nor-dio 1—3 p—ac e tate
Sodium borohydride (0*3 g) was dissolved in aqueous
methanol, and a solution of 25-keto-nor-cholesteryl acetate
(0.4 g; rtf.0.73 in benzene:ethyl acetate:acetone:>10:5:3)
in ether (10 ml) was added slowly while stirring the solution
gently. The reaction mixture was left at room temperature
for one hour. Complete reduction to a more polar product
was shown by TLC (Kf.0.72, solvent system same as above).
The reduction product was worked up as usual, and the
ethereal residue was crystallized from methanol to yield
25-hydroxy-nor-cholesteryl acetate as flat plates.
Ei.p. ■ 120° Reported 122°
Mj5 „ -17.9
IR (V) - Fig. 8.
C ,8^46^3 reRu*r®* C«78.1, H«10.7; found C«78.2S, H-11.17
20-chloro-nor—cholesterol Acetate
25—hydroxy—nor—cholesterol acetate (Rf.0.33 in benzene:
petroleum ether:ether::2:2:1.25) was dissolved in anhydrous
ether (20 ml) and cooled to 0°, dry pyridine (0.1 ml) and
freshly distilled thionyl chloride (0.1 ml) was added and
the mixture left overnight. Approximately QOfc conversion
to a less polar compound was shown by TLC (Rf.0.82 in benzene:
petroleum ether:ether::2:2:1.25)• The mixture was refluxed
for two hours, allowed to cool and then filtered. Pyridine
hydrochloride was washed with more ether and the combined
etheral solution was washed with NaliCOg solution (5%), water
62.
and then dried over anhydrous sodium sulphate and evaporated.
The residue (0.42 g) was dissolved in petroleum ether and
chromatographed on neutral alumina (15 g). The column was
eluted with increasing proportions of benzene in petroleum
ether and finally ethyl acetate in benzene gave pure
25-chloro-nor-cholesteryl acetate (0.27 g) on crystallization
from petroleum ether as needles,
m.p. - 117.5°
C28H45°2 C1 re<luirM C-74.01, H-10.03, Cl-7.01} found C-75.15,
H-10.07, Cl-7.70.
The column was further eluted with 20$ and 40$> ethyl acetate
in benzene and 25-hydroxy-nor-cholesteryl acetate (120 mg)
was recovered.
25-cyano—nor-cholesterTl-acetate
0.25 g, 25-chloro-nor-cholesteryl acetate (ftf.0.68 in
benzene:petroleum ether:ether::2:2:l) was dissolved in
dimethyl sulphoxide (5 ml) and refluxed with KCN (0.25 g)
under nitrogen. The reaction was followed on TLC. No
further reaction took place after four hours. The reaction
mixture was cooled, poured into water and extracted with
ether. The ethereal extract was washed free of cyanide ions
with water (no ppt. with AgNO^ solution) dried and evaporated.
The residue shoved one main spot corresponding to 25-cyano-nor
-cholesteryl acetate (Rf.0.57) and three smaller spots
corresponding to the starting material, 25-chloro-nor-cholesterol
(Hf.0.185) and 25-cyano-nor-cholesterol (Hf.0.13).
63.
Cholest-5-en-3[3-ol-26-oic Acid
The above mixture was not further purified but was
hydrolysed in aqueous-dioxane (20$, 5 ml) and KOH (150 mg)
at reflux temperature for 8 hours, under nitrogen, cooled,
diluted with water and extracted vith ether (2 x 5 ml) to
remove non-acidic material* The aqueous phase was acidified
with dilute hydrochloric acid and left overnight, filtration
gave an insoluble precipitate, which was washed neutral with
water and dried* Recrystallization from ethanol and water
O
gave cholest-5-en-3/*-ol-26—oic acid (Ca.100 mg) (m*p. 172-175
reported 176-178°)•
When hydrolysis was performed in alcohol for 30 hours,
almost all of the 25-cyano-nor-cholesterol was recovered from
the alcoholic hydrolysate after dilution with water and
extraction with ether. Very little acidic product could
be extracted with ether after acidification.
Choleat-5-en-3ft*26-diol
Cholest-5-en-3/3-ol-26-oic acid (50 mg) was dissolved in
tetrahydrofuran (2 ml) and was dropped in a suspension of
LiAlH^ (100 mg) in THF (5 ml). The mixture was refluxed for
two hours and worked up as usual. Chromatography of the
product on neutral alumina furnished pure cholest—5-en-3/?,26-
diol in 20$ and 30$ ethyl acetate in benzene. The residue
from these fractions was crystallized from benzene and white
needles of cholest-5-en-3/^,26-diol were obtained. The
64.
ooaponnd im identical with that obtained fron kryptogenin*
Melting and nixed nelting point - 177°- 179**
Figure. 17.
65.
Cho 1 es t-5-en~3 ft. 22 £-di o1 -3/3-ao e tate
clcLcL
3ft-tfydroxy-bisnorchol-5-enic/(5 g) was refluxed with
acetic anhydride (3 ml) in a Mixture of pyridine and benzene*
Hecrystallization of the residue from acetone/benzene afforded
3^-acetoxy-bisnorchol-5-enic acid (3 g) which was dissolred
in freshly distilled thionylchloride (10 ml) and left
overnight. Dry benzene was added, taken to dryness in vacuo
and the residue crystallized fron/small volume of benzene,
(yield 1.0 g). The acid chloride was then thoroughly dried
under high vacuum*
A Grignard reagent was prepared from 0*23 g of magnesium
in ether (40 ml) and 1.01 g of iso-amyl bromide, and refluxed
for a further fifteen minutes* The flask vas cooled in an
ice-bath and anhydrous cadmium chloride powder (0*6 g) was
added while stirring. The ice-bath was removed and the
mixture refluxed for 45 minutes. To the suspension of
liquid di-isoamylcadmium in ether vas added a benzene solution
of the acetoxy-bisnorcholenic acid chloride) and the mixture
refluxed for one hour, and left overnight at room temperature*
Hydrolysis was accomplished with 10$ hydrochloric acid) the
ether layer vas separated and the acidic layer re-extracted
thrice with ether. The ether extracts were combined, washed
until neutral with water, dried over sodium sulphate and
evaporated to dryness. The residue was chromatographed on
deactivated (5$) neutral alumina (100 g) • The column was
prepared in petroleum ether and the residue dissolved in 20$
66.
benzene in petroleum ether was adsorbed, Elution with
40fit 60% and 76% benzene in petroleum ether afforded
cho 1eat-5—en-3|3-acetoxy-22-one on evaporation. The
residue was crystallized from ether-methanoi and pure
cholest-5-#n-3/i—acetoxy-22-one was obtained (Rf.0.59 in
benzene (petroleum ether: ether s :2>2il).
m.p. » 152-153 deported 154-155
aa
(oc)J° - -63.3 (c,0.505jd,0.16) -63.7
la (V) • Fig. 9.
C29H46°3 re1uires C-78.73, H-10.40; found C-78.71, H-10.15
The mother liquor was evaporated and the residue
(300 mg) was reduced with Na J3H^ in aqueous methanol in
the usual way. The reaction mixture was left overnight
at room temperature. TLC assessment on the following
morning showed incomplete reduction, therefore it was
refluxed for one hour. The reduction mixture was acidified
and extracted with ether, washed until neutral, dried and
evaporated. The residue (320 mg) was chromatographed on
neutral alumina (15 g) deactivated with \% water.
CHROMATOGRAPHY
The reduction mixture was dissolved in petroleum ether
and passed through the column. Elution of the column with
20^, 50/<, 60% benzene in petroleum ether and then pure
beazene left no residue on evaporation. Ethyl acetate in
benzene (2^, 6% and then 10^) removed some more mobile
impurity and 15$ and then 20$ ethyl acetate in benzene
ft7
fractions ( 25 ml oseh ) goro pure cholost-5-«n-3/3-*ceto*y-22t-ol
( Kf. 0*63 in benzene t ethyl acetate is 111 ).
■•Pj . 168-169.5°
- -68.0 ( c, 0.31) d» 0.105 )•
IB (V) - Fig, 10.
C20H48°3 re(iuire* C-78.37, H-10.81; found C-78.48, H-10.67
68.
Cho lea t—5—en—3 ft, 4 (3-di o 1
This compound was prepared according to the method of
Uosenheim and Starling (1937).
Selenium dioxide (ii.5 g) was dissolved in water (1.5 )
and glacial acetic acid (50 ml) was added. The solution was
heated to 80°C, and was rapidly added to the benzene (d5 ml)
solution of cholesterol (5 g) also heated to 80°C. The
mixture turned yellow and finally red. After one hour
refluxing, sodium acetate (10 g) was added and the heating
continued for an additional 10 minutes. The solution was
filtered into half-saturated sodium chloride solution (100 ml)
and the benzene layer separated, washed with water, dried
over sodium sulphate and evaporated under vacuum. The
residue was washed with petroleum ether, and crystallized
once with acetone and finally with 85$ methanol, to yield
slightly yellowish needles.
in.p. * 176° deported 176-177°
Mjj6 » -61.0 (c,1.0;d,0.305) -60
Itt (V) = Fig. 11.




Cholesterol (5.0 g) and haematoporphyrin (14 mg) were
dissolved in dry pyridine (100 ml) and photo-oxygenated for
fourteen hours. The reaction was followed on TLC as
described in details elsewhere. After six hours 50 per cent
conversion was observed on the TLC plate (cholesterol Rf.0.76{
5ot—hydroperoxy product Rf.0.5 in benzenesethyl acetate::3:2)
Pyridine was removed under high vacuum on a water-bath
not exceeding 45° using solid C0^ in acetone traps. The last
traces of pyridine were removed by treatment with dry
chloroform free from alcohol, and subsequent evaporation
until a dry residue was obtained.
The residue was treated with dry chloroform (100 ml)
left overnight in the dark and filtered the following morning.
The residue (R^) was resuspended in sufficient dry chloroform
and left for 48 hours for isomerizatiou with occasional
shaking at room temperature. Some of the residue did not
dissolve during the first twelve hours and more chloroform
was added. After forty-eight hours the solution was filtered
to remove any suspended material and the filtrate evaporated
under vacuum on a water-bath maintained at 45°C. The
residue (2.0 g) was dissolved in ether (1000 ml) and reduced
with hydrogen using palladium-on-charcoal catalyst (0.5 g)•
After one hour no spot corresponding to hydroperoxide was
detected on TLC plate and the catalyst was filtered and the ether
70.
evaporated. There were two spots on TLC plate, the nost
polar corresponding to the 7«>(.-hydroxy-chole8terol, and the
second was an unknown product having the same mobility as
cholesterol. The ether residue was dissolved in 30# ether
in petroleum ether (60-80) and chromatographed on silicio
acid (50 g). The column was eluted with increasing amounts
of ether in petroleum ether and 100 ml fractions were collected.
Ether (90#) in petroleum ether (200 ml) gave pure 7°c-hydroxy-
cholesterol (1.6 g). Crystallization from methanol afforded
1.3 g of white needles.
m.p. - 187-188° Reported 188°
Mj2 - -91.4
IR (1>) - Fig. 18.
C^H^gO^ requires C-80.59, H-ll.44; found C»80.83, H>11.6
The filtrate from residue (R^) was treated with
charcoal to remove the catalyst. Filtration and then
evaporation gave a residue which was disao lved in 20# ether
in petroleum ether and chromatographed on silicic acid (3#
water) and 30# and 35# ether in petroleum ether eluted
cholesterol, while the 45# ether fraction gave a residue
o o
r ,82
m.p. 152-155, t*)D - 1<20 which showed a single spot on TLC.
Catalytic reduction of this residue gave several spots on
TLC. From the reduction mixture pure 7<*-hydroxycholesterol
could not be obtained by direct chromatography. Chromato¬
graphy of the acetylated mixture was not attempted.
In another experiment when photo-oxygenation was conducted
71.
for twenty-three hour* the overall yield of 7^-hydroxy-
cholesterol was only 18J&.
When a portion of the filtrate obtained from the
residue above was reduced catalytically (H^-Pd on C) white
needles were deposited during the reduction. The reaction
mixture was filtered and the crystals mixed with catalyst
were thoroughly washed with a generous amount of ether.
The residue was then extracted with tetrahydrofuran and
evaporation of this solvent gave a powdery residue which
was sparingly soluble in hot alcohol. The amorphous
powder was crystallized from pyridine-methanol in white
needles. The identity of this compound was established
by mixed melting point with known synthetic cholest-4—en—3/3,
6/3-diol (page ) and co-chromatography.
m.p. - 257-260°
7d.
Chromatographic separation of cholest-5-en-3ftt7°C-diol and
choleat-5-en-3/3.7/3-diol throuc.li tlieir diacetatea.
eru-
A mixture of cholest-5-en-3/3,7/3-diol and cholest-5-j(5/3,7<x-
3/9
diol was obtained by the reduction of cholest-5-en-^ol-7-one by
meana of NaBH^. The reaction product was acetylated in
pyridine at room temperature for Id hours and worked up as
usual. The mixture of diacetates thus obtained did not
separate on ILC and run as a single apot (Kf.0.5d in benzene:
petroleum ether:ether::d:d:l; cholesterol acetate and
cholesterol had lifs.0.84 and O.dd respectively). The mixture
(600 mg) was chromatographed on neutral alumina (50 g). A
solution of diacetates in petroleum ether was passed through
the column and eluted with dO/k, 40/e, 60^, 80% benzene in
petroleum ether followed by d/& ethyl acetate in benzene.
These fractions (100 ml each) gave more mobile impurities.
The later ethyl acetate in benzene fraction (100 ml) gave
a residue (340 mg) from which a few mg on hydrolysis with 5%
methanolic NaOH gave two spots on TLC corresponding to the
7/3- and 7oC-hydroxycholesterols (Hf.0.d5 and O.d respectively
in benzene:ethyl acetate:: 1:1) . Then 6/c ethyl acetate in
benzene gave a residue (130 mg) which on hydrolysis afforded
pure cholest-5—en—3/3, 7/3-diol. Further elution with \0% and
t&Q/o ethyl acetate in benzene followed by elution with pure
ethyl acetate gave partially hyurolysed products (31 mg).
Physical characteristics of cholest-5-en-3/3,7/3-diol
73.
m.p. = 178° reported 178°
COjJ6 - +15 +7
Itt ^V) = Fig. 13.
requires C=80.5, 11=11.4; found 0=79.98, 11=11.79
/the
Residue fron./4/o fraction (340 mg) was again chromato-
graphed on neutral alumina (35 g) and eluted as described
above using 50 ml eluants each time. Up to 2,cjo ethyl acetate
in benzene left no residue on evaporation. However the 3'jo
ethyl acetate in benzene was collected in two portions -
30 ml and dO ml. The residue from the 30 ml portion was
hydrolysed and pure cholest-5-en-3|S,7oc-diol (10 mg) was
obtained. The dQ ml portion gave a residue (76 mg) which on
hydrolysis furnished a lsl mixture of cholest-5-en-3^,7<x:-diol
anu cholest—5-en—3/5,7^3-diol. The 6ft and 8/c ethyl acetate in
benzene fractions gave a residue (176 mg) which on hydrolysis
gave pure choiest-5—en-3/5, 7/i-diol. Later the 50^> ethyl
acetute in benzene gave a partially hydrolysed product (36 mg)
which on hydrolysis gave a mixture of isomeric diols in almost
e^ual proportions.






Choiest-5-en-3y3-acetoxy-7-one was prepared according to
the uiethod of Fieaer, Fieaer and Chakravurti (1949) uaing
chromic anhydride in glacial acetic acid and choleaterol
was hydrolysea in methanol (500 ml) and potaaaium carbonate
(3 g in 40 ml water) at room temperature for twenty-four hours.
The solution was warmed, diluted with water and left for
crystallization. Crystals were separated, washed, dried,
dissolved in 10^ ether in petroleum ether and chromatographed
on neutral alumina (80 g). fcther eluted cholesterol and
7-ketocholesterol was obtained by elution with 10$ acetone in
ether followed by 50$ acetone in ether (m.p. 169-171°).
Separation of 7oc and 7/3-hydroxycholesterols
A mixture of 7<x- and 7/?—hydroxycholesterols was obtained
by the reduction of 7-ketocholesterol with sodium borohydride.
For the separation of these two isomerio diols, the mixture
was placed on a neutral alumina column with varying amounts of
water. The column was prepared in petroleum ether and eluted
with 10$ acetone in petroleum ether. The solid mixture was
stirred occasionally to facilitate its solution; care was
taken not to disturb the alumina surface. In all cases 15$
acetone in petroleum ether invariably dissolved all the solid
mixture on the column. More alumina of the same activity
,a
was then added to the column to give/1 cm. covering layer.
The results are given in tabular form. The percentage of
acetate. 7-ketocholesterol acetate
Ift-Figure 14.
9 g/) thus obtained
75.
water on the alumina was critical for a good separation of
these isomers. When active neutral alumina was used or
when deactivated (3^ water) alumina wus used almost no
separation of the two isomers could be achieved* increasing
the activation of the alumina from 3fo to 2!)c water improved
the resolution of the two isomers and the best separation
was achieved when \f> water was used for deactivation purposes*
Physicul characterestics of (a) cholest-S-en-S^^/i-diol
m.p, - 178° iieported 178°
wf - +15 +7
(b) cholest—5—en—3[*t 7<-diol
m.p. 187-188° deported 188°
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5ft-Choleatan-3<sC--l2<C-dio 1 (Dihydroxy coprostane-OHC)
Anodic Coupling of Deoxycholic and Isovaleric Acids:
. o
To a solution of Deoxycholic Acid (m.p. 174-176, 20 g;
0.0685 molar) in methanol (700 ml) was added a solution of
sodium methoxide (3 g sodium metal dissolved in 100 ml
methanol) and Isovaleric acid (87 ml or 81 g; molar ratio 1:12).
The solution was electrolysed between two Vt-plates (l" x 2")
as electrodes, 0.2 cm. apart for nineteen hours with 18 v.
and 1.75 amps in a beaker cooled with surrounding icewater.
The reaction was followed on TLC plates every three hours
(solv.system chloroformiacetone:ethanol:acetic acid::
54:19:7:0.3 ml ;) and at the end of eighteen hours there was
a trace of starting material (kf.0.25 same solvent system).
After electrolysis was complete (19 hours) the reaction
mixture was concentrated to half its volume, made alkaline
and left overnight. The following morning it was extracted
with ether and the ether extract worked up as usual. The
oily residue (20 g) was dissolved in petroleum ethermethylene
chloride::1:1 and chromatographed on a silicic acid (200 g)
column made in petroleum ether, and eluted continuously with
aft methanol in methylene chloride. The first fraction
(400 ml) was discarded as it contained less polar impurities.
An oily product was then eluted which was collected
separately and shown to be impure dihydroxy coprostane (150 mg).
The next fraction (600 ml) gave an oily residue which was
78.
shown to be a single spot on TLC (iif.0.64; chloroform:acetone:
methanol::9:3:l). The next fraction (150 ml) gave impure
DiiC (3*0 g) from which pure DHC (l.O g) was obtained on
re chroma tography.
The oily residue from both the chromatographic
procedures - 9.5 g were crystallized from acetone/water to
give white needles (8.4 g).
m.p. « 109-111° ileported 108—110°
(m +41.3 (c,0.0^6}d,0.13) +45
Itt ())) - Fig. 15.
C-,-H.o0 requires C-80.^, H-11.88; found C-80.14, 11-11.89
6 1 4b 6
5/3-cholestan-3-one-ld<<.-ol
5/*-choleatan-3oCtl<i'*-diol (6.07 g) was refluxed with
Aluminum-isopropoxide (9.0 g) in dry benzene (dOO ml) and
dry acetone (175 ml) for eighteen hours. The reaction
mixture was acidified with 3N-HC1 and the acidic phase
extracted twice with benzene. The benzene extract was
washed until neutral with water, dried over anhydrous sodium
sulphate and evaporated to dryness in vacuum. Chromatography
on neutral alumina (3^ activated; 300 g) was performed by
dissolving the residue in benzene:petroleum ether (1s1) and
passing the solution through a column prepared with the same
mixture of solvents. The column was then eluted with
benzene,and 5% ethyl acetate in benzene. Elution with ethyl
acetate (7.5^),(400 ml) gave an oily residue (150 mg)
79.
presumably 5p-cholestan—3,12—dione (Hf.0.78, benzene:ethyl
acetate:acetone::10:5:3) which could not be crystallized.
Elution with 10$, 15$ and 20$ ethyl acetate in benzene
(200 ml) eluted the pure 3-oxo compound (Rf.0.63 in the same
solvent system as above, 3.85 g). Further elution with 20$
ethyl acetate in benzene (200 ml) gave impure 3-oxo compound
contaminated with compound *0' (Kf.0.46). Further elution
with 30$ ethyl acetate in benzene gave pure compound '0* which
was crystallized from hot petroleum ether. Finally 100$
ethyl acetate gave no residue on evaporation and 5% acetone
in ethyl acetate (200 ml) and 15$ acetone in ethyl acetate
(400 ml) gave the starting material (1.9 g). These
dihydroxy coprostane fractions were pooled and the residue on
crystallization from acetone/water afforded 1.7 g of pure
. o
starting material (m.p. 108-111 C with slight softening at
105°C).
5^-cho 1 estan-3-one-l2<C-o 1 (3.85 g) was crystallized from
petroleum ether in white flakes (3.0 g), while at room
temperature with slow crystallization thick needles were
deposited. Themother liquor was worked up, recrystallized
and a fairly pure second batch of crystals (0.5 g) was
obtained.
in.p. - 126—127° Reported 122°
OA
COJ . +42,2 (c,0.474jd,0.l) +51
I K 0>) m Fig. 16.
C,,_H.-0o requires C-80.5, 11-11.5; found C-79.96, H-11.53dl 4o a
80.
Cho 1 e a t-4-en-3-one-l 2°C-o 1
A solution of 5/3-cholestan-3-one-12<-ol (2.0 g) and
selenium dioxide (1.6 g) in ethanol (400 ml) was kept at
0
60 C and the reaction was monitored on fluorescent TLC plates
every twenty-four hours (solvent system benzenesethyl acetate::
l:l). For the first three days 3e0^ (0.5 g) was added and
the reaction was slow. On the fifth day another 0.5 g SeOg
was added and the reaction was stopped after 148 hours, when
50conversion to a U.V. absorbing product (Rf.0.48, solvent
system same as above)less mobile than the starting material
(Rf.0.58) was observed on TLC.
The reaction mixture was filtered to remove precipitated
black selenium, evaporated and the residue dissolved in ether.
The ether solution was washed with IN-HC1, dried over
anhydrous sodium sulphate and evaporated. The residue (8.0 g)
was dissolved in benzene and chroi tla^r...phed on deactivated
(5%) neutral alumina (150 g). The column was eluted with
increasing amounts of ethyl acetate in benzene so that 5J&
(150 ml) and lOJfc (130 ml) removed all traces of less polar
impurities (total 175 mg)• The last 20 ml of 10^ and then
16% ethyl acetate eluates afforded fairly pure starting
material (1.03 g). Then 20% and 25^ ethyl acetate in
benzene (150 ml each) gave fairly pure cholest-4-en-3-one-12<x—
ol (0.69 g). In spite of rechromatography, charcoal
treatment, the material could not be completely freed from
traces of colloidal selenium. Finally on crystallization
81.
from acetone/water cholest-4-en-3-one-12<<-ol (0.5 g) was
obtained. Identity was established by comparison with the
known cholest-4-en-3-one-12<£-ol obtained from an independent
route by mixed melting point and co-chromatography.
m.p. « 150-152.5° Reported 142-143°
max m 242
r -«27
(oOj, - +96.38 (c,0.332jd,0.16) +86
IR (V) ■ Fig. 17.
C27fl44°2 r®1uir«» C-81.00, H-ll.Oj found C-81.22; H-11.03
Further elution of the column with ethyl acetate afforded
50 og of cholei
acetone/water.
which was
l st-l,4-diene-3-one-12<<-ol, recrystallized from
m.p. =» 196-197.5°
(oc)jj5*6. +40
^\max - 246 Figure 18a.
IR IV) = Fcg. is.
requires C»81.4, H-10.55; found C*=81#21, 11*10.67
Choleat-5-en-3^.12°c-diol (l2<-hydroxycholesterol)
Enol-acetylation of cholest-4—en-3-one-12oc—ol (0.5 g) was
accomplished by dissolving it in benzene (40 ml) containing
p-toluene sulphonic acid (70 mg) and isopropenyl acetate
(2 ml), and slowly distilling about 30 ml of the solvent in
three and a half hours. At the end of the first and second
hour 1 ml of isopropenyl acetate was added. The solution
was evaporated to dryness and the residue dissolved in ether








The reaction mixture after (A) after refluxing with
reduction with LiAlH . methanolic hydrochloric acid.
1= Cholest-5-en-3 »12 -diol.




washed with 5$ sodium carbonate and then with water. The
ethereal residue was dissolved in redistilled ethanol (100 ml)
oit
and after cooling to 5 C was added to a solution of sodium
borohydride (l g) in 25 ml 70$ ethanol and the mixture stored
overnight at 5°C. The solution was then heated to boiling,
20 ml 5$ aqueous sodium hydroxide was added, refluxed for half
on hour and then most of the ethanol evaporated in vacuo.
There was no hydrolytic product on such treatment. After
acidification and extraction with ether, the dry residue was
dissolved in ethanol (35 ml) containing 3 drops of ocnc.
hydrochloric acid and refluxed for one hour to dehydrate
any 4-ene-3-ols formed to cholest-3,5-diene-12<<-ol• Under
such a iaild treatment 12«t-hydroxy or 5-ene-3—ol groupings
were unaffected.
/Solution ,The ethanol/was concentrated to about l/4th of its volume.
Excess ether was added and the ether layer washed with
sodium bicarbonate solution and worked up. The dry residue
was reduced with LiAlH^ (0.4 g) in THF to remove the acetoxy
group formed at and the reduction mixture then worked up.
The residue was dissolved in benzene and chromatographed on
deactivated (5/ water) neutral alumina (60 g) and eluted with
increasing amounts of ethyl acetate in benzene. Benzene -
2/t ethyl acetate fractions gave the dehydration product i.e.
cholest-3,5-diene-12<>(-ol (Kf.0.71 in benzene:ethyl acetate::
1:1) while 20$ and 25$ ethyl acetate in benzene furnished
cholest-5-en-3/),12°(-diol (ftf.0.38). Crystallization from
83.
benzene afforded pure Id -hydroxycholesterol in white needles,
m.p. - 152-153.5° deported 149-150°
- -28 (c,0.55;d,0.08) -27
IH (})) - Fig. 19.
C27H48°2 re<luire» C-80.5, 11-11.4; found C-80.71, H-11.48.
Cholest-3,5-diene-12o<-ol was crystallized from chloroform—
methanol in white needles,
m.p. ■ 119—121°
C°0f " -84,9
IH (V) - Fig. 20.
\max « 229, 235, 244. Figure 20a.
C27H44° re<luires c-84.34, H-11.45} found C-84.71, H-11.69.
Cholest-4-en-3-one-12«-ol dini trophenyl hydrazone
5/5-cholestan-3—one—12«—ol (0.5 g) was dissolved in
glacial acetic acid (6 ml) and bromine solution (0.65 ml)
prepared by diluting 0.2 ml bromine with 2 ml acetic acid,
was added dropwise at room temperature. The bromine colour
was immediately discharged and after standing for half an hour,
acetic acid was removed in vacuo, and the residue redissolved
in acetic acid (20 ml), 2,4-dinitrophenyl hydrazine (300 mg)
added and the mixture warmed under nitrogen to dissolve the
hydrazine. After a few minutes heating the hydrazone started
to crystallize out and heating was interrupted after an
additional three minutes. Cooling the solution overnight
under nitrogen deposited a coloured hydrazone. Excess
chloroform was added to dissolve all the hydrazone, and the
84.
chloroform solution was washed with water, concentrated and
crystallized after adding ethanol. Filtration and washing
with ethanol afforded pure dinitrophenyl hydrazone (430 mg
iif.0.82 in benzene sethyl acetate: si si) •
m.p. «■ 240-241 *5° deported 237—239°
CHClg
A max - 394 ynfL
IH (V) - Fig. 21.
^33it48I,l4®5 re<lu*re* n"9.6| found N«9.02f»
Cho 1 e s t-4-en-3-one-l 2oC-o 1
A chloroform (30 ml) solution of the hydrazone (420 mg)
was mixed with pyruvic acid (13 g) and 2.5 ml, 5*5 N-hydrogen
bromide in glacial acid. Fyruvic acid formed a separate
upper layer and therefore the mixture was shaken occasionally
while it was warmed between 50-60°C for five hours. It was
then diluted with more chloroform and pyruvic acid or its
hydrazone removed by washing the solution with aqueous sodium
carbonate. The coloured residue from chloroform was
chromatographed on deactivated (5fc) neutral alumina (50 g)
as before. hlution with 15$ ethyl acetate afforded
cholesv-4-en-3-one-12°c-ol (100 mg) • A slight yellow colour
of the residue was decolorised by treatment with activated
charcoal in ether. Crystallization of the ethereal residue
from methanol-water furnished pure cholest-4—en-3-one-12<—ol
(80 mg).
85.
■•p. - 151-153° ttoportod 143—148°




Choi eat-5-en-3|3, 7«c ,26-triol
Piihl'AitAT ION
(i) In chloroform.
A solution of cholest-5—en-3/J,k6-diol (-50 mg, for
preparation refer section I) in chloroform (50 ml; dry and
alcohol free) was photo-oxygenated with haemutoporphyrin methyl
ester (10 mg) for ten hours.
The reaction was followed on thin layer chromatoplates
(TLC) every hour. Two spots of the sample mixture were put
on the fluorescent TLC plates, well separated from one another,
and run in a solvent system (benzene:ethyl acetate:acetone::
10:5:5). After drying off the solvent the plate was viewed
against a U.V. lamp, but no dark spot was located* Half of
the plate was sprayed with 10% KI in kO% aqueous ethunol
acidified with acetic acid, and the other half was sprayed with
phosphotungstic acid (LTA). Hydroperoxides give a yellow spot
(ilf.0.5) of liberated iodine with Kl-solution after heating the
plate at 1-0°, The total number of products i.e. starting
material, desired 7«—hydroperoxide and decomposition products
of hydroperoxide such as hydroxy and icetonic compounds were
seen on the FTA—sprayed side. This reagent gave a
characteristic pink colour with hydroperoxides, flesh colour
darkening to chocolate brown with cholest-5—en—3fl, 26-diol
(iif.0.7) and a blue colour with cholest—5—en—3|i, 7<x.,li6_triol,
cholest—6—en—5<C—26—triol or cholest—5—en—3)3,7/5,26-triol.
87.
No distinction between the latter two compounds could be made,
because both had the same mobility and colour response with
PTA, on TLC.
The photosensitizer was removed by treatment with
charcoal and filtration. The clear filtrate was taken to
dryness under reduced pressure at 40°C, and reduced with
LiAlH^ in tetrahydrofuran (TIlF). hxcess hydride was
decomposed with water and the product extracted with ether
several times after the addition of a saturated solution of
potassium sodium tartrate (Hochelleta halt) (10 ml). Thin
layer chromatography showed incomplete reduction, hence the
product was reduced again. The second reduction was almost
complete and there were three main spots, the least mobile
(iif.0.3) being the 7«c-isomeric triol, and the second more
mobile blue spot was deduced to be cholest—6-en-3|i,5o(—b6-triol
(Kf.0.4), the third being the starting material (tif.0.7).
C HUPAtAT0hitAPHY
The desired 7<<»-isoraeric trio! was separated on
preparative TLC-plates. The plates were run tnrice for
forty-five minutes in benzene:ethyl acetate (ltd) and for
each subsequent run the plates were air-dried. In this way
the two main reduction products were separated sufficiently
apart (Kfs.0.37 and 0.54). both sides of each plate were
sprayed with PTA and the areas corresponding to the
cholest-5-en-3|5,7cC,.i6-triol was scraped off and extracted
from the silica gel by means of methanol. The solution was
88.
from methanol and water afforded an amorphous powder (30 mg).
Ihysical characteristics
IK (V) = fig. 22.
C27U46°3 reKuire* C-77.51, H-11.00; found C=77.31, H-11.03.
(ii) In pyridine solution
Cholest-5-en-3/J,20-diol (l.O g) was dissolved in dry
pyridine (100 ml) containing haeuatoporphyrin (14 mg; and
after sixteen hours an auditional 6 ug) und the solution
poureu into a photo—oxygenation tube* Oxygen was bubbled
in a steady stream for twenty-four hours under illumination.
The reaction was monitored on fluorescent TLC—plates as
described earlier. After nineteen hours no substantial
decrease in the amount of starting material was observed.
At the end of twenty—four hours there were four spots on the
plate, one having the same mobility as cholest-5-en-3/3,2t>—diol,
the second and major spot being cholest-G—en—3/3, at—diol-5<<-
hydroperoxide ^yellow spot with Ivi-solution) followed by two
less mobile spots (blue with i'TA) in the region of cholest-
5-en—3p,7<£,a6-triol and cholest—b-en—3/3,6<c,dC-triol. The
photo-oxy^enation mixture was then treated with charcoal to
remove the catalyst, onu the pale yellow solution was
concentrateu in a rotary evaporator at 45°C. Traces of
m.p. " 218° deported 108-172
(*}£• - -77.3 (oc^4 - -79
89.
pyridine were removed by treatment with chloroform* The dry
powder thus obtained was suspended in 100 ml chloroform
(acid, alcohol free) and left at room temperature for thirty
hours with occasional shakings, filtered, and the filter
paper washed with hot chloroform. The filtrate was then
evaporated on a water pump at 40°C and the residue dried under
high twcuum for several hours. A TLC-plate at this stage
showed no further decomposition products. deduction of the
performed
isomerised product with LiAlH^ was /y : in TilF. The LiAlH^
(0.5 g) was suspended in <40 ml freshly distilled THF and a
solution of isomerised product in the same solvent (5 ml)
was dropped in carefully. After standing for one hour at
room temperature the mixture was refluxed for half an hour,
cooled and excess of LiAlH^ decomposed by careful addition
of water. A saturated solution of potassium sodium tartrate
was added and the reduction products extracted several times
with ether and worked up as usual. The residue,when run on
TLC-plates still showed substantial amounts of unreduced
hydroperoxide and therefore the product was reduced again.
This time the reduction product showed only a trace of a
hydroperoxide spot on TLC. The reduction products were
comparable to those obtained with direct photo—oxygenation
in chloroform.
Chromatography of the product on neutral alumina (with
or without water) did not separute cholest-b-en-3/S,5«c,<46-triol
from cholest-5-en-3/J,7o(,«56-triol. All the fractions
90.
containing the chole;it-5-en-3p, 7«><,d6—triol were contaminated
with cholest-G-en-3/5,5<rt,2G-triol. Those fractions which had
a little impurity of cholest-G-en—3/J, 5ot,<i6—triol were pooled
and the residue crystallized several times from ethyl acetate,
but the crystals were mixed with the more mobile 5<-triol.
Cholest-5—en-3/J, 7°c,26-triol was then purified in the following
manner.
The mixture (0.5 g) as white amorphous powder was
transferred to a boiling tube provided with a drawn out long
neck. Acetone in petroleum ether (50:50) (10 ml) was poured
in, the glass tube was then sealed up after adding a few
glass beads, and subjected to equilibration between solid
and solution phases on an oscillating shaker in a cold room
for a fortnight. The more soluble cholest-b—en-3/J,5<*,26-triol
went into solution and the less soluble cholest-5—en-3/3,7<*,
26-triol initially dissolved was precipitated. The tube
was opened, centrifuged, and the clear supernatant containing
mainly the 5°<-triol was pipetted off. Five to six such
treatments gave pure cholest-5-en-3/i,7«,26-triol (*i40 mg).
The amorphous powder was then crystallized from hot
ethyl acetate as white semicrystulline needles. A mixed
melting point with the previous sample did not depress the
melting point and confirmed the identity of the two products,
m.p. = 218°
91.
■SEPARATION OF Clll. .ST-")-. -3fl, 7°C.k6-TllIOL AND C110LE3T-6-
EK—3/3. 5oC. 26—THIOL AFTLH ACETYLATION
the
A mixture of/isomeric triols (300 mg) was acetylated in
pyridine (5 ml) with acetic anhydride (0.5 ml) at room
temperature for four days and worked up as usual. The
ethereal residue (320 mg) of triacetates showed a single
spot on TLC plates in two different solvent systems (Rf.0.7
in benzene:ethyl acetate::1:1, and 0.4k in benzene:petroleum
ether:ether::1:1:1 or 0.3 in 2:2:1) and was chromatographed
on alumina (Spence '0' type; 15 g). The triacetate mixture
was dissolved in petroleum ether and passed through the
column, which was eluted with increasing amounts of benzene
in petroleum ether i.e. 10, 20, 30, 40, 50, 75 per cent
benzene, followed by pure benzene and finally with Z'fo ethyl
acetate in benzene. All these fractions (25 ml) left no
residue on evaporation. The ethyl acetate in benzene (.5?<>)
fraction gave 100 mg of residue which on hydrolysis with 5/t
NaOH in aqueous methanol overnight at room temperature gave
pure cholest-5-en-3/?,7c<,26-triol. Further elution with
7.5> and 10^ ethyl acetate in benzene gave B5 and 30 mg of
residue respectively, which on hydrolysis gave a mixture of
the two isomeric triols. Further elution resulted in
hydrolysis of the product on the column, therefore the column
was washed with methanol and the total isomeric mixture was
reacetylated and rechromatographed on neutral alumina (10 g)
and eluted as above. The ethyl acetate (5^>) fraction on
92.
hydrolysis as above gave pure cholest-5-en-3^,7oC>26—^triol
(Rf.O .20 in benzene: ethyl acetate : ace tone:: 10*: 5:5) . The
next 10/' fraction on hydrolysis gave a mixture and finally
the 20/k ethyl acetate in benzene fraction on hydrolysis
gave pure cbolest-6-en-3p,5°f,26-triol (Rf.O.32). The
product was crystallized from methanol-water as white needles.
Very little hydrolysis was encountered on neutral alumina.
The identity of cholest-5-en-3/3,7<*}26-triol was established
by mixed melting point and co-chromatography.
Melting point and mixed melting point ■ 218° - no depression.
When a solution of cholest-6-en-3/S,5<>f,26-triol (20 mg)
in chloroform (3 ml) was treated with MnO^ (0.2 g) for eight
hours with occasional shaking no ultra-violet absorbing
material was detected using fluorescent TLC-plates. Under
the same condition cholest-5-en-3/3,7/3-diol was completely
converted to the more mobile ultra-violet absorbing material
i.e. cholest-5-en-3/?-ol-7-one.
Physical characteristic of cholest-6-en-3fi,5«,26-triol:-
O
in • p • * «s05""«-07 «5
Wp6 " -io
IR (V) * Fig.23.




Cholest-5-en-3/S-ol-24-one-3/3-acetate (l.O g m.p. 130-132°
- Organon) was hydrolysed with k) *n aqueous
methanol at room temperature for twelve hours* The mixture
was warmed for one hour and the free sterol precipitated with
water and left for crystallization in cold* Filtration
and crystallization from benzene:methanol afforded pure
O
cholest-5-en-3/3-ol-24-one (0*9 g; m.p* 137—139; Kf.0.58 in
benzene:ethyl acetate:acetone::10:0:3).
Cholest-5-en—3^—ol-24—one (0*9 g) was dissolved in dry
pyridine (100 ml) and photo-oxygenated with haematoporphyrin
(14 mg) for twenty-four hours as before. Most of the
starting material was converted to another product, presumably
cholest-6-en-3/3-ol-5«(-hydroperoxy-24-one (yellow spot with K1
solution; Rf.0.46). The photo-oxygenation mixture was worked
up as before. Isomerization was achieved by leaving at room
temperature for twenty-four hours in chloroform (150 ml) and
the product reduced twice with LiAlH^ (0*9 g) in THF, because
the first reduction was incomplete. There were two main
spots of the reduction product, the least mobile being
choleat-5-en—3/5,7<* ,24 £ -triol (iif.0.2) and the more mobile
(kf.0.3) presumably cholest-6-en-3/3,5*,24 £ -triol, in almost




The residue from the ether extract was chromatographed
on deactivated neutral alumina (4% water; 50 g). A
suspension of the residue in ether (4 ml) was passed through
the column prepared in petroleum ether* The flask was
washed thrice with <2 ml ether each time and the washings were
transferred on to the column, which was then washed with
100 ml petroleum ether* Acetone in petroleum ether 5% and
10% removed the more mobile impurities and the 15% acetone
fraction on evaporation afforded cholest-5—en-3/i, 44^-diol
(50 mg, m.p. 174°) • Acetone in petroleum ether fractions
(40 and 45%) removed other unidentified oily products, which
were more mobile than cholest-6-en-3f3,5<>c,44£-triol • The
latter was expected to have a similar mobility to cholest-
5-en-3/3,7^,44^-triol by analogy with cholest-6-en-3/3,5<<--diol
and cholest-5-en-3^,7^~diol* The 30% acetone in petroleum
ether fraction afforded cholest-6—en-3^,5°c,44£-triol (187 mg).
The 35% acetone in petroleum ether fraction gave slightly
impure cholest-5-en-3/5,7<*,44£-triol (450 mg), and the 40% and
50% acetone in petroleum ether fractions afforded pure
cholest-5-en-3p,7«<,44^-triol (410 mg).
The 35% acetone in petroleum ether fraction was
rechromatographed on deactivated neutral alumina (45 g) as
above. The 30% acetone in petroleum ether fraction gave
cholest-6-en-3/i,5<=(,44$-triol (50 mg) followed by a mixture of
7and 5°c-epimeric hydroxy-triols (100 mg) in the 35% acetone
95.
in petroleum ether fruction. In the 40Jfe, 5Q$> and 60$> acetone
in petroleum ether pure cholest-5-en-3/}j 7«<.,24£-triol (140 mg)
was obtained.
Total yield of cholest-5-en—3p,7°f,24^-triol ■ 350 mg.
" " » cholest-6-en-3/i,5«r,24^-triol - 237 mg.
Mixture of cholest-5-en-3/*,7cf,24£-triol and
cholest-6~en-3^ ,5<*,24i-triol « 100 mg.
PHYSICAL CHAKACTEKISTICS
(a) Cholest-5-en-3p,7<rt.f24(-triol.
m.p. « 204° (previous softening at 172°)
-76.8
IK (V) - Fig. <14.




Cholest-5-en-3/5,25-diol (l.O g) was dissolved in anhydrous
pyridine (100 ml) containing 14 mg haemutoporphyrin and 6 mg
more added after nine hours* The mixture was photo—oxygenated
for nineteen hours. Analysis by TLC showed one main spot
corresponding to chol@st-6-en-3^|25-diol-5«(-hydroperoxide
(ilf.0.34 in solvent system benzenesethyl acetate:acetone::
10;5;5) together with starting material (Rf.0.5) and traces
of cholest-5-en-3/!>,7°Cf25-triol and cholest-O-en-3^,54,25-triol
(Rfs.0.17 and 0.24 respectively).
The reaction mixture was taken to dryness as before and
the residue suspended in dry chloroform (150 ml) and kept for
two days at room temperature for isomerization of the 54-
hydroperoxide to the 7<-hydroperoxide. The mixture was then
filtered and evaporated as before. The residue after drying
overnight under high vacuum was reduced with LiAlH^ (0.8 g)
as usual, but increasing the reflux time for one hour. Again
TLC showed incomplete reduction of the hydroperoxide and hence
the reduction was repeated with a fresh batch of LiAlR^. On
this occasion there was no truce of a spot on TLC corresponding
to the hydroperoxide. There were again two main spots of the
reduction product corresponding to cholest-5-en-3^, 7«c,25-triol
and cholest-6-en—3/J,5«*, 25-triol in almost equal proportion.
Acetone (3 ml) was added to the semicrystalline residue
(0.98 g) and left for twelve hours at 0°C. The residue was
97.
then transferred to a boiling tube provided with a narrow
glass tube. Acetone (8 ml) and glass beads were added and
after sealing) the glass tube was left on a slow shaker for
a fortnight in a cold room to equilibrate between the solid
and solution phases* The sealed tube was then carefully
cut open, centrifuged, and the acetone solution sucked off
by means of a Pasteur pipette. This acetone solution showed
by TLC,mainly the G°(-isomeric triol and the starting material
i.e. cholest-5-en-3/5,d5-diol. The 60% acetone in petroleum
ether solution was used for solid-solution equilibration
purpose, and the process repeated several times* The
amorphous white solid was still impure* This method of
purification was very slow and therefore further purification
was achieved through acetylation and chromatography of the
acetylated product*
CHHOMATOtittAPHY
(a) The acetone solution was evaporated and the
residue (dOO mg) was acetylated in pyridine and acetic
anhydride at room temperature for twelve hours. The reaction
mixture was worked up as usual and the acetylated product
chromator,raphed on neutral alumina (15 g). The chromatographic
column was prepared in petroleum ether and the mixture
dissolved in 40% benzene in petroleum ether was adsorbed on
the column which was then eluted with increasing amounts of
benzene in petroleum ether. Lthyl acetate in benzene 4%
gave cholest-5-en-3y3,d5-diu,cetate (8 mgj which on hydrolysis
98.
gave cholest-5-en-3p,25-uiol. hthyl ucetute in benzene (8/£)
fraction after hydrolysis gave material with the same mobility
as cholest-5—cn-3/S,7oC,25—triol (3 mg) . fhe ],<£$ ethyl
acetate in benzene fraction after hydrolysis gave traces of
both 7oC-and 5ot-isomeric triols. The dQc/o ethyl acetate in
benzene fraction after hyurolysis gave cholest-5-en-3)%,25-diol
(a8 mg) . The 30% ethyl acetate in benzene fraction gave
mixtures of two isomeric triols ufter hydrolysis (70 mg) while
the 40% ethyl acetate in benzene fraction gave impure cholest—
G—en—3/i,5ot,25-trioi (8 mg) . I'ure ethyl acetate gave choiest-
0-en-3fif 5ot, a5-triol (85 mg) .
rhysical characteristics of cholest-G-en-3^,5<=c-d5-triol.
O
m.p. = d32 (softening at 172; shrinking
and recrystaliization at Ud).
wf -
Id (V) = Fig. 25.
C II 0 requires C=77.51, H-11.00: found C= 69.88 H-»o.*7.
2.7 46 3
(b) fhe amorphous white powder was acetylated and the
acetylated product (780 mg) was chromatographed on neutral
alumina (50 g) as described above. fhe 4% ethyl acetate in
benzene fraction gave impure cholest-5-en-3JJ, 7<*,25-triol
(21G mg; which was purified on preparative TLC and cholest-
5—en-3^,7oC,k5—triol was obtained. ihe ethyl . e te in
benzene fraction (8^) (140 mg) gave relatively pure
cholest-5-en-3|3, 7o<,25—triol after hydrolysis from which a pure
product was obtained on crystallization from methanol—water.
99.
'fine 15/; ethyl acetate in benzene fraction gave a residue
(110 lag) from which cholest-G-en-3J5,5oC,a5-triol was obtained
on crystallization from ether and ethanol—water. The £0i»
ethyl acetate in benzene fraction (180 mg) gave a mixture
of both isomeric triols from which the desired cholest-5—en—
3|J,7of,-5-triol was obtained by, preparative TLC-plutes.
The ethyl acetate in benzene fraction yielded 40 mg pure
cholest-5-en-3/5,7«*,d5-triol on crystallization from methanol-
water. The 30'fr and 40$ ethyl acetate in benzene fractions
gave a residue (d5 mg) which was discarded, while the 50$
and 00$ ethyl acetate in benzene gave pure cholest—0—en—3/5,
5<*,d5-triol ufter hydrolysis.
The pattern of chromatography is complicated because
both tertiary hyaroxyl groups at C—5 and C—were only
partially acetyluted. The acetylation was performed at 4°C
but the reaction mixture was left for a considerable time.
Physical characteristic of cholest—5—eu-!jp, 7eC,25—triol.
m.p. = 529° (softening and recrystallization
between 215-^50°)
C°0jf * -89.1
Id ^V) = Fig. 26.
C _il„„0o requires C=77.51, 5=11.00; found C=77.97, il*10.81
a Y 40 3
Solvent front
Origin
Thin layer chromatogram showing relative mobilities




(D) CholesV6-en-3P» 5*» 12*"~triol»
(E) Cholest-5~eh~3/3»7*#12*-triol•
100.
Choi eat—3-en-3fS, 7cc, 12«(-triol
Cholest-5—en—3p,ldeC-uiol (50 mg) was photo-oxygenated in
pyridine (Ca. 10 ml) in the presence of haematoporphyrin
(Ca. a mg) as usual and the reaction followed on TLC. After
approximately ten hours all of the starting material (kf.0.76)
was converted to a more polar product (ftf.0.01 in benzene:
ethyl acetate::7:13). The reaction mixture was worked up as
before and the product isomerized in chloroform for eighteen
hours. The chloroform solution was taken to dryness and the
residue reduced with LiAlH^ solution in T1IF (10 ml). The
reduction mixture was refluxed for 1.5 hours and as TLC showed
incomplete reduction hence more LiAlH was added and the
mixture kept at reflux temperature for another 0.5 hour. Again
TLC revealed incomplete reduction. The reaction mixture was
then worked up as before and the ethereal residue, cholest—
5—en—3^,7oc,12°t-triol and cholest—0-en—3/5>,5<*,la<><—triol were
separated on preparative TLC plates using benzene:ethyl
acetateJacetone::10:5:5. Crystallization from methanol-water
afforded pure choie3t-5-en-3/3,7«c, ld«-triol and pure cholest-
ii-en—3p>f 5ocf ld«t-triol.
Choiest—5-en-3/3, 7<*,ld°c-triol. m.p. 193°
Cholest—6—en—3/J,5°c, ld«-triol. m.p. a4d° (decomp.)
No other characteristics could be determined due to




Cholest-4-en-3-one (11 g) and chloruuil (40 g) were
refluxed in t-butyl alcohol (350 ml) under nitrogen for three
hours. After cooling the reaction mixture, the unreacted
chloranil was filtered off and washed with ether. The filtrate
and ether washings were combined and evaporated, the residue
was dissolved in ether, washed with water, 5$> sodium hydroxide
and finally washed neutral with water. The other solution was
dried over anhydrous sodium sulphate and evaporated under
vacuum giving 9.0 g of a yellow product which was then
chromatographed on silicic acid.
The residue was dissolved in petroleum ether and passed
through the column (125 g silicic acid) washing with an excess
petroleum ether until a yellow band moved down the column and
separated clearly. Ether in petroleum ether (5% - 250 ml)
eluted the residual yellow reagent. Ether in petroleum ether
(8/and lOJfo) gave pure cholest-4,6-diene-3-one (8.0 g). A hot
solution of methanol was seeded and the flask wrapped in a
cloth for slow cooling to room temperature, when most of the
product cryatallized. Further crystallization was
accomplished in the cold. Filtration afforded 7.4 g flat
needles•
m.p. = 80-81° Reported 81.5°
(°0p7 - +35 +30
Xmax „ t-njUL
C27%a0 requires C-84.75, H-11.07; found C-84.40, H-11.21
102.
(a) hpoxidation at 5°c in ether
an
Cholest-4,6-diene-3-one (5.73 g) was dissolved in/ether
solution of monoperphthalic acid (36 ml; 1.26N; 121 mg/ml) and
the total volume made up to 45 ml. The solution was kept at
5°C and the first sample for TLC was taken out after forty-
eight hours when 50% conversion to the less mobile epoxy
compound was noted. More monoperphthalic acid (10 ml) was
added and the mixture left over for another twelve hours. A
conversion of 70-75% was detected by TLC. The reaction
mixture was diluted with ether and the suspension washed with
5% sodium carbonate. The alkaline ether solution was washed
neutral with water, dried over anhydrous sodium sulphate and
evaporated to dryness. The residue (5.0 g) was taken up in
10% benzene in petroleum ether and left for twelve hours at
room temperature. A crystalline product separated and washed
with 10% benzene in petroleum ether. The filtrate and
washings were chromatographed on deactivated (4%) neutral
alumina (85 g) with increasing amounts of benzene. Benzene
25% in petroleum ether eluted a less polar substance and 35%
benzene in petroleum ether gave a mixture of dienone and less
polar product. Benzene 45% in petroleum ether eluted pure
starting material and this was followed by fractions which
gave impure epoxide (l.B g). Crystallization from methanol
afforded pure needles (1.2 g).
m.p. » 137.5-138.5° deported 138.5-139°
(<x)jj6 - -56.6 (c,0.406;d,0.115) -59
Ili(V) = Fig. 27.
103.
X max ■ 242 m jji
C,7H420, requires C«81.4, 11—10.5; found C*81.19, 11*10.46
(B) At -.7° in chloroform-ether
Cholest—4,6-diene-3—one was epoxidized using chloroform
(9 mi; auu an ether solution of monoperphthalic acid (l.26 N).
The reaction mixture was kept at 5°C for five hours and then
at 27°C for a further nineteen hours. The reaction product
was worked up as before. The residue (5.3 g) was chromato—
graphed on deactivated neutral alumina (3>, 100 g) as above.
Benzene 30% and 30$ in petroleum ether gave a less polar
product. Benzene 40% and 50$ furnished impure dienone
(1.74 g). Bure benzene and 5$ ether in benzene gave almost
pure epoxide (1.4 g). Crystallization from methanol afforded
needles (l.l g)•
m.p. ■ 137—138°
X max a k42 m |ul
(C) Dienone (3.3 g) was epoxidized as above in a mixture of
chloroform and ether solution of monoperphthalic acid (60$
conversion). Unreacteu monoperphthalic acid was removed by
filtration of the reaction mixture through neutral alumina
(50 g). Elution with chloroform (500 ml) gave only 2,2 g
of the product which showed more dienone than epoxide.
Chromatography on neutral alumina (3$, 50 g) gave 1.1 g
starting material and impure epoxide (0.56 g). Crystallization




The foregoing epoxide (400 rag) was reduced with LiAlH^
in THF as usual. The mixture was refluxed for half an hour
and after decomposition of excess of hydride with ethyl
acetate, a saturated solution of potassiura sodium tartrate
(Rochelle's salt) was added and the mixture extracted several
times with ether. The ether extract was worked up as usual.
Chromatography on TLC plates showed two spots corresponding to
the cholest-4-en-3/*,7<x-diol (major spot Rf.0.29| benzenes
ethyl acetate:acetones >10:5:3) and cholest-4-en-3*,7c(-diol
(minor spot Rf.0.22). Infra—red spectrum at this stage
showed no carbonyl peak and there were large hydroxyl peaks
as expeoted. Since both 3«- and 3^-allylic hydroxyl groups
can be oxidized by means of hnO^ in chloroform solution to
<=c,^-unsaturated ketone, the mixture of the diols was dissolved
in chloroform (40 ml) and manganese dioxide (4 g) prepared
acoording to Mancera (1953) was added. The suspension was
kept at room temperature for ten hours and the reaction
followed every two hours. After six hours very little
starting uateriai was left. The catalyst was filtered off
and washed with chloroform to ensure quantitative recovery.
The residue from the chloroform solution was dissolved in
5-10 ml of 50^ benzene in petroleum ether and the solution
chromatographed on deactivated (6$) neutral alumina (15 g)
column prepared in petroleum ether. The column was then
washed with 50$ benzene in petroleum ether followed by 80$
105.
benzene in petroleum ether and then pure benzene. Elation
with 5/o ether in benzene and 10^ ether in benzene gave a
residue (300 mg) which was pure on TLC assessment.
Crystallization from ether afforded white needles of cholest—
4-en-3-one-7<<-ol •
m.p. = 183-134° Reported 183.5-184.5°
(oc)*6 - +67 +67
X max » 242 nn jx ♦ IR ())) = Fig. 28.
^27^44^2 retiuire# C-80.95, H-ll.l; found C-80.78, H-11.29
15>% and then pure ether gave (30 mg) the starting material.
106.
5ft-cholestan-S-one-T^-o1
S/'-cholestan-S*,7«c-diol (DHC) vas prepared by electrolytic
coupling of chenodeoxycholic acid and isovaleric acid as
described by Bergstron and Krabisch (1957).
5/J-cholestane-3«,7<<-diol (400 mg) vas refluxed with
aluminium isopropoxide (800 mg) in dry benzene (15 ail) and
acetone (7*5 ml) for three hours* The reaction mixture vas
acidified vith aN-H^SO^ and vorked up as usual* Chromato¬
graphy of the ether residue (390 mg) on aeac tivated (4$)
neutral alumina (25 g) vith increasing percentage of ethyl
acetate in benzene eluted 5/*-cholestan-3-one-7«c-ol in 5$ and
7*5$ ethyl acetate* The residue from these fraotions vas
crystallized from acetone-water (140 mg)• Starting material
(OHC 130 mg) vas recovered from 4t#> ethyl acetate*
m.p* ■ 118-120° Reported 121°
- +15.7 +16
IR (V) - Fig. ^9.
C27H46°2 re1uires C-80.50, H-11.44; found C-80.14, H-11.60
 
107.
5|3-cholestan-3cCt7cC.12cC-triol: (Trihydroxycoprost.ne or THC)
THC was prepared by electrolysis for sixteen hours of
cholic acid) 15 g (0.05 mole) and isovaleric acid) 67 ml or 61 g
(0.6 mole) sodium 2.2 g in methanol 750 ml with 1.25 amp
between two platinum electrodes (lM x 2") placed i" apart.
Thin Lay r Chromatography showed only a trace of cholic acid
(ilf.0.1, chloroform:acetone :ethanol: j 54t 18:6 drops of acetic
acid) and main spot of THC (Bf.0.36).
The mixture was worked up according to Kazuna and Mori
(1954). Crystallization of this mixture afforded impure THC
(9.1 g) which showed traces of impurities on TLC.
The mother liquor was extracted four times with ether and
from the residue (2.7 g) impure THC (0.5 g) was recovered
through chromatography on silicic acid.
Crystals (9.1 g) were dissolved in CH^Cl^ and the solution
chromatographed on a silicic acid column (200 g) prepared in
the same solvent and eluted with 3$ methanol in CH^Cl^. After
700 ml of eluant) each fraction of 100 ml was collected from
which fractions III to X gave pure THC on crystallization from
acetone-water (5.8 g)•
Fraction XIy the mother liquor, and the 0.5 g impure THC
were pooled (2 g), dissolved in benzene and chromatographed on
alumina (type '0' Spence). The column was eluted with
increasing amounts of acetone in benzene. Methanol in acetone
(5/v and 10$) afforded 0.55 g of pure THC after crystallization
from acetone-water.
108.
m.p. • 100-192° Reported 186-180°
r -.26
- +28.2 (c,0.78jd,0.1l) +30.4
IB (]>) - Fig. 30.
C27H48°3 re<luires C-77.14, H-11.73; found C-77.07, H-12.00
109.
5 fi-cfao lea tane-3-one-7oc, 12<*-di ol
Trihydroxycoprostune (3.3 g) was refluxed with aluminium
isopropoxide in dry benzene (<200 ml) and acetone (120 ml) for
twelve hours. ilefluxing was stopped because of vigorous
bumping nand after cooling the reaction mixture was treated with
3N-HgS0^ and the benzene layer separated. The acid layer was
extracted twice with benzene and the extracts were combined)
washed with 2% Na^CO^ solution and then washed neutral with
water* The residue was suspended in benzene (50 ml) and poured
onto the deactivated (5%) neutral alumina (150 g) column* The
container was washed with 5ethyl acetate in benzene (100 ml)
and the extract passed through the column) which was eluted
with increasing amounts of ethyl acetate in benzene} collecting
150 ml fractions* Elution with ethyl acetate in benzene (20J&
and 30$) gave less polar products) (Rf»0.82 and 0*78; chloroforms
acetonemethanols:48:12:6) 50$ (last 50 ml) and pure ethyl
acetute gave the 0/b-cholestan-3-one-7°ct12°c-diol (1,86 g) • The
column was then eluted with 10$) 20$ acetone in ethyl acetate
and then pure acetone* Methanol in acetone (20$ and 25$) gave
pure trihyaroxycoprostane - the starting material (0*96 g)•
5/3-cholestan-3-one-7oc,12°c-diol (1.86 g) was crystallized
from hot ethyl acetate:petroleum ether (ls2} 50 ml) and the
pure compound (1.45 g) was obtained. The residue from the
mother liquor was recrystallized from ethyl acetate:petroleum
ether (ls3, 10 ml) and a second crop of pure crystals obtained.
110.
m.p. - 211-213° Reported 209-210°
- +32 +42.6
IR (V) - Fig. 31.
C2TH46°2 re<luires C-T7.M, H-11.00} found C-T7.92, H-11.14
111.
Choleat-4-en-3-one-7oC,12t<-diol
(a) A solution of 5/S- chole3tan-3-one-7«c,12«(-.diol (140 mg)
and selenium dioxide (110 mg) in ethanol (35 ml) was left at
60°C for twenty-eight hours. More selenium dioxide (60 mg)
was added after twelve hours. At the end of twenty-eight
hours, on most of the starting material (Rf.0.55) was
converted to the less mobile cholest-4-ene-3-one-7cC,12<<-diol
(Rf.0.36, benzenesethyl acetate»acetoneti10s5:5) the reaction
mixture was filtered, evaporated and chromatographed on
deactivated (6$) neutral alumina (10 g). The benzene solution
was passed through a column which was eluted with 20$ ethyl
acetate in benzene (50 ml), the last 20 ml giving starting
material (26 mg)• The first 15 ml of 30$ ethyl acetate in
benzene fraction (50 ml) further afforded starting material
containing traces of cholest-4-en-3-one~7oC,12<-diol, and the
remaining 35 ml gave rise to cholest-4-en-3-one-7<>c,12<=C-diol
(74 mg). Crystallization from acetone-water afforded the
pure compound (50 mg).
m.p* m 228-2a9° Reported 228—229°
- +80.2 vc,0.40O;u,0J.75) +8§.0
max • 242 m
IR (V) - Fig. 32.
C*27H1103 reRuire8 C-77.8, H-10.58; found C»78.36, H-10.64
(b) 5p-cholestan-3-one-7cC,12<<-diol (300 mg), SeOg (270 mg)
alcohol (60 ml) were treated as above. More SeQg (100 mg) was
112.
added after sixteen and twenty-five hours and the heating was
continued for forty-one hours. On TEC there was only a truce
of starting material the main product corresponded to cholest-
4-en-3-one-7oc,ldoC-diol. The reaction mixture was worked up
and chromatogruphed as above on alumina (25 g). Ethyl acetate
40c/o in benzene (50 ml) gave 125 mg of cholest—4—en—3—one-7oc,
ldoc-diol containing traces of starting material from which
pure cholest-4-en-3-one-7c<tl^o(-diol (77 mg) was obtained after
rechromatography. Ethyl acetate 50^> in benzene followed by
60$> ethyl acetate gave 127 mg of cholest—4—en-3—one-7°c, 12°(—diol.
Total cholest-4-en-3-one—7<<,12oC-diol (204 mg) was
crystallized from acetone-water and pure cholest-4—en-3-one-
7oC,l2<-diol (152 mg) was obtained,
m.p. * 220°
\ max - 242 jj.
IK (V) - Fig. 32
(c) When 30 mg of coprostune-3-one-7°f, 12<-diol was
refluxed with 30 mg of 3e0^ in 10 ml ethanol, although the
reaction was complete in sixteen hours, more of the 1,4-diene—
3—one was formed than in the previous two cases, i.e. when




3/3-hydroxy- ^^-cholenic acid methyl ester (4.5 g) was
re11used for ten hours with aluminium isopropoxide (6 g) in
dry benzene (180 ml) and acetone (100 ml). The reaction
mixture was acidified and the benzene layer separated. The
acidic phase was extracted twice with benzene. The total
benzene extract was washed with water, dried, and evaporated
in vacuo. The residue was taken up in petroleum ether and
chromatographed on a silicic acid column (50 g) eluting with
increasing amounts of benzene. Pure benzene followed by 5%
and 10/k ether yielded methyl 3-keto-chol -4-enate (3.5 gj
Hf.0.5d Bz:htAC::3:M). Further elution with 10% ether gave the
starting material (0.4 g; Uf.0.4).
m.p. * 1^8.5—1^9.5
G*)jj6 - +8M.7 (c,0.532jd,0.ad)
IK (V) - Fig. 33.
\ max • <24d ynjx.
CjkHoo0o requires C-77.72, H-9.85; found C-77.71, H-10.54HO OO o
3-keto-chol—4—enic acid
Methyl 3-keto-chol-4-enate (1.5 g) was refluxed for eight
hours with aqueous methanolic K^CO^ (l g). hqual amount of
water was added and the reaction mixture neutralized with
acetic acid, extracted with ether, dried and evaporated. The




X max * 242
Ift (» - Fig, 34.
C24H36®3 re1ttir** C-77.42, H-9.67j found C-77.60, H-9.71
Figure# 2 2.,
115.
5^-cho 1 e atan-3oct 1 ad-di o 1 -24-one
1. iieoxycholic acid (3°Sl2°c-dihydroxy-5/3-cholanic acid)
was acetylated in the usual way.
The oily residue of 3oc,12t£-diacetoxy-5^—cholanic acid was
dried under high vacuum giving rise to a dry sponge-like
material which was treated with freshly distilled thionyl
chloride in dry ether and worked up according to Cole and
Julian (1945). The diacetoxy deoxycholyl chloride thus
obtained was dissolved in dry benzene and the solution added
to the di-isopropyl-cadmium prepared according to Cason and
Prout (1955) using cadmium bromide instead of cadmium chloride.
The reaction mixture was worked up after Cole and Julian (1945).
The residue was hydrolysed with methanol!c sodium hydroxide
and extracted with ether. The residue from the ether extract
was chromatogruphed on deactivated (5^) neutral alumina. A
benzene solution was passed through the column and eluted with
increging amounts of ethyl acetate in benzene. Fthyl acetate
in benzene (75/k) eluted an oil which showed a single spot on
TLC (lif.0.22; benzene:ethyl acetate:acetone::10:5:3). The
oily residue could not be crystallized but when the ether
solution was evaporated under high vacuo, it gave rise to a
dry powder, which was dried in a drying pistol at 80° to
yield a pale yellow glass,
m.p. - 84—86°
Mf - +43.2
IK 00 - Fig. 35.
C >^H _0„ requires C-77.51, H-11.00; found C-76.82, 11-11.14<27 40 o
116.
Cholestan-3fo 5°c,6fi-triol
This compound was prepared according to the method of
Fieser and Hajagopalan, (1949).
Preparation. Cholesterol (20 g) was suspended in 88% formic
acid (200 ml) and heated briefly to 70-80°. The 3/3-formate
thus formed separated as an oily layer, and the mixture was
allowed to cool to room temperature. Hydrogen peroxide
(20 ml of 30?) was added and the reaction mixture shaken
occasionally for one hour and then left overnight. It was
then treated with hot water (300 ml)) shaken, cooled and the
white solid filtered, dried, hydrolysed in aqueous methanolic
sodium hydroxide and worked up as usual.
Chromatography. The white solid thus obtained was chromato-
graphed on active alumina (3pence type '0'). The material
was dissolved in acetone:ether::1:1 and the column eluted with
increasing amounts of acetone whereupon methanol:acetone
(1:3) eluted the triol. This fraction was crystallized from
aqueous acetone and afforded white needles.
Physical characteristics:
uwp. « 231-233° deported 237-239°
and 229—233°
(oc)jj6 - +3 (c,1.0;d,0.015)
IH (V) - Fig. 36.
C27H48°3 re<luire* C-77.14, U-11.43 ; found C= 7^.66, H= 10-96.
CZ1 H^803 x H^O 7M.2M , R-_
117.
Cholestan-3^3.5c(-diol-t>-one
This compound was prepared following the method of Fieser
and Hajagopalan (i. »4^r.
Preparation* Cholestane-3/3,5<<,6/S-triol (.3 g) was dissolved
in 10$ aqueous dioxane (4 ml) and the solution treated with
N-bromosuccinimide (0*2 g). The oolour of the solution
changed from yellow to light orange, light yellow and then
colourless, whereupon the reaction product began to crystallize
out. The mixture was kept at room temperature for ten minutes
and then allowed to crystallize in the cold, filtered, and
washed with 50$ methanol. The mother liquor was diluted with
water, extracted with ether, washed, dried and concentrated
until crystallization started, and a second crop of crystals
was obtained (m.p. 231-232° reported 232-233°). On TLC
analysis the product showed a considerable amount of starting
material. Purification was effected by chromatography on
neutral alumina (10 g).
Chromatography. The material was dissolved in 40$ ethyl
acetate in benzene and adsorbed on the column prepared in
benzene and elated with increasing percentages of ethyl
acetate in benzene followed by pure ethyl acetate then
increasing amounts of acetone in ethyl acetate. Pure acetone
and 5% methanol in acetone gave cholestane-3^ ,5o(-diol—6-one.
Crystallization from acetone-water afforded white needles
(Hf.0.356 in benzene:ethyl acetate::7:13)
118.
■•p. - 236—238° Reported 232-233°
(°0j7 - -40.14 (c,0.548jd,0.11) -31.9 (Schultat, 1959)
IR (V) - Fig. 37.
^27®46®3 re<lu*re® C-77.51, H-11.00; found C«"7"7-06,
119.
Chole a tane-3/9-ol-5<*.6c<-epoxide
Cholesterol benzoate (10 g) was dissolved in chloroform
(80 ml) and a solution of monoperphthalic acid in ether
(40 ml; IdO mg/ml) vas added. The mixture vas kept at 0°
overnight and then at room temperature for twenty-four hours.
The precipitated phthalic acid vas filtered off and vashed
with more ether. The chloroform—ether solution vas vashed
vith sodium carbonate solution (5$) to remove excess pe-racid,
and then vashed neutral vith water, dried over anhydrous sodium
sulphate and evaporated to dryness. The residue vas dissolved
in boiling ethyl acetate. The first crop consisted of
"c(-choleateryl benzoate" (m.p. 109-170° reported 168-109°).
Cholestane-3/?-ol-5<*.,©"(-epoxide vas obtained on hydrolysis of
"4-cholesteryl benzoate" in methanolic potassium carbonate.
The reaction mixture vas refluxed for seven hours and poured
into water, extracted vith ether and vorked up as usual. The
residue on TLC shoved incomplete hydrolysis and vas chromato-
graphed on alumina (Spence '0' type). The mixture vas
dissolved in benzene:ether>>1>1/ and applied on to the column
and then elated vith increasing amounts of ether in benzene,
followed by acetone-ether mixtures. "<*-cholesteryl benzoate"
eluted vith £0% acetone in ether and cholestane-S/i-ol-S*,©*-
epoxide vas eluted vith 35% acetone in ether. The residue
from this fraction vas crystallized from methanol (ttf.0.5<2 in
benzene:ethyl acetate:>7>13).
1^0.
m.p. - 144° Reported 142.5°
C°c)p7 - -44 -40
IR (V) - Fig. 38.
requires C-80.6, ti-11.45; found C«78.65,H»11.54.
^27^46^2 ^2^3^** requires C=78.9, H=11.48.
121.
Cholest-6-en-3^-ol-5o<.-hydroperoxide
A solution of cholesterol (5 g) in anhydrous pyridine
(100 ml) was photo-oxygenated for twenty-seven hours with
kaematoporphyrin hydrochloride (5 rng) using oxygen/s^CO^*
More photo-sensitiser (5 mg) was added after three and seven
hours.
The mixture was taken to dryness in vacuo and the residue
was treated with 111 mixture of glacial acetic acid and
methanol (40 ml). The suspension was filtered and the
residue was washed with cold methanol. Crystallization of
the residue from hot aqueous methanol yielded white needles
(2.8 g).






Shin layer chromatogram showing relative mobilities
of the following compounds*
(A) CholeHt-5-e»-5/?»7/3**diol*
(B) Cholestan-3/3,5o<j-diol*
(C) Chole8'v>*6—ejst-3/8 * 5°0,wdiol*
(D) Cholest-5~en~3/9t4j(Hliol*
Solvent system t- benzene t ethyl acetate «t 1 t 2*
122.
holestan-3/5, ooc-diol
Cholesterol (0.5 g) was dissolved in ury pyridine (40 tui)
and huemutoporphyrin hydrochloride (6 mg) was added. The
solution was photo-oxygenated for twelve hours. Pyridine was
evaporated in vacuo and the residue was crystallized from
methanol several times. Colourless needles (m.p. 140°,
J ^
{*);■ - +35) were dissolved in dry ether and reduced with
hydrogen over 10)i> palladium on charcoal as catalyst. When
the hydroperoxide was completely reduced there were two main
spots on fLC, (iif.0.33, light blue colour with phospho-
tungstic acid; itf.0.26, pink colour with PfA) corresponding
to the choies t-b-en—3/5, 5oc-diol and choie3tane-3/5,5°c-diol
respectively. There were also truces of 7<*-hydroxycholesterol
^df.0.23 dark blue colour with PTA). The reduction was
continued until there was no blue spot on TLC corresponding to
the more mobile cholest-6-en-3/i, 5<*-diol (iif.0.33). The
catalyst was then filtered off, the ether evaporated, and the
residue acetyiated with acetic anhydride in pyridine at room
temperature for twelve hours and worked up as usual. The
ether extract was evaporated and the residue dissolved in
benzenespetroleuru ether:: 1:1 and chromatographed on a neutral
alumina (15 g) column, prepared in petroleum ether. The
column was eluted with benzene followed by &c/> and 5> ethyl
acetate in benzene which removed less polar impurities such as
cholest-5-en,3/5, 7°C-diacetate. hthyi acetate in benzene (10/®
and 50/® gave cholest-b-en-3/J-acetoxy—5oc-ol. The residue was
123.
completely hydrolyaed with 5c/o aqueous methunolic sodium
hydroxide by warming and then leaving at room temperature for
three hours.
Water was added and the reaction mixture left in the cold
for crystallization. Silky needles separated and the mother
liquor was extracted twice with ether. The crystals and
ether extracts were combined, washed with water and dried.
Crystallization from methanol afforded pure cholestan—3/?>,5oc—
diol.
m.p. - 225° deported 224°
(oc)jj6 - +21.8 +21.2
lit (V) - Fig. 39.
^27^48^2 re<iuires C«80.2, 11-11.88; found C-80.33, H«ll.91.
Id4.
Cholest-6-en-3|/3.54-dlol
Cholest-6-en-3/?-ol-54-hydroperoxide (d40 mg) prepared
according to Schenck et. al (1957) was dissolved in tetra-
hydrofuran (10 ml) and reduced with lithium aluminium hydride
(O.d g) at reflux temperature for one hour* The reaction
mixture was worked up as before and the residue chromatographed
on neutral alumina (id g)* The reduction mixture was dissolved
in benzene and chromatographed with increasing percentages of
ethyl acetate in benzene. Each fraction (d5 ml) of 5$, 10$,
15$, d0$, d5$, 30$, 40$ and 50$ ethyl acetate in benzene
removed traces of more mobile impurities. In the same way 60$,
80$, 90$ and then pure ethyl acetate gave a mixture of 54.- and
74-diols (Hfs.0.33 and 0.d3 in benzenetethyl acetate::1:1).
Pure cholest-6-en—3/3,54-diol (assessed by TLC) could not be
obtained after several crystallizations from methanol. The
mixture (195 mg) was acetylated at room temperature in pyridine
for ten hours and cholest-6-en-3/3-acetoxy-5o(-ol (m.p. 145°
reported 143°) was separated easily on column chromatography
from cholest-5-en-3/3,7oC-diol-diacetate, as described on page ldd
for cholestan-3/3-acetoxy-54-ol. Deactivated (l$) neutral
alumina (id g) was used as adsorbent and elution with 10$ and
15$ ethyl acetate in benzene gave pure cholest-6-en-3/J-acetoxy-
54-ol (160 mg). Hydrolysis in 5$ methanolic sodium hydroxide
afforded cholest-6-en-3^,54-diol. kecrystallization from
methanol yielded white needles.
125.
m.p. • 182.5° (with previous softening Heported 181°
between 170-175°)
O)*6 - -18 (c,0564}d,0.05) -16
IR ())) - Fig. 40.





Uholesta.H-3/?,5^,(j/5-triol (700 tag) was dissolved in
pyridine (2 ml) und acetic anhydride (8.8 ml). The solution
was allowed to stand for twenty-four hours at 4°C. The
reaction mixture was poured on to crushed icef extracted with
ether, washed with water, dried and evaporated. The residue
(840 mg) was crystallized from methanol and white needles
(760 mg) were obtained (df.0.84 benzene:petroleum ether:ether::
8:8:1).
m.p. « 170-170.5 deported 166°
(oc)^6 . -46.8(c,1.01;d, .835) -45
Id (») - Fig. 41.
C31H58^5 re<lu*re8 C-74.00, 11-10.31; found C-73.82, H-10.51.
Choi est-4-en-3/3,6/3-diol-diacetate
Cholestan-3/5,6/3-diacetoxy-5<X-ol (0.58 g) was dissolved in
anhydrous pyridine (3 ml) and the solution was cooled to 0°C.
Thionyl chloride (0.8 ml) was added dropwise with shaking, the
solution turned yellow and a**rhite solid formed (fetrow,
dosenheim and Starling 1938). The mixture was kept at 0°C
for fifteen minutes and then allowed to reach room temperature,
water was added and the white solid turned oily. After some
hours the oily mass solidified again, and was filtered, washed,
dried, dissolved in petroleum ether, chromatographed on neutral
alumina (15 g) and eluted with increasing amounts of benzene in
10.7.
petroleum ether. benzene in petroleum ether (80^<>) and then
pure benzene eluted the least polar impurity. Ethyl acetate
in benzene (4^«f 6$> and 12$ gave cholest-4-en-3/3,6/^-di acetate
(360 mg). Crystallization from methanol afforded needles
(ftf.0.68 benzenespetroleum ether:ether::1si:l). Ethyl
acetate in benzene (20/£>, 30/t and 50^>) gave 190 mg. of the
starting material (Kf.0.3 in benzene:petroleum ethersetherst
lilll).
m.p. « 135° Reported 136°
to*6 - -13.2 (c,0.76jd,0.05) -13
Itt ()l) - Fig. 42.
631**5064 reRu^re® C-76.54, H-10.29; found C»76.09, H-10.51
Cholest-4-en-3^,6fi-diol
The diacetate was hydrolysed in methanolic sodium
hydroxide overnight at room temperature, diluted with water
and the precipitate filtered) washed and dried. Cholest-
4-en-3/i,6/J-diol was obtained pure by TLC (Uf.0.2, benzene:
ethyl acetate:slsl).
m.p. - 254-255° Reported 256-258°
IR (D) - Fig. 43.





In/biological hyuroxylation whenever an oxygen atom is
introduced at a carbon atom a direct replacement of the
hydrogen atom with the hydroxyl group takes place and molecular
oxygen is usually involved. In the cholesterol molecule many
carbon atoms can be hydroxylated but the most important
positions affected are 1, 2, 4, 5, 6, 7, 11, 12, 17, 20, 22, 24,
25 and 26. The monohydroxy derivatives of cholesterol
synthesized (diols) include all these positions except 11 and 17.
In the production of triols (fig.18,IV a,b,c and d) having
3[i, and 7«c-hydroxyls and a 5,6-double bond with additional
hydroxyl at position 12, 24, 25 or 26, advantage was taken of
the method of photo-oxygenation originally developed by Schenck
and further studied by Naqui and Boyd (1964). The conformation
and position of the newly introduced group in the formation of
triols from the diols was based on the following considerations.
Bhoto-oxygenation of cholesterol in pyridine is known to
yield mainly cholest—L-en—3/3-ol—5«c—hydroperoxide, which
isomerises to cholest-5-en-3/S-ol-7«c-hydroperoxide in chloroform
solution. If such a chloroform solution of cholest-6-en-3/*-
ol—5«—hydroperoxide is reduced with LiAlH^, and in case the
isomerisation has not taken place quantitatively, then the
reduction product will contain cholest-6-en-3/3,5°f-diol derived
from the original 5«c-hydroperoxide. The reduction product
will also contain cholest-5-en-3/3,7oc—diol obtained from the
isomerised 7°c-hydroperoxide, and possibly cholest-5-en-3/3,7/3-diol
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obtained from the cholest-£>-en—3/3-ol-7-one. The latter
compound ia a known product of decomposition of cholest-5-en-
3/3-ol-7°c-hydroperoxide by dehydration. Since certain triols
discuased in this work were also prepared through the photo-
oxygenation of certain derivatives of choleaterol in pyridine,
by analogy with cholesterol photo-oxygenation the newly
introduced hydroxyl group may be either 5°< or 7°(. or 7/3. The
extent of formation of these three hydroxyl groups will depend
upon the extent of isomerization from the respective 5<x-hydro—
peroxide to the 7°c-hydroperoxide or their 7-oxo decomposition
products.
If the rotation values of cholesterol (^D-SS)0), cholest-
5—en—3/3,7<<—diol —90°), cholest—5—en—3^7Z3—•diol (^^+7) and
cholest-6—en-3/i,5«c-diol (<*D-16) are considered then it will
be observed that the introduction of a 7/3-hydroxyl into the
cholesterol molecule contributes a positive rotation of +97.
Similarly the net change in the conversion of cholesterol to
cholest-6-en-3/3,5°c-diol is responsible for a rotation
contribution of +74°. Contrary to this the introduction of a
7°c-hydroxyl group in cholesterol molecule contributes a
negative rotation of -51°. If the cholest-5-en-3/3,7*,12°c-triol,
cholest-5-en-3/i,7oc,24£-triol, cholest-5-en-3/3,7oc,<i5-triol and
cholest-5-en-3/3,7eC,d6—triol synthesized were the 7/3- or the
5<*-hydroxy derivatives, then their rotations would have been
less negative than the starting diola as the contribution of









rotation is positive. Since the contribution of the newly
introduced group in the molecule accounts for the increment
o o
of negative rotation ranging from -46 to -49 it seems
reasonable to assume that the nevly introduced group was
7°C—hydroxyl • This evidence in conjunction vith other
information led to the confirmation of the configuration of the
hydroxyls introduced at C^.
The 24-hydroxycholesterol, 25-hydroxycholesterol and
26-hydroxycholesterol were prepared by knovn methods. 12°c-
hydroxycholesterol was prepared according to the scheme given
in fig. 24* Danielsson (1961) also synthesised this compound
based on conventionaloc-bromination of a saturated 3-ketone of
the 5/3-series followed by dehydrobromination through a^
dinitrophenylhydrazone, and finally cleavage of the hydrazone
vith pyruvic acid. This procedure involved three steps and the
yield vas poor. We have converted the saturated 3-ketone to
oC,/3-unsaturated ketone in one step using SeO^ in ethanol in
much better yields.
When these diols having an extra hydroxyl at position 12 or
24 or 25 or 26 vith 5-ene-3/3—ol moiety vere photo-oxygenated in
pyridine vith a photosensitiser, mostly the 5°(-hydroperoxide
vas formed. The isomerisation of the 5°C-hydroperoxide
derivative to the 7<=C-hydroperoxy compound vas not smooth,
(quantitative) as reported by Lythgoe and Trippett (1959) for
cholest-5-en-3/J-ol-5oc-hydroperoxide. While this vork vas in
progress Derseus, Danielsson, and Einarsson (1967) reported the
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synthesis of cholest-5-en-3/3,7°<,ia«(-triol from cholest-5-en
3/3-12«-diol diacetate. Their reaction sequence was based on
the work of Bide et.al (1948) for the allylic 7-bromination
by means of N-bromosuccinimide. Treatment of the 7-bromo
derivative with Ag^O according to Schaltegger and Bullner (1951)
followed by reduction with LiAlH^ gave the desired triol in
about a 80% yield. In the present studies this triol was
prepared directly from 13<x-hydroxycholesterol by means of photo-
oxygenation, which does not require any protection of the hydroxyl
groups present in the molecule.
In the photo—oxygenation of cholesterol a high melting
point compound (857—860°) was also isolated. Its I.R. spectrum
showed hydroxyl peaks. On the basis of its solubility in
alcohol and high melting point this was suspected to be
cholest—4-en—3/5f6/3-diol. To establish its structure synthesis
of cholest-4-en-3/J ,6/?-diol was undertaken according to the
scheme given in figure 33. Cholestan-3/3, 5°<f 6/$-triol was
prepared according to the method of Fieser and Hajagopalan
(1949). The triol was acetylated in pyridine and acetic-
anhydride at 4°C overnight. Under this condition the
equatorial and therefore less hindered 3fif and 6/3 hydroxyl
groups were acetylated and the tertiary 5°c-hydroxy (axial) was
left free.
In general axial alcohols are more readily dehydrated than
their equatorial epimers if the hydroxyl and one of the
hydrogen atoms on the adjacent carbon atoms are in the same
Fig. Ji5.
13a.
plane but trans in their conformation.
In cholestan-3/3,6/3-diacetoxy—5°<-ol the tertiary 5<X-
hydroxyl (axial) was readily dehydrated in the 4 position by
means of Darzen's reagent, because of the geometric relation
of/4/S-H: 5°c-0H (trans: diaxial refer fig.2a.) which facilitates
ready elimination of water. Hydrolysis at room temperature
with alcoholic NaOH gave cholest-4-en-3/5,6/3-diol • A mixed
melting point and co-chromatography showed that the compound
obtained in photo-oxygenation was identical with the authentic
cholest-4-en-3/3,6/J-diol.
An attempt to prepare cholest-4-en-3/i,6/l-diol from
cholest-5-en-3/i,4/3-diol according to Petrow, Rosenheim and
Starling (1943) by/short treatment with acetic acid at reflux
temperature, and then acetylation by means of acetic anhydride^
resulted in cholest-&-en-3/*,4/}-diacetate.
Compounds having a 4-ene-3-one moiety with <x-hydroxyl
groups at positions 7 or 12,or both,were prepared according to
the scheme given in figure 25 • The preparation of various
coprostanes (II) is based on the method of Kazuno and Mori
(1954) as simplified by Bergstrom and Krabisch (1957) which
involves electrolytic coupling of potassium salts of appropriate
bile acids with potassium isovalerate. Since anodic coupling
of the salts of the bile acids also occurs resulting in loss of
bile acids as starting material, the use of excess of iso¬
valeric acid was found to be advantageous in improving the
yield of the desired product. Using isovaleric acid 10-12
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times in excess 40-45^ yields of these coprostanes were
obtained*
The oxidation of a 3«—hydroxy group in the 5/3 (H) series
to a ketone in the presence of a 7°c—hydroxyl group or a I2<x-
hydroxyl group (or both) in these coprostanes cannot be
achieved by such oxidizing agents as N-bromosuccinimide,
sodium chromate or dichromate or chromium anhydride where the
rate determining step is an attack on the less hindered
equatorial C-H bond rather than 0-H bond.
In the coprostane series, an °f—hydroxyl group at position
3 is equatorial with respect to the ring A therefore less
hindered, hence the hydrogen is axial and hindered* Such a
conformation of the <*-hydroxyl group at position 3 makes
acetylation easy but oxidation mere difficult* The situation
is reversed in the case of the axi^l hydroxyls at positions
7<* and 12°c which have easily accessible hydrogens in the least
hindered equatorial conformation* Further the 12«f-hydroxyl
induces an instability factor in the ring C by a 1:3 inter¬
action with the of—hydrogens at positions 9, 14 and 17*
Similarly the ct-hydroxyl at also exhibits 1:3 interactions
with the of-hydrogens at 9 and 14 coupled with an equivalent
1:3 interaction with the methylene group at (fig*2b)»
Since the transformation of a hydroxylic tetrahedral C-atom
to a trigonal carbonyl carbon atom eliminates some or all of
these repulsive interactions responsible for such instability,
a relief of these strains provides a driving force sufficient
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to promote oxidation of the axial hydroxy! groups (Sehreiber
and Eschenmoser 1955)* Because of these interactions coupled
vith the equatorial orientation of the hydrogen at or C^g
(or both) the -hydroxyl groups at these carbon atoms vill be
oxidized readily in the presence of the 3°(-hydroxyl by the
oxidizing agents mentioned abore.
In the Oppenauer oxidation, although oxidation at Cg of
an equatorial hydroxyl may be facilitated by a 5,6-ethe:;oid
linkage, the presence of a homoallylic double bond does not
appear to be essential, as oxidation of the saturated compounds
of the 5/5-series having 7°c and 12<=c-hydroxyls, for example the
bile acids or their methyl esters proceeds smoothly and remains
confined to the 3 position (Riegel and Mcintosh 1944). This
points to the fact that in the case of the Oppenauer oxidation
the rate of oxidation is dependent on the ease of severance
of the 0—H bond and therefore Till depend upon the degree of
hindrance of the hydroxyl groups. The attack by aluminium
alkoxides is so selective (or stereospecific) that the °c-
hydroxyls at Cj or C^g or both in the coprostane series need
not be protected. The lB^-hydroxyl group was found to be
least reactive, the 7<<-hydroxyl group intermediate and the
3«c-hydroxyl group was most reactive. Further it was found
that the 7°C-hydroxyl group was quite reactive in the absence
of a l<i<x.—hydroxy group in the same molecule, but in the
presence of a lBrt-hydroxyl group the reactivity of the 1<K-
hydroxyl group was considerable reduced. This conclusion is
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based on the fact that when 5/3-cholestan-3oc,7°c-diol was
oxidized by the Oppenauer method and the reaction was conducted
for more than three to four hours lower yields of 5/3-cholestan-
3-one-7°c-ol were obtained due to the formation of a dione
(see Danielsson 1961 also) while the oxidation of 3°ct7of,12oc—
trihydroxy_coprostane and 3^,12°<—dihydroxycoprostane was
conducted for thirteen hours with only 15$ and 4$ conversion
to other products was found calculated on the basis of solid
residues obtained from different chromatographic fractions*
An allylic double bond is usually introduced in steroids
with a carbonyl by bromination to the oc-bromo ketone which on
dehydrobromination would result in an °tifl-unsaturated ketone*
This reaction depends on the direction of enolization which
appears to be controlled by the stereochemical configuration
of the nearest bridge—head* For example the 3-ketones of the
5°f-series enolize to give 2-enes, whereas a 3-ketone of the
g
5/l-series is converted preferentially to the A-enol acetate
(Dauben, kicheli and Lastham 1952)* Consequently bromination
ofA-ketone of the allo-series gives a 2-bromoketone and a
3-ketone of the normal series affords a 4—bromoketone. Since
the purpose of this synthesis was to obtain a 4—ene-3-one
moiety,Acetones of the 5/3-series were employed. Bromination
with bromine or N-bromosuccinimide affords both axial and
equatorial epimers. In the 5/3-series the 4^-bromo is the
stable configuration and is thus not susceptible to a
transelimination of HBr*
136.
Kosenkranz, Maneera, tiatioa and Djerassi (1950) have
described a novel method of introducing a 4—ene—3—one moiety
in the 3 keto-allosteroida, which involves the formation of
2<*,4«-dibromoketone* Brief treatment of this dibromoketone
with sodium iodide in acetone solution gives a 2£ iodo-41*-
bromoketone, which on boiling with collidine undergoes
deiodination and dehydrobromination, yielding a 4-ene-3-one
moiety. The conversion of 2<*,4«<-dibromo—allo-3-ketone to
4-ene-3-one can be accomplished in 60$ overall yield without
isolation of the intermediates*
2/3,4/S-dibromo-3—ketones of the 5/v-series can be obtained
in 90$ yield (Djerassi and Rosenkranz 1951) but unfortunately
these compounds do not react with sodium iodide in acetone*
The monobromo-3-ketones of the 5/3-series dehydrobrominate
in poor yield when refluxed with pyridine because of the 2
isomeric, 4—bromo derivatives* Facile transelimination of
HBr only occurs with the << —stereoisomeric 4—bromo compounds*
However if the 3-keto, 4—bromo—derivatives were treated
with a slight excess of dinitrophenyl hydrazine with or without
the addition of sodium acetate in the absence of oxygen,
4—bromo dinitrophenylhydrazones were formed rapidly which
dehydrobrominated to 4-ene-3-keto-hydrazones in 90$ yield*
Furthermore cleavage by exchange with pyruvic acid in the
presence of HBr regenerated the°c ,^-unsaturated ketone almost
quantitatively (Uattox and Kendall 1948). The practical
value of this method totally depends upon the quantitative
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regeneration of the unsaturated ketone from its hydrazone.
It is believed that the water content of the pyruvic acid
greatly influences the extent of cleavage, and therefore the
results are dependent on the purity of the pyruvic acid.
Djerassi (1949) has modified the method of Uattox and Kendell
for pyruvic acid cleavage of hydrazones, and has claimed to
obtain reproducible results. However in our hands Djerassi's
method has also given only partial regeneration of unsaturated
ketone. Our yield corresponds with that reported by
Danielsson (1961).
Further, this method of introducing a double bond through
d-bromoketone and subsequent dehydrobromination can be applied
only in those steroids where no 7<*-hydroxy function is present.
The presence of 4,5-double bond activates the Cg-hydrogen
atoms and the elimination of water from the 6/J-hydrogen (axial)
and 7oC-hydroxyl (axial) group gives a dienone under the
influence of acid or alkali. The 7<<-hydroxy group of cholest-
4-en-3—one-7oC-cl and cnolest—4-en—3—one-7<*,l&<-diol becomes so
acid and alkali labile that even am acetoxy group is
eliminated when boiled with pyridine or p-toluene sulphonic
acid in a neutral solvent.
A search in the literature revealed that 2,3-dichloro—
5,6 dicyano-benzoquinone (DD£)) mediated dehydrogenation can
be used for the introduction of a single double bond in a
saturated 3—ketone, and the structure of the starting material
determines which hydrogen atoms are removed.
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kingold and Turner (1962) reported that the DDQ dehydrogenation
of 5°(-androBtane-l 7/?-ol-3—one and 5^-androstane-l 7/3—ol-3—one in
boiling xylene follows the known direction of enolization
leading to l-ene-3-one and 4—ene-3-one respectively, as the
major product, but the reaction time was not given* An
exploratory experiment was conducted refluxing 100 mg of
coprostan-3—one-12<-ol, lxl equivalent of DD£ in 10 ml of
dio.iune and the reaction followed on TLC using a solvent
system that separated the starting material, cholest-4—en*-
3-one—12<<-ol and cholest-1,4-diene—3—one-12«<-ol from each
other* After every hour the reaction mixture was run on TLC
and the amounts of the products compared* During the first
four hours the amount of cholest-4—en—3—one—12*—ol increased,
and then the quantity decreased as cholest-1,4-diene—3-one—12<x-
ol formed later, and in eight hours the reaction mixture
seemed to have acquired equilibrium. Although the reaction
was carried out for fifteen hours no change in the ratio of
the products was noted. No doubt cholest-4—en-3-one—12°c-ol
was the major product, but still a large amount of starting
material was present; it was therefore concluded that this
method may be of theoretical interest, but it cannot be used
for this particular preparative purpose, (dee Walker and
Hiebert 1967 for a review on DDQ).
Selenium dioxide has also been used for dehydrogenation
purpose. Dy analogy with broiuination of a 3—ketone (5/J-)
series, this reagent would be expected to attack first the
139.
4y6-poaition. This compound when used at reflux temperature
with acetic acid or t-butanol with or without acetic acid is
excellent for converting 4—ene-3—ones or 3-ketones to
1,4—diene—3—ones• When used in 96% ethanol at a temperature
below its boiling pointy SeO^ has given yields of 4-ene-3-one
compounds from saturated 3-ketones of the 5/3-seriesy and
further dehydrogenation at the lyk-position was very much
arrested. At reflux temperature the yield of the 4—ene-3-one
derivative was considerably reduced because at higher
temperatures or in the presence of acetic acidy formation of
1y4-diene-3-ones from 4-ene—3—ones was facilitated. There
seemed to be a difference in the rate of dehydrogenation of 5/3-
cholestan-3-one-7<>c-ol y 5/?-cholestan-3-one-7<*,12«c-diol and 5/3—
choleatan-3-one-12<*-ol with 3e0gf which suggested that a
7°C-hydroxyl group had a promoting effect on the 4t5-dehydrogenationy
contrary to the expectation that its presence might hinder the
ex -approach of the reagent.
When several reagents perform similar functions the choice
falls to that reagent which gives not only a better yield but
also can be used on a variety of compounds. In this work the
best results were obtained by converting the 3-ketones of the
5/3-series to 4—ene-3-one derivatives , even vhen the 7<x.-hydroxy
function was present in the molecule, by the use of SeOg
dehydrogenation in ethanol.
12«-hydroxycholesterol was prepared through the enol
acetate of cholest—4—en-3-one—12<x—ol which on reduction with
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NaBH^ in aqueous methanol according to the method of Balleau
and Gallagher (l95l) for the preparation of cholesterol from
cholest-4-en-3-one, furnished 12«-hydroxycholesterol in good
yield. Preliminary experiments with cholest-4-en-3-one
shoved that the proportion of cholesterol formed was favoured
,a
by lower/temperature but no improvement in the yield of
cholesterol was found when "inverse addition" technique was
used contrary to the finding of Daubcn and Eastham (l95l).
Since small amounts of 4-ene-3<<- and 3^-alcohols were also
expected to be formed) the reduction mixture wtis refluxed with
,the
acidified methanol) and/allylic alcohols were dehydrated to
3.5-dienes through the intermediate formation of 2,4-dienes.
The 3/J-and 3<<-hydroxyl groups with a 5,6-double bond were
unaffected) and the li*<-hydroxyl was not dehydrated. The
3^-confarmation of/hydroxy group was confirmed by its
formation of an insoluble digitonide complex, and the
5-ene-3/3-ol grouping ascertained by its colour response with
50$ H^SO^ (v/v). The presence of a 5,6-double bond is also
indicated from the consideration of molecular rotation
relationship. A comparison of specific rotations of
cholest-5-en-3«<-ol (<<3-45) and 5/5-cholestane-3o(—ol f<D+30)
shows a negative rotational contribution (-75°) for the
5.6-double bond* A contribution of -69.3° is observed when
the rotations of 5/J-cholestane—3«,12o<-diol («D+41.3°) and
cholest-5-en-3/5,lB<<-diol (*3-28°) are compared.
As a rule,hydride reduction of a non-hindered ketone
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gives predominantly the equatorial isomer, and the hindered
ketones give axial alcohols. The proportion of 3j3-isomer
formed suggests that the reduction of the enol acetate after
hydrolysis has taken place through the formation of a ketone
before the isolated double bond moved to the stable
allylic position.
This method of converting 4-ene-3-ones to 5-ene-3/i-ols
could not be applied for the preparation of cholest-5-en-3/4,
7oc,12<x-triol because in the preparation of /enol acetate of the
,this
4-ene-3-one moiety/involved acid catalysed conditions to which
the 7oC-hydroxy function in the starting material was labile.
Although very mild conditions for the enolization were used
(Djerassi et. al 1952) cholest-4,6-diene-12°(-ol-3-one was
rapidly formed ("Xmax 282).
Cholest-4-en-3-one-7oC-ol was prepared according to the
sequence given in figure 19.
Nickon and Bagli (1961) prepared the dienone III directly
from cholesterol using the Wettstein modification of the
Oppenaur oxidation, which proceeds via a cyclic intermediate
involving the 7<*"-hydrogen, and they reported yields ujj to 62$,
/a
The dienone III was obtained in/two step synthesis.
Cholesterol was converted to cholest-4—en-3-one using the
original Oppenauer oxiuution, The conversion of cholest-
4-en-3—one to dienone by a chloranil-mediated dehydrogenation
was based on the work of Agnello and Laubach (i960) for the
dehydrogenation of corticosterone with chloranil. In 1957
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these workers reported that the steroidal 4-ene-3-ones were
converted to the corresponding 4,6-diene-3-one by the action
of chloranil in solvents such as boiling t-butanol, or xylene
and suggested that the reaction involved slow enolization to
a 3,5-diene-3-ol followed by a quinone abstraction of a
hydride ion from We conducted this reaction in t-butanol
and found it to be complete in three hours, without using any
catalyst such as p-toluene sulphonic acid for promoting
enolization. The work up procedure was modified and 85-70%
of crystalline dienone was obtained, and the compound
characterized by its absorption maximum at 282 nn/x. etc.
Compound IV was prepared by the method of Nickon and
Bagli (1961). The olefine-peracid reaction has been used
for epoxidation in steroids. The electrophilic character of
the reagent attacking the double bond may be inferred from the
fact that electron attracting substituents such as carbonyl,
carboxyl etc. near the unsaturated bond reduced the reaction
velocity in accordance with their inductive properties whereas
the electron releasing substituents e.g. alkyl groups
accelerate the rate of epoxidation (Swern 1949).
The bulky angular uethyl groups on the front (ft) aide of
the molecule cause most reagents to approach from the rear (°0
side of the molecule (Fieser 1950). In this connection
peracid reactions are particularly stereospecific and
of-epoxides are usually obtained from olefines if (a) the ring
system is relatively flat with 5*, 8/5,9*, 10/5,14°c, configuration,
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(A/ii tru.us) and (b) additional bulky groups of -configuration
are not too close to the double bond. However an exception
to this postulation is the behaviour of the ^—unsaturated
alcohols which seem to exert a promoting effect in the
formation of epoxides together with a directive influence to
give cis-epoxy-alcohols. This behaviour of the 7^-hydroxyl
is of interest because the shielding effect of the angular
methyl groups on the /S-face is pronounced. Nevertheless
the predominant formation of a fi—epoxide from cholest—5-en—3/S-
benzoyloxy—7/3—ol shows that the frontal approach of the reagent
is facilitated by the hydroxyl group and is more favoured than
the approach from the less hindered rear side of the molecule.
This behaviour can be explained by assuming that hydrogen
bonding causes an association of the reactant favourable for
interaction between the electrophilic peracid oxygen and the
double bond. We believe that the formation of the 5/3,6/3-epoxide
when cholesterol is epoxidized with peracids is the result of
such an interaction, although the effect of the 3/5-hydroxyl
will be less pronounced because of its homoallylic nature
with respect to the double bond at the 5»6-position.
The attack of monoperphthalic acid on the dienone was
stereoapecifically on the 6,7-double bond from the <*-side of
the molecule| and exclusively the 0<*}7<*-epoxide was formed} as
shown by its reduction product which was exclusively the 7<*—
hydroxy isomer. In the reduction of a steroidal epoxide by
means of LiAlH^ we propose that the C—0 bond was cleaved which was
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maximally displaced from its normal position and therefore
under greater strain. llence the hydroxyl group formed would
retain its normal configuration whereas the newly introduced
hydrogen at Cg would acquire the inverted fi-conformation of
the reduced ring 6.
ile—oxidation of the isomeric allylic alcohols (V) was
performed by MnO^ prepared according to Mancera et.al (1953)
but complete conversion to an <*, unsaturated ketone was never
achieved. Probably the <K-isomer (axial) formed in the
reduction was little oxidized whereas the ^-isomer (equatorial)
was oxidized in good yield.
Similar observation has been reported by Nlekon and Bagli
(1961) for different rates of oxidation of &-ene-7c<-ol and
5-ene-7/5-ol. The quasi-equatorial 7/?-isomer was oxidized
ten times faster than the quasi-axial 7oC-hydroxy compound.
3/3-hydroxycholestenoic acid was prepared by a modification
of the method of Dean and Whitehouse (1966) as given in fig. 16.
26-ketonorcholesterol acetate was reduced with NaBH^
which does not reduce the acetate grouping ( LiAlH^). The
26—hydroxynorcholesterol acetate thus obtained was oonverted
into 26-chloro-norcholesterol acetate using freshly distilled
(1966)
thionyl chloride. Dean and Whitehouse used the bromocompound
which they prepared from thionyl bromide prepared in turn
from thionyl chloride. The chloro-compound was efficiently
converted to the 26-cyanonorcholesterol acetate using KCN in
DMS. This reaction was almost quantitative but was
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accompanied by some hydrolysis of the 3^-acetate group* The
cyano—coapound was not purified but was hydrolysed by means
of KOH in aqueous dioxane (10$), because when the hydrolysis
(1966)
was performed in alcoholic KOH according to Dean and Whitehouse,
even after twenty-four hours refluxing, most of the 26-cyano-
compound was recovered from the alkaline hydrolysate. The
hydrolysis was complete in aqueous dioxane at reflux
temperature in six to seven hours. The position of the
26-carboxylic group was ascertained by its reduction to
' *
26-hydroxycholeaterol with excess of LiAlH^ in THF, followed by
comparison of the 26-hydroxycholesterol with an authentic
sample. -a
St.
The unknown compound isolated from the chromatography of
26-ketonorcholesterol acetate was identified as 3/S-acetoxy-20~
hydroxychol-5-enic acid lactone on the following basis. The
I.H. spectrum showed acetate (3/i) peak at 1738omanother peak
at 1763<vmcharucteristic of a 5-membered lactone. The melting
point and optical rotation were almost identical to the known
compound reported in the literature.
Chromatography of cholest-5-en-3/3,7«>c-diol and cholest-5-
en-3|J,7/i-diol and their diacetates both on TLC on silica gel
and neutral alumina column chromatography with or without
water presented interesting problems. The relative
mobilities of cholest-5-en-3/5,7«<-diol and cholest-5-en-3/?,7/i-
diol on partition chromatographic systems seem to conform to
the generalization that the axial epimer is more mobile
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(Savard 1954) than its equatorial epimer. Thus Schubert,
Hose and Burger (1961) using paper partition chromatographic
system and Uosbach, Nierenberg and Kendall (1953) using
partition column chromatography found that the 7«tf-epimer was
more mobile (polar) than the 7/5-epiner.
Using adsorption chromatographic procedures, the reverse
order of mobility was observed for the 7-epimeric hydroxy
clioicsterols, both on TLC (Claude and Beaumont 1966} Smith,
liathews, Bachmann and Reynolds 1966; Uutton and Boyd 1966) and
column separations (Ruzicka, Prelog and Tagmann 1944).
Cholest-5-en-3^,7/}-diol was more mobile on TLC silicic
acid than the 7oC-isomer, but cholest-5-en-3,3-7/J-diacetate and
cholest-5-en-3/&,7<<-diacetate did not separate from each other
in mixtures of benzene, and ethyl acetate or petroleum ether,
diethyl ether and benzene. Further, on column chromatography
using neutral alumina, little separation of cholest-5-en-ty3,7^-
diol and cholest-5-en-3/3,7°c-diol was observed using increasing
amounts of acetone in petroleum ether. The addition of water
to the adsorbent achieved the separation of the two 7—isomers.
The 7/5-isomer was more mobile than the 7<*-isomer similar to
their behaviour on silicic acid TLC. A mixture of cholest-
5-en-3/3,7/5-diacetate and cholest-5-en-3/i,7«<-diacetate was
resolved on neutral alumina with or without water, using
mixtures of benzene and ethyl acetate for elution.
Unexpectedly cholest-5-en-3/S, 7<*-diacetate was found to be more
mobile than cholest-5-en-3/3,7y8-diacetate.
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Wintersteiner and lluigh (1942) prepared cholest-5-en-
3/J, 7«-diol and cholest-5-en-3/3,7/1-diol from the Meerwein
i'onndorf reduction of cholest-5-en-3p-ucetoxy-7-one. Fieser,
Fieser and Chakravarti (1949) obtained the 7-isomeric diols
on reduction of cholest-5-en-3^-acetoxy-7-one with LiAlH^,
benzoylation, and separation of 7/5- and 7°C-isomers by
chromatography on alumina using petroleum ether and benzene
mixtures, as described by Buser (1947).
In this work separation of cholest-5-en-3/3,7*-diol and
cholest-5-en-3/J,7/i-diol from a mixture was achieved after
acetylation and chromatography on neutral alumina using
petroleum ether-acetone mixtures, as well as chromatography
of the free diols on 1^> deactivated neutral alumina.
Cholest-5-en-3/l-acetoxy-22—one was prepared as described
by Fieser and Huang (1953). deduction with NaBH^ furnished
cholest-5-en-3)S—acetoxy-22£-ol.
On hydrolysis this compound gave cholest-5-en-3^,22£-diol,
and treatment with phosphorous oxychloride gave the novel
cholest—5,20(22)-diene-3/5-ol, which on controlled epoxidation
may give another novel cholest-5-en—3/3-ol-20T22-epoxide of
interest in cholesterol side chain cleavage reactions.
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APPENDIX I
COLUkN AND TLC METHODS USED
Silicic acid is an excellent material for lipid
separations including sterols. However the control of
variables such as activation of silicic acid batches, water
content, loading factor, particle size etc. for reproducibility
of resolution prove difficult. For these reasons silicic acid
was only used in cases where better separation on alumina could
not be achieved. Similarly active alumina (basic) was seldom
employed because this adsorbent is known to induce various
reactions in steroids. For example when steroids with a
4-ene-3-one-7<=(-ol grouping were subjected to column
chromatography on active alumina (basic) or neutral alumina
in both cases dehydration of the 7oc-hydroxyl group was
encountered, giving rise to a dienone grouping. However tlw*e.
steroids were successfully chromatographed on deactivated
neutral alumina. When acetates were chromatographed on
active or neutral alumina, substantial hydrolysis was observed
during the chromatography. This problem could be overcome
by the addition of water to the neutral alumina.
Neutral alumina was prepared from active alumina (type 0
of Peter Spence) by the addition of dilute hydrochloric acid
to a slurry of active alumina in methanol until the pH was
slightly acidic. The slurry was stirred well and the excess
acid neutralized by the addition of a further amount of active
alumina. This treatment saved prolonged washing with water,
149.
the methanol was decanted off, the alumina washed thrice with
water, dried at 110 C for 12 hours and stored in an air tight
container*
Deactivated grades of neutral alumina were prepared from
neutral alumina on adding fixed amounts of water (l-10^ v/w)
and mixing thoroughly.
Silicic acid for column chromatography was prepared
according to Ahrens and tiirach (1958)* Silicic acid was
washed twice with methanol and after standing for half an
hour the methanol was decanted off and it was washed twice




TLC has furnished a new approach for rapid and
excellent resolution of closely related steroids in small
amounts. The importance of this method is enhanced, since
chromatography can be used for both qualitative and
quantitative purposes. In addition to this it can also be
utilized for preparative work where purification could not
be achieved by ordinary column chromatography and other
techniques of purification. New advances in this field
have utilised the incorporation of AgNO^ Barrett, Dallas
and F.is. jfadley (1962) or ammonical silver nitrate, Wood
and Snyder (1966) into the silica gel or alumina TLC plates
Kammereck, Lee, Paliokas and Schroepfer (1967) for the
separation of steroids differing in the number of double bonds
per molecule. The undecan-impregnated silica gel TLC system
can be used for ordinary partition chromatography or reversed
phase partition chromatography for the separation of sterols
which differ only by an alkyl group or by the position of the
double bond (Heftmann 1965).
TLC with the use of nondestructive reagents for the
location of steroids is even more useful. Iodine either in
vapour form or in solution is a useful nondestructive reagent
which gives yellow stains. However no rigorous tests were
done to this end. Even spraying the plate with water and
viewing the chromatoplate against a dark background makes
some spots visible. Ultra-violet absorbing steroids are
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readily detected nondestructively as dark spots against
fluorescent background by the inclusion of aninorganic
phosphor such as zinc silicate or sulphide into the silicic
acid. If the chromatogram is viewed under ultra-violet
light and if the compound does not absorb ultra-violet
radiation then the extinction is low and the difference in
intensity between the zone and the background nay be too
small to be detected. However, if the compound adsorbed has
an absorption maximum in the ultra-violet region then it will
appear as a black spot on a fluorescent background. By
using a series of interference filters in the range of the
entire ultra-violet spectrum with a hydrogen lamp, this
method will not only show the position of the substance on
the plate, but, by determining the wave length of maximum
extinction, would indicate the ultra-violet absorbing
properties and thus information on its possible molecular
structure can be obtained (Boyd and Button 1963).
TLC is used in kinetic or reaction rate determinations
in synthetic organic chemistry and in the steroidal field.
By using labelled materials coupled with radioautography or
scintillation counting this method has proved very useful,
decent advances in kinetic studies of biological reactions
are also based on "tracer" techniques coupled with TLC. The
use of labelled substrates in synthetic organic work will
have the added advantage over the use of "cold" materials
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because the origin of the bye-product can be determined.
It is possible to manipulate the side product and at the
same time some idea about the nature of the intermediates
involved in a reaction can be obtained if serial sampling
and analysis is available. In steroidal reactions where
the starting material or the products do not give a colour
reaction, the isotopic labelling of the substrate can
be used for identification and quantitation. Also because
of its high sensitivity and accuracy information can be
obtained on small amounts, where it may be almost impossible
to detect a compound by a colour reaction.
Since the purpose of this work was mainly to synthesise
possible intermediates in the degradation of cholesterol to
bile acids, no effort was made to quantitate this method
accurately either by colorimetry, dilution to minimum
detectable amount or using labelled starting materials, in
order to study the kinetics of the reaction. Visual
comparisons were sufficient in order to evaluate the
practicability of certain reactions. In this work TLC was
used as a tool for the following purposes.
(a) To follow up the time-course of the reaction.
By running TLC plates of small aliquots of reaction
mixtures at suitable intervals in various solvent systems
the progress of the reaction can be followed. It can be
noted whether the reaction was complete or had attained
chemical equilibrium.
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(b) To determine the purity of the product.
TLC was used as a tool for criteria of purity.
Compounds prepared by the known methods although hawing the
same physical and chemical constants as reported in the
literature were/found to be heterogeneous on TLC. Only those
compounds were regarded as pure which were homogeneous on TLC.
(c) To monitor the efficiency of chromatographic columns in
determining the best solwent mixtures on pilo1| experiments
for optimum resolution as well as to check different
fractions for the desired product.
The conventional method for judging the performance of
a chromatographic column was based on evaporation* of each
fraction for obtaining solid residue and analysing the
individual residues for the desired product by crystallization
etc. By using TLC a quick appraisal of the nature of the
product in different fractions can be obtained, and therefore
the desired product can be easily located and fractions which
contain this product may be pooled.
(d) To evaluate the practicability of a chemical reaction
on a small scale.
Such reactions were done on the milligram scale and the
course of the reaction followed on TLC. With the help of
this method it was possible to determine the extent of the
desired product formed without using the cumbersome method
of isolation of the pure product by crystallization.
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(e) It was also used as a guide for the purification
technique to be adopted. For example if the impurities on
TLC were less mobile (colloquially — less polar) than the
desired product and were well separated on TLC, purification
was achieved by simple crystallization with a less polar
solvent. When impurities were not very well separated from
the desired product, column chromatography was used. It
was not possible to transfer information obtained on TLC
directly on to the column chromatography, particularly vhen
separation of the isomeric products (*- and fi -hydroxy Isomers)
was desired. It was often observed that although such
isomers were separated on TLC, they could not be separated
on column chromatography. On the other hand sometimes the
acetates of such isomers could not be separated on TLC but
were successfully separated on alumina column chromatography.
Loev and Snader (1965) have described a method called "Dry-
Column" chromatography, which gives the same resolution of
components as is obtained on TLC. The method recommends
the use of silicic acid to give an activity comparable
to silica gel TLC plates and to be packed in the column dry.
The material is loaded by conventional methods and the column
is developed by using the same solvent system which has been
tried on TLC. The solvent mixture is allowed to move down
the column by capillary action, not by liquid thrust, by
controlling the solvent head to a maximum of 2 cms. and the
ratio of sample to the adsorbent at 1:500. By the use of
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certain specific colour reactions in conjunction with
fluorescent TLC information is obtained about the structure
of possible side products as well as the desired product.
Colour reaction with co-chromatography or relative mobility
versus reference steroids can be used very successfully in
the identification and characterization of a product.
The "stationary phase" or adsorbent for TLC was prepared
by spreading over a glass plate a slurry of 0% zinc silicate
in kiesel gel G or H in water to give a uniform thickness
(0.5 mm.). The plate, covered completely with the layer
of silicic acid was left at room temperature for a few
minutes until air-dried, and then activated at 110° for
30 minutes before use.
The substance in solution was applied to the plate and
allowed to dry. The plate was then developed for 30-40
minutes in a suitable solvent system in a tank lined with
paper for vapour saturation purposes. The plate was removed
from the tank and after drying in the air, viewed in front of
an ultra-violet lamp with the glass-side towards the observer
and marked for any ultra-violet absorbing material if present.
Finally the plate was sprayed with 10% phosphomolybdic acid
or phosphotungstic acid in ethonol or 50% aqueous (V/V)
sulphuric acid, heated at 110° for 10 minutes, and the colour
of the spots noted. Sulphuric acid and phosphotungstic acid
gave different colours with different steroids. Both these
7<* Or
reagents gave intense blue colours witb^p-ol-S-ene and
156.
6-«ne-5ct-ol». A sulphuric acid spray gars red, magenta
and violet colours with 5-ene-3/J-ols, and shades of yellov
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The following systematic names are given to the
compounds referred to by trivial names.
Cholesterol
7«-hydroxycho1estero1
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